var title_f4_30_4576="Linear EUS normal anatomy";
var content_f4_30_4576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F77966&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F77966&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Linear EUS normal anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal anatomy of target region as demonstrated by linear endosonography.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyrighted and used with permission of Mayo Foundation for Medical Education and Research.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4576=[""].join("\n");
var outline_f4_30_4576=null;
var title_f4_30_4577="Scedosporium apiospermum microscopy";
var content_f4_30_4577=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scedosporium apiospermum microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microscopic appearance of S. apiospermum illustrating cylindrical uninucleate conidiogenous cell (arrow) with conidium attached.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Barbara D. Alexander, MD, MHS and Sylvia F. Costa, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4577=[""].join("\n");
var outline_f4_30_4577=null;
var title_f4_30_4578="Gram stain sputum 1";
var content_f4_30_4578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain sputum 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 237px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4578=[""].join("\n");
var outline_f4_30_4578=null;
var title_f4_30_4579="Lidocaine (ophthalmic): Drug information";
var content_f4_30_4579=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lidocaine (ophthalmic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?12/39/12915?source=see_link\">",
"    see \"Lidocaine (ophthalmic): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/59/30642?source=see_link\">",
"    see \"Lidocaine (ophthalmic): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8768586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Akten&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F8768605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Local Anesthetic;",
"     </li>",
"     <li>",
"      Local Anesthetic, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F8768810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Anesthesia, ocular:",
"     </b>",
"     Apply 2 drops to ocular surface in area where procedure will occur; may reapply to maintain effect.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F8768808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/59/30642?source=see_link\">",
"      see \"Lidocaine (ophthalmic): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Anesthesia, ocular:",
"     </b>",
"     Refer to adult dosing",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F8768811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8768880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, ophthalmic, as hydrochloride [drops, preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Akten&reg;: 3.5% (1 mL, 5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8768591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F8768648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     To provide local anesthesia to ocular surface during ophthalmologic procedures",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F8768670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Burning",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Conjunctival hyperemia, corneal epithelial changes, diplopia, visual changes",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F8768656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None specified in labeling",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F8768657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Corneal ulceration: Prolonged use may cause permanent corneal ulceration and/or opacification with loss of vision.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For ophthalmic use only; not for injection.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8768698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8768651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8768652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies with systemic lidocaine have not shown teratogenic effects. Lidocaine and the MEGX metabolite cross the placenta. Cumulative exposure from all routes of administration should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F8768654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F8768655\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Although systemic exposure is not expected following application of the ophthalmic gel, cumulative exposure from all routes of administration should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Akten Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.5% (1 mL): $26.56",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F8768756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local anesthetics block both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F8768759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 20 seconds to 5 minutes (median: 40 seconds)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 5-30 minutes (median: 15 minutes)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?4/30/4579/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10224 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-812927D4EA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4579=[""].join("\n");
var outline_f4_30_4579=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768586\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768605\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768810\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768808\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768811\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768880\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768591\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768648\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768670\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768656\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768657\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299602\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768698\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768651\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768652\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768654\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768655\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322278\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768756\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768759\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10224\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10224|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/39/12915?source=related_link\">",
"      Lidocaine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/59/30642?source=related_link\">",
"      Lidocaine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/54/14184?source=related_link\">",
"      Lidocaine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/58/36772?source=related_link\">",
"      Lidocaine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/11/20663?source=related_link\">",
"      Lidocaine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=related_link\">",
"      Lidocaine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?28/46/29413?source=related_link\">",
"      Lidocaine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/50/33574?source=related_link\">",
"      Lidocaine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_30_4580="Flunisolide (nasal): Patient drug information";
var content_f4_30_4580=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Flunisolide (nasal): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/62/30691?source=see_link\">",
"     see \"Flunisolide (nasal): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/24/22915?source=see_link\">",
"     see \"Flunisolide (nasal): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8097134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Flunisolide&reg;;",
"     </li>",
"     <li>",
"      Nasalide&reg;;",
"     </li>",
"     <li>",
"      Rhinalar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness. It may take 2 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702136",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to flunisolide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid being near anyone with chickenpox or measles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sinus irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698280",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nosebleed.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699040",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad nose irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694774",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use in your nose only. Keep out of your mouth and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694567",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blow your nose before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694631",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Close 1 nostril.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694584",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your spray use with your doctor at each visit. Read and follow the facts on how to use the spray. Make sure you use the spray the right way.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11680 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-6BC967DE50-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4580=[""].join("\n");
var outline_f4_30_4580=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8097134\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031171\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031170\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031175\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031176\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031178\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031173\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031174\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031179\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031180\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/62/30691?source=related_link\">",
"      Flunisolide (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/24/22915?source=related_link\">",
"      Flunisolide (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/34/9766?source=related_link\">",
"      Flunisolide (oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?33/49/34581?source=related_link\">",
"      Flunisolide (oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_30_4581="Tinidazole: Patient drug information";
var content_f4_30_4581=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tinidazole: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/14/5349?source=see_link\">",
"     see \"Tinidazole: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F228029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tindamax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       An alike drug has been shown to cause cancer in mice and rats. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691909",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703036",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tinidazole, metronidazole, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are less than 12 weeks pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697170",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any diseases of the brain, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697172",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any nerve problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696624",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks. Do not take alcohol for at least 72 hours after the last dose. Drinking alcohol or products that have alcohol, such as cough syrup, may cause cramps, upset stomach, headaches, and flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697037",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are being treated for a disease caused by having sex, your partner may need to be treated too. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696734",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not breast-feed for at least 3 days after you have stopped this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696486",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For some infections, you will get a single dose.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699467",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) at room temperature. Throw away any part not used after 7 days.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11539 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-B28792CD2A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4581=[""].join("\n");
var outline_f4_30_4581=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228029\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017540\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017542\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017541\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017546\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017547\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017549\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017544\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017545\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017550\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017551\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/14/5349?source=related_link\">",
"      Tinidazole: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_30_4582="Plesiomonas shigelloides infections";
var content_f4_30_4582=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Plesiomonas shigelloides infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4582/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4582/contributors\">",
"     J Glenn Morris, Jr, MD, MPH&amp;TM",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4582/contributors\">",
"     Amy Horneman, PhD, MS, SM (ASCP)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4582/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4582/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4582/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4582/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/30/4582/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plesiomonas shigelloides (formerly known Aeromonas shigelloides) is an oxidase-positive, facultatively anaerobic gram-negative bacillus found in soil and water. It has emerged as a cause of enteric disease in humans, especially following the consumption of raw seafood. It has also been isolated from a number of extraintestinal sites [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The species name \"shigelloides\" is derived from the fact that many strains crossreact antigenically with Shigella, particularly Shigella sonnei [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2968528\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecular phylogenetic studies have shown that the ancestry of Plesiomonas is most closely aligned with the family Enterobacteriaceae [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/5\">",
"     5",
"    </a>",
"    ]. Therefore, Plesiomonas has been re-categorized from the family Vibrionaceae to the family Enterobacteriaceae, in which it is the only oxidase-positive member [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    P. shigelloides grows readily on selective and nonselective media. The organism is a nonlactose fermenter and therefore should be identified readily with routine stool culture on MacConkey agar. Colonies are oxidase positive, which provides a rapid differentiation from Shigella (with which Plesiomonas may crossreact on serologic testing). Some strains can be isolated from cefsulodin-irgasan-novobiocin (CIN) medium, normally used to isolate Yersinia and Aeromonas species. On CIN agar, plesiomonads are opaque without a pink center; subculture on sheep blood agar is needed for oxidase testing [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/3\">",
"     3",
"    </a>",
"    ]. Once appropriate colonies are picked, the organism is readily identified in standard conventional and rapid identification systems.",
"   </p>",
"   <p>",
"    Outbreaks of diarrheal disease have been associated with contaminated water and oysters containing P. shigelloides, and reduction in the severity and duration of symptoms following appropriate antimicrobial therapy has been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. However, efforts to confirm virulence in experimental settings (including one human volunteer study) have been inconclusive [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/1,2,9,10\">",
"     1,2,9,10",
"    </a>",
"    ]. In a case-control study in Ecuador, detection of P. shigelloides alone was similar between patients with diarrhea and controls, although co-infection with P. shigelloides and another gastrointestinal pathogen was associated with diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/11\">",
"     11",
"    </a>",
"    ]. It is likely that certain strains of P. shigelloides are capable of causing diarrhea, and that host susceptibility influences the risk of illness. Some virulence factors have been identified, although their role in causing disease remains uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/12-16\">",
"     12-16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;P. shigelloides is primarily a freshwater aquatic organism, with increased rates of isolation in the warmer months of the year [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/17\">",
"     17",
"    </a>",
"    ]. The organism requires a minimum temperature of 8&ordm;C and the absence of salt for growth, which limits its aquatic habitats [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus, P. shigelloides is generally found in fresh or estuarine (brackish) waters rather than marine environments. It is most frequently observed in tropical or subtropical areas, although it has been isolated from surface waters in Europe as far north as Sweden [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of P. shigelloides infection can be reduced by avoiding contact with untreated water supplies and consumption of raw or undercooked shellfish (particularly during warmer summer months). Individuals who are immunocompromised or have hepatobiliary disease are at increased risk of infection associated with water-related injuries.",
"   </p>",
"   <p>",
"    Like Aeromonas, P. shigelloides is widely distributed among warm and coldblooded animals, including cats, dogs, pigs, poultry, cattle, vultures, toads, snakes, lizards, freshwater and tropical fish, newts, and shellfish, including shrimp and oysters [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/1,21-24\">",
"     1,21-24",
"    </a>",
"    ]. P. shigelloides has also been identified in gull feces in southwestern Lake Michigan bathing beaches [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There have been several well documented outbreaks of diarrheal disease associated with P. shigelloides in Japan, China, and Cameroon [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/7,8,26-28\">",
"     7,8,26-28",
"    </a>",
"    ]. In a study including 2500 cases of neonatal diarrhea in Bangladesh, 1.6 percent of cases were associated with infection with P. shigelloides [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/29\">",
"     29",
"    </a>",
"    ]. Risk factors for P. shigelloides gastroenteritis include travel to the tropical regions, consumption of raw or undercooked shellfish or contaminated water, and exposure to reptiles and tropical fish [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/6,30\">",
"     6,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional pathogens have been isolated in patients with P. shigelloides and diarrhea. In a series including 69 pediatric cases of P. shigelloides diagnosed within one year in Taiwan, mixed enteric organisms were recovered in one-third of cases; Salmonella spp (especially group B) was the most common additional isolate [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/31\">",
"     31",
"    </a>",
"    ]. Of 111 cases, 35 percent occurred in children under the age of 2 years (age range 22 days to 72 years).",
"   </p>",
"   <p>",
"    P. shigelloides infection in HIV-infected patients has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. P. shigelloides has also been isolated from patients with inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period for illness ranges from 24 to 48 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/2\">",
"     2",
"    </a>",
"    ]. Patients with diarrhea due to P. shigelloides most frequently develop watery or secretory diarrhea, but some have an invasive, dysenteric illness [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/1,2,21,23\">",
"     1,2,21,23",
"    </a>",
"    ]. Severe abdominal pain and cramping are common in adults. In a study of Bangladeshi children, presenting symptoms included watery diarrhea (84 percent), dysentery (16 percent), vomiting (71 percent), and fever (8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/36\">",
"     36",
"    </a>",
"    ]. Diarrhea lasted 14 days or longer in 13 percent of cases. Symptoms are typically self-limited; in some patients, a subacute to chronic presentation lasting between two weeks and three months occurs.",
"   </p>",
"   <p>",
"    Case reports of extraintestinal infections with P. shigelloides include cellulitis, bacteremia (which may be preceded by enteric symptoms), peritonitis, meningoencephalitis (usually in neonates, with an associated case fatality rate of 80 percent), eye infections, pneumonia and cutaneous abscess following trauma in fresh water [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/18,37-44\">",
"     18,37-44",
"    </a>",
"    ]. Extraintestinal infections have frequently involved immunocompromised hosts, including neonates and patients with underlying hepatobiliary disease or hemochromatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/37-39,45-48\">",
"     37-39,45-48",
"    </a>",
"    ]. Bacteremia in a liver transplant donor who had succumbed to freshwater drowning and peritonitis in association with continuous ambulatory peritoneal dialysis have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, the gastroenteritis caused by P. shigelloides tends to be mild and self-limited. Antimicrobial therapy is reasonable in more severe cases, particularly among immunocompromised hosts, the elderly, or young children.",
"   </p>",
"   <p>",
"    Data on the efficacy of antibiotic therapy in diarrheal P. shigelloides-associated diarrhea are limited. One retrospective study suggested that treatment with an appropriate antimicrobial agent shortens the course of diarrhea compared with no treatment of infections or treatment with antibiotics to which the organism is not susceptible [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/51\">",
"     51",
"    </a>",
"    ]. In contrast, however, another retrospective series found no difference in the duration of fever or diarrhea among treated or untreated children with P. shigelloides [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most strains of P. shigelloides carry a variety of beta-lactamases and therefore are resistant in vitro to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , carbenicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"     piperacillin",
"    </a>",
"    , and ticarcillin [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/3,52-54\">",
"     3,52-54",
"    </a>",
"    ]. Most strains are also resistant to aminoglycosides and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    . Antimicrobial agents with activity against P. shigelloides strains include cephalosporins, fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. In a series of 197 isolates from Hong Kong, all were sensitive to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/60/35776?source=see_link\">",
"     ofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    , 95 percent were sensitive to chloramphenicol, and 88 percent were sensitive to TMP-SMX; many isolates were resistant or partially resistant to ampicillin and tetracycline (72 and 67 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4582/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on these data, for situations in which antibiotic therapy is clinically indicated, we favor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    for treatment of P. shigelloides. Reasonable alternatives include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , amoxicillin-clavulanic acid, or cephalosporins. Duration of therapy is dictated by clinical response. For most patients with diarrhea severe enough to require antimicrobial therapy, three to five days of therapy should be adequate. Patients with extraintestinal infections will require more prolonged antimicrobial therapy, in the range of one to two weeks or more, depending on underlying conditions and clinical response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2968408\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plesiomonas shigelloides is a facultatively anaerobic gram-negative bacillus found in soil and fresh water. It has emerged as a cause of enteric disease in humans, especially following the consumption of raw seafood. It is likely that certain strains of P. shigelloides are capable of causing diarrhea, and that host susceptibility influences the risk of illness. (See",
"      <a class=\"local\" href=\"#H2968528\">",
"       'Microbiology and pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of P. shigelloides infection can be reduced by avoiding contact with untreated water supplies and consumption of raw or undercooked shellfish (particularly during warmer summer months). Individuals who are immunocompromised or have hepatobiliary disease are at increased risk of infection associated with water-related injuries. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with diarrhea due to P. shigelloides most frequently develop watery or secretory diarrhea, but some have an invasive, dysenteric illness. Other symptoms include abdominal pain, cramping and vomiting; fever occurs occasionally. Extraintestinal manifestations have also been reported (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The gastroenteritis caused by P. shigelloides tends to be mild and self-limited. More severe cases benefit from antimicrobial therapy, particularly among immunocompromised hosts, the elderly, or young children. In such cases, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/1\">",
"      Brenden RA, Miller MA, Janda JM. Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans. Rev Infect Dis 1988; 10:303.",
"     </a>",
"    </li>",
"    <li>",
"     Janda JM, Abbott SL, Morris JG Jr. Aeromonas, Plesiomonas, and Edwardsiella. In: Infections of the Gastrointestinal Tract, Blaser, Smith, Ravdin, Greenberg, Guerrant (Eds), Raven Press, Ltd, New York 1995. p.905.",
"    </li>",
"    <li>",
"     Abbott SL. Klebsiella, Enterobacter, Citrobacter, Serratia, Plesiomonas, and Other Enterobacteriaceae. In: Manual of Clinical Microbiology, Ninth Ed, Murray PR, Baron EJ, Jorgensen JH, et al (Eds), ASM Press, Washington, DC 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/4\">",
"      Chida T, Okamura N, Ohtani K, et al. The complete DNA sequence of the O antigen gene region of Plesiomonas shigelloides serotype O17 which is identical to Shigella sonnei form I antigen. Microbiol Immunol 2000; 44:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/5\">",
"      MacDonell MT, Colwell RR. Phylogeny of the family Vibrionaceae and recommendation for two new genera: Listonella and Shewanella. Syst Appl Microbiol 1985; 6:171.",
"     </a>",
"    </li>",
"    <li>",
"     Janda JM. Plesiomonas. Bergey's Manual of Systematic Bacteriology. In: Aeromonadacea, Second Ed, Garrity GM (Ed), Springer-Verlag, New York 2005. p.740.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/7\">",
"      Tsukamoto T, Kinoshita Y, Shimada T, Sakazaki R. Two epidemics of diarrhoeal disease possibly caused by Plesiomonas shigelloides. J Hyg (Lond) 1978; 80:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/8\">",
"      Rutala WA, Sarubi FA Jr, Finch CS, et al. Oyster-associated outbreak of diarrhoeal disease possibly caused by Plesiomonas shigelloides. Lancet 1982; 1:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/9\">",
"      Herrington DA, Tzipori S, Robins-Browne RM, et al. In vitro and in vivo pathogenicity of Plesiomonas shigelloides. Infect Immun 1987; 55:979.",
"     </a>",
"    </li>",
"    <li>",
"     Farmer JJ III, Arduino MJ, Hickman-Brenner FW, et al. The Genera Aeromonas and Plesiomonas. In: The Prokaryotes, Second Ed, Balows A, Truper HG, Sworkin M, et al (Eds), Springer-Verlag, New York 1992. Vol III, p.3028.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/11\">",
"      Escobar JC, Bhavnani D, Trueba G, et al. Plesiomonas shigelloides infection, Ecuador, 2004-2008. Emerg Infect Dis 2012; 18:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/12\">",
"      Okawa Y, Ohtomo Y, Tsugawa H, et al. Isolation and characterization of a cytotoxin produced by Plesiomonas shigelloides P-1 strain. FEMS Microbiol Lett 2004; 239:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/13\">",
"      Cizn&aacute;r I, Hostacka A, Gonzalez-Rey C, Krovacek K. Potential virulence-associated properties of Plesiomonas shigelloides strains. Folia Microbiol (Praha) 2004; 49:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/14\">",
"      Tsugawa H, Ono T, Murakami H, Okawa Y. Invasive phenotype and apoptosis induction of Plesiomonas shigelloides P-1 strain to Caco-2 cells. J Appl Microbiol 2005; 99:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/15\">",
"      Tsugawa H, Ito H, Ohshima M, Okawa Y. Cell adherence-promoted activity of Plesiomonas shigelloides groEL. J Med Microbiol 2007; 56:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/16\">",
"      Gonz&aacute;lez-Rodr&iacute;guez N, Santos JA, Otero A, Garc&iacute;a-L&oacute;pez ML. Cell-associated hemolytic activity in environmental strains of Plesiomonas shigelloides expressing cell-free, iron-influenced extracellular hemolysin. J Food Prot 2007; 70:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/17\">",
"      Miller ML, Koburger JA. Plesiomonas shigelloides: an opportunistic food and waterborne pathogen. J Food Protect 1985; 48:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/18\">",
"      J&ouml;nsson I, Monsen T, Wistr&ouml;m J. A case of Plesiomonas shigelloides cellulitis and bacteraemia from northern Europe. Scand J Infect Dis 1997; 29:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/19\">",
"      Medema G, Schets C. Occurrence of Plesiomonas shigelloides in surface water: relationship with faecal pollution and trophic state. Zentralbl Hyg Umweltmed 1993; 194:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/20\">",
"      Islam MS, Alam MJ, Khan SI. Distribution of Plesiomonas shigelloides in various components of pond ecosystems in Dhaka, Bangladesh. Microbiol Immunol 1991; 35:927.",
"     </a>",
"    </li>",
"    <li>",
"     Janda JM, Abbott SL. The Genus Plesiomonas. In: The Enterobacteria, Second Ed, AMS Press, Washington, DC 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/22\">",
"      Arai T, Ikejima N, Itoh T, et al. A survey of Plesiomonas shigelloides from aquatic environments, domestic animals, pets and humans. J Hyg (Lond) 1980; 84:203.",
"     </a>",
"    </li>",
"    <li>",
"     Horneman A, Josko D. Vibrio, Aeromonas, Plesiomonas, and Campylobacter species. In: Textbook of Diagnostic Microbiology, Third Ed, Mahon, Lehman, Manuselis (Eds), WB Saunders Co, Philadelphia 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/24\">",
"      Davis WA 2nd, Chretien JH, Garagusi VF, Goldstein MA. Snake-to-human transmission of Aeromonas (Pl) shigelloides resulting in gastroenteritis. South Med J 1978; 71:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/25\">",
"      Kinzelman J, McLellan SL, Amick A, et al. Identification of human enteric pathogens in gull feces at Southwestern Lake Michigan bathing beaches. Can J Microbiol 2008; 54:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/26\">",
"      Hori M, Hayashi K, Maeshima K, et al. Food poisoning caused by Aeromonas shigelloides with an antigen common to Shigella dysenteriae. J Jpn Assoc Infect Dis 1966; 39:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/27\">",
"      Bai Y, Dai YC, Li JD, et al. Acute diarrhea during army field exercise in southern China. World J Gastroenterol 2004; 10:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/28\">",
"      Wouafo M, Pouillot R, Kwetche PF, et al. An acute foodborne outbreak due to Plesiomonas shigelloides in Yaounde, Cameroon. Foodborne Pathog Dis 2006; 3:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/29\">",
"      Khan AM, Hossain MS, Khan AI, et al. Bacterial enteropathogens of neonates admitted to an urban diarrhoeal hospital in Bangladesh. J Trop Pediatr 2009; 55:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/30\">",
"      Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009; 80:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/31\">",
"      Tseng HK, Liu CP, Li WC, et al. Characteristics of Plesiomonas shigelloides infection in Taiwan. J Microbiol Immunol Infect 2002; 35:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/32\">",
"      Ahmad M, Aggarwal M, Ahmed A. Bloody diarrhea caused by Plesiomonas shigelloides proctitis in a human immunodeficiency virus-infected patient. Clin Infect Dis 1998; 27:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/33\">",
"      Suthienkul O, Aiumlaor P, Siripanichgon K, et al. Bacterial causes of AIDS-associated diarrhea in Thailand. Southeast Asian J Trop Med Public Health 2001; 32:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/34\">",
"      Meyer AM, Ramzan NN, Loftus EV Jr, et al. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004; 38:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/35\">",
"      Mylonaki M, Langmead L, Pantes A, et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004; 16:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/36\">",
"      Khan AM, Faruque AS, Hossain MS, et al. Plesiomonas shigelloides-associated diarrhoea in Bangladeshi children: a hospital-based surveillance study. J Trop Pediatr 2004; 50:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/37\">",
"      Lee AC, Yuen KY, Ha SY, et al. Plesiomonas shigelloides septicemia: case report and literature review. Pediatr Hematol Oncol 1996; 13:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/38\">",
"      Woo PC, Lau SK, Yuen KY. Biliary tract disease as a risk factor for Plesiomonas shigelloides bacteraemia: a nine-year experience in a Hong Kong hospital and review of the literature. New Microbiol 2005; 28:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/39\">",
"      Terpeluk C, Goldmann A, Bartmann P, Pohlandt F. Plesiomonas shigelloides sepsis and meningoencephalitis in a neonate. Eur J Pediatr 1992; 151:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/40\">",
"      Alca&ntilde;iz JP, de Cuenca Mor&oacute;n B, G&oacute;mez Rubio M, et al. Spontaneous bacterial peritonitis due to Plesiomonas shigelloides. Am J Gastroenterol 1995; 90:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/41\">",
"      Marshman WE, Lyons CJ. Congenital endophthalmitis following maternal shellfish ingestion. Aust N Z J Ophthalmol 1998; 26:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/42\">",
"      Schneider F, Lang N, Reibke R, et al. Plesiomonas shigelloides pneumonia. Med Mal Infect 2009; 39:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/43\">",
"      Herve V, Bigaillon C, Duhamel P, et al. [Cutaneous abscess due to Plesiomonas shigello&iuml;des consecutive to a trauma in fresh water]. Med Mal Infect 2007; 37:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/44\">",
"      Klatte JM, Dastjerdi MH, Clark K, et al. Hyperacute infectious keratitis with Plesiomonas shigelloides following traumatic lamellar corneal laceration. Pediatr Infect Dis J 2012; 31:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/45\">",
"      Delforge ML, Devriendt J, Glupczynski Y, et al. Plesiomonas shigelloides septicemia in a patient with primary hemochromatosis. Clin Infect Dis 1995; 21:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/46\">",
"      Riley PA, Parasakthi N, Abdullah WA. Plesiomonas shigelloides bacteremia in a child with leukemia. Clin Infect Dis 1996; 23:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/47\">",
"      Ozdemir O, Sari S, Terzioglu S, Zenciroglu A. Plesiomonas shigelloides sepsis and meningoencephalitis in a surviving neonate. J Microbiol Immunol Infect 2010; 43:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/48\">",
"      Auxiliadora-Martins M, Bellissimo-Rodrigues F, Viana JM, et al. Septic shock caused by Plesiomonas shigelloides in a patient with sickle beta-zero thalassemia. Heart Lung 2010; 39:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/49\">",
"      Bonatti H, Sifri C, Sawyer RG. Successful liver transplantation from donor with Plesiomonas shigelloides sepsis after freshwater drowning: case report and review of literature on gram-negative bacterial aspiration during drowning and utilization of organs from bacteremic donors. Surg Infect (Larchmt) 2012; 13:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/50\">",
"      Woo PC, Lau SK, Wong SS, Yuen KY. Two cases of continuous ambulatory peritoneal dialysis-associated peritonitis due to Plesiomonas shigelloides. J Clin Microbiol 2004; 42:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/51\">",
"      Kain KC, Kelly MT. Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea. J Clin Microbiol 1989; 27:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/52\">",
"      Visitsunthorn N, Komolpis P. Antimicrobial therapy in Plesiomonas shigelloides-associated diarrhea in Thai children. Southeast Asian J Trop Med Public Health 1995; 26:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/53\">",
"      Avison MB, Bennett PM, Walsh TR. beta-lactamase expression in Plesiomonas shigelloides. J Antimicrob Chemother 2000; 45:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/54\">",
"      Wong TY, Tsui HY, So MK, et al. Plesiomonas shigelloides infection in Hong Kong: retrospective study of 167 laboratory-confirmed cases. Hong Kong Med J 2000; 6:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/55\">",
"      Kain KC, Kelly MT. Antimicrobial susceptibility of Plesiomonas shigelloides from patients with diarrhea. Antimicrob Agents Chemother 1989; 33:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4582/abstract/56\">",
"      Clark RB, Lister PD, Arneson-Rotert L, Janda JM. In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations. Antimicrob Agents Chemother 1990; 34:159.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3132 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-189.2.19.178-294E67EF58-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4582=[""].join("\n");
var outline_f4_30_4582=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2968408\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2968528\">",
"      MICROBIOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2968408\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_30_4583="Nail biopsy diagram";
var content_f4_30_4583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 508px\">",
"   <div class=\"ttl\">",
"    Diagram of the nail biopsy techniques",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 488px; height: 526px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4583=[""].join("\n");
var outline_f4_30_4583=null;
var title_f4_30_4584="Internal podalic version";
var content_f4_30_4584=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58961%7EOBGYN%2F71779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58961%7EOBGYN%2F71779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Internal podalic version",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note use of long version gloves.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pritchard, JA, MacDonald, PC. Williams Obstetrics, 16th Edition, Appleton-Century-Crofts, New York 1980. Copyright &copy;1980 McGraw Hill. p.1078.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Internal podalic version",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 304px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEwAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDurq3lnO1wNsb5Tao6d/59KYA0sjQzKFEakRgAHjOMcd60ywZyxQFWAYMASc1C00axACMK2Qev3Of/AK9ABa2vlQlFZlVeiqcVctppFT7zIpYEBuN31/GqeVjkkBD725L46DoDU8VxvKRrtJOCeSAD60AXY7p1z5sZ2sME55BB+tJe37Kc7m2r8oGAc/T/AD2qoWCnc5VCe27isDWPEtjbTust1DknorZI7g4H060Aas2oBkAYvvJCg47/AF9Ka9+VRnJDADgEYC46/hXB3Hi60FxJ5amQ8FRk889PpVKfxbceUwitGlG3P3yAST/nmgD0az1mMAFyFfqQuevY/lT7LURGylHABOSpB6HpxXkketXxuVKw4GPlyx+mKvprN4hV0igaVmAXdIeMmgD2KHUCECpLkYx06ZxxTFm8lQ0bBg3TIryyHxbc221ZLFZ+Ods2fy4rRh8ZDygtxp11Apyd+0sPzx9PyoA7me4xGfNO5gBnaeR/nNVvPlO2KWdgjHA2nGea43/hLtPmmVUuUSQ4BL5HHPHNOW+jmuo/KuWRWzv2sdvJ9f60Ad3ZavcWjkQ3M7JuJKyYPTjHt+dakHiGTz1DwEA4b5TnPufxrjICpKknoTgqSd3XI9ucVpW0iKqkzKiH5sMe/wBf8igDu4/ENqWHmF4UPBLrwfxH9RW3FPnqc5HOefp7V58jqjKwz0wQD1qcX1xbXIa3ldWUE+W2dhyP55oA9BguH3AEFhjnAyanjnVhktj6/XiuTsdcDBEvkEUm0ZZCSM454xkV0loYp7cNbShiRyyk4oAtq+dvB5zyBwKfUWwb22gg456jJ69alAx3J+tABUNypZQByx4AwD2qRTnJAYfUUkgD/LkhuoI7UAVkZUlHmIF/HgY9BSvcttAAxIR6ZqqVIbBBz6d6eIm3bMAk9Dz0z1oAs+eyZMiEZ5Htx0qF7jJUquCnT0P4VLIm5GwAQrHHB/L8KhMT7CdjY4wP5mgCJnOAoH3QcEd/8/1p29sBCB8uTyKYyEjB3KDg56cUR2pzgZUKM4JwKAL0TyHnDYB+YN16f/q7U9pGCbtpztztx0+pqOBFkVSUKkEEH1/+tTXjCBnRQFGMbsgn9eKAHFpFRVKnBB3EgHHvTmZxbKV5JHYe1RssWGU4yxJU54quRgHYzkA56YGaAEjdjEVbG4jAwPfpSEtjac4HY9qMFRgr15BNMmzu3BNz9QCfWgCTfllcAA49Mc0k85ZMynAXvjrVZomCCMys5Zsk+3pSG1jHJBYnH3v/AK1AC3khVeg3E/l7+1VYPly7KSo6n0/zmlmRRIwX1J6dP88/lTmSMqoDDjqfr2J/+tQBG8YUeam4A8jn3NDyPllbHfI96nmRAQBnavbOeT2xmq7ogOxuRg5479gaAI3bcxyWZjweaqzQFggXqAeCecdh/Sp4lRCypgeozmmTQswYq2WwQO3fNAGbIpYDazKQe3+eaKdgjJODnlcjp2ooA4yW7iljBsrkSIrD7sg5IPIqa3uAsJe5Kszr1Bz9AffvxXFf2tBpxWVm8u3Zjnbg5OOMY6nntzWTqGqam8Uez/RLSQZ3lQHYZx8q/wCetAHoF5rdlYczMibQTy4y3HQc5rMbxRd3MD/2JYnGB+/ZgPyUDJrkbQCO5lKwNLI+WPnRh5CCAfmzwP1IrYTVkhttt4+xlAHlw/MgPu2cdO2D07UARTrqVxse81GVh94pG4GfXhev4kVOdFs7OzEtwfmfPMrhc+nHWse88R3SPts0SLjAwnJ6d+v61h35mnaV7lmKsT0PUn1/KgDWutRtrV1WFoVhXABQ5yQPwrKuNa8yN444mETjBJUDPfr1/Ws4wzkbY15boAMcdM9fpU1tp8iL86IxJGUB60AP+1OsqlHRE5yG+b+dWv7QvkQG0mjXyz8pCAbeODwtPkSENsdAhIPyovOeta1lpQm8vzZJFQ4O5I8IB9ef84oA54+IL1oxI0s5mOATGBjP6VoRajJJGvm3d20n913yAc9vm/p61cutEb7O7W6Eo2MMHXIG76fzrNjt3mmZYoSrcjONpH4Z60ASX8y3AMc6rMjDaTLjPGO/X8jUtvDaxw+bHHPERjmGbPbsCc+vQ0xtM1FVMi+cVHH3Bx2/Pmmql8sMgnmZCqj5WhGDyfToaAL0Gr3CPGLfVl3BsFbhipH5jj9a2k8TTLcCS4iikjwMtBOrjjntXKz2dw253ggl427tmG/LiqlwAsYb7O0fA/gxj8utAHrNn4otrm3GyT5uqoduceuPyqNvFrx3EqyxusMZ4cEFSfbvx/SvJZLgDYNxXHA47+gNW7bVLiGRcENGOCCo/wA9zQB7ZY6skyrIzbnI6Z56d+c1s6drUqbDC5hJxlQcfp34rx/TPECSMq7dkoAGNgG/jP4//rrpbLVwFTAAdQcjrnngjn86APadL8RRSEJeMI+uZGICjHr6V0O5dobcNvXOeK8Rt9SW7gMeV3bT1XBPt+Vbmk63PpNuFmkU2gUfLgnAHf8AKgD1MnkcH6+lIR8wI49eOtY2iavbX8SyQybo9oP3MY/T/Oa2dowR1B655oAgKgSEcFyefmOevp9KhdPLVVUjkZcZBPHPSk8glsLxwcbsZ+mKl2EIvyjBCglsADnmgCZHJGXGCegHOR68VHEXkOHKsFOSwPWq8zM7t34yCP7vvT4I5fmQ5VO/HWgCeTcvK7R8n5Uwy+U7AsrKBwo9aiFvIJD8o2k4/CkkR5DhI2AyTgjFAFiOdc7GcEj+LoDSRD92zJwWONzHP5VALdtgJBAPPHJqaNSWPA8raMAD8en40AMdEADfLjkbuxPbpULls7SwIICjDccVYEQLgFRyx6AfdGKilhCAsqZLBeSpyPb0/wD10AI8jDIV8qv09aqzyFCXOSD2yP60/nnII+veoZizblVM47kcf56UALJNsH8LcDHOMmoorgl85JTGCQehz37VFKhxgJubhSR2I4x/Lmo0SSTJC5Hbbx+dADiSJSytkg/eHsPT0qQSKXTI2NjAbPQduDS28IkjVn+Uk47cjFK0TN8u1Cyjnn8Mf1oAheZyF+YjjHBpqyEA8nJOcg81NJbSAHaFfoBzgilu1K7QoGOcADtxQBVqJHOPnK4B2+5NPwSe64PGO9UTG+zMgxgZyTzjPP8AOgCN2O9vmzyeR3oprkttOemc+9FAHzlF5FvcLdTSm7ulK7XfJjh69B0+n0/GrF6bY24lmuked4zIWDFmBzkL32/j7/SudvppXiiSAeS46Luz82MFv0/Wq1p5toPM1CXzGwdqg/TJP6UAdDc3+LaEKAsQYfu0JznPc+lNW8idRuUIThtrDJHuPT/61YD6jGFZmB+bLAZBI+mPpVE6gZsonLEgnI5x1x7UAb0t/GHYDGTgkpwfz/Om/wBohIuCFj5O3GT17knpXPaxqMekLCt4Q1xKgZYEI3cnGWI+76gY5rCFtrevO7lvJtlJdYs4GMjjA6/jQB01x4w06ykISYuVwwVCW/lxn8ayLrx2S6skEx4yGaU4Ppnj2qWy8A3Tt+4ikaQ4C7euf6VHdeHRAu10EkoB3KScDnnpQBVbx1fb2KWVr5noS7Efrir1v8SNQh2g6TaSPgAkCTJ49d3B/CorfQpGJKoFA445/WtCG0MTlhEFOADlvb249eKAIF+IGq3TAHR1YEYGwuOuP8KT/hMNWiAb+xs4yMszN+B6elWrKSOCfYI2kYDLY+Uda6CzvrBpFNyhX5tvD9PbpQByJ8a6muJW0qLzFI4+fkenX2NIPH94Plm0tZDs6GV12847+2BXpsml6ZeQH+z3Uu4GckYB9OD1+tYM+g2skchcRN5YH3ZB6/5H+FAHIL48tN2ZNOuBInIb7V09gNvvViDxzbbiJllhIPGcspPfpTtY8MWgVsRbWJ6KcY/zgVxt9p9xHMfKZWXrzg/56UAeg/8ACX6bLIAklv6OQzJn8Wx+lalrqemXWVWSMkk7XQ546A8HmvGjazRlvMjznjqM/X/PrV+LRtQdvMhiaNCflYNzj8OaAPYIoFknCiYMvGOCD/n6Zq6kstqj4m82KQH93IWOB7dx0FeUW9x4i04gi6Z1B5DnccfiMj863dK8dT2UbJqsEyEjAKkOmOP4T06+poA9s0HW7SSO3+0skVzkoUckZwODnpjmumgvYHyZvLjAYZ68jp1+mPr1ryW1vLDV7RZLKeJY2O5mjkyoYdc/3TntgVettVvLPck+6W1BXqQzDjr6HigD1i21I74fKIATgsoKsDnjFdxpHiaVljjvdiAjh/T2IryDSdYiukZo7gOuMqOCMZwM/l+taUWrsuySRmEYY5JPX/CgD3OOaOWVGDDtg4zuyP061OchBiQbj/ERnP4fjXlmj+LHhkUbmkjVtrRkjIGP8/Wu+sNShu0R4ZMlxyA49f0oAvfaNkjA5xknBB/Coo3b5gHOW54Bzn2pLglmIJDKOQQelRA4bPOOmBQBopIJdyhSRjqeM/4UsRLdwdpKnrVeKNY2PnYBA/vdfwq0oAAwSM/rQAyViVULuDNx0PGaaJgULbzgY4IzxT35YYOD06n+hqkVYMqgMvG0+9AFjzcOWkJ2Dlfl65qkxY5bGSTzUs8jn5CxKj17iq0kyxqC3Xpgc0AM89d+ODk4znilMoK5B2r6n/Csya4Vf9ZIc4zyfrUMt4Ao5JZieN31oA0mlO7JkAxyQnf6VEsrZbLD5hg5qktyhlO4nBAwSeP8/wCFPF2Ac5YHk8H6/wCfxoA0l8xDtQ7xz94dTn/P61H9pOwkBQcgD1xVJrvO4liG5Ugt/wDX6VGblRIqkcHHOfWgC69027glcc98VG7luWPA59qz5pi6J8xBx29c9/yoWRhxIzFWGQc/kf0oAnnnGzCEh+vPBFVGbeWZuWwKPNcjDMSp6g1HndznOec+tAFe4kcMAu5QASSPb/I/OimuJlJw6n1J4JGP8/nRQB81XUxtrSOQo3nOqyHag2qvYk+/Fc5qN9JPBI2NoJ5YALxnHp7imalqm0tb/aF5AcgdW/x//XWVNcp87Dgs21ck8cjoPwoAmdZHVQqj/WHCgEnP+eade6s+mOttpu6XVHK7R5YbaCM8jpn/ACapy3U3nLY6YhuNRk+UYXLJkdvevZPhj8JodP2X2u7Lm93K4AzlePu89+cH6UAcn8PPhZqWqXH23UI33SlXLOo5JOTj3r6I8O+CdN0W0VBbRvMM4ZowTk9h6cVt6VZRWp+XARAFQAYA9Bj/AD0q+obyyQ6knO3APJ7nHrQBSFpEFMUMYjDcfKAuBgn9cn8647XvBdtdTGfyv34j2DIAC+hA7YHc/wBa7rDFsccc5BIHQY/KrDQB4xvQM2MZOcEigDyF/AStDI8ZYME5O0Zb6GuY1jwlPZvlo2KMMllHGOgFfQb2sTHaARwfUiq1xpcM8JWVA44XaR1FAHy/e6O8WzzEdFOAMcd/zrKnjMTNGS4XJxkd6+jNV8MW9xGQsSA5yflzkg+n+e9cDrvgncXkjCRlWY7duQw9vT8qAPJP4txWRC2DuXtx+dEd5OuWR/McdVIycZ6A9K6O/wDD0katJkkjAA55wK524tDGxG4kbcYUdOelAGfe626RCNsL3IIIIP8Ak1k3GqLM4wu2LjcBwT9Ku6zDHc2rLOMn728dunBrnrWzJv445NyRllIIPp/kUAesfDHw1b6xKJL/AOWAKGJZeq5yV9vrXR67otvaXhNrEwh3YQ7QM+59+au/DuEi0Chl2hQoOMgnJz/X9ateJAUvQryjBZiqgZxyMCgDi9V06HdtXO4KpcED8a5O+hjWJkK5CjkEcn2re16RIYZHjLMwwVC9j9fWuX+3+WrrIAAxwecEE96AK8dobOf7Vps7WtwucMACMH1H4frXX+F/EovQ1lqCxwX8kixxosZ8ifgDGc5Rv0+lcUbxZJ2XKkL8pA4zwcU5PKlZhKVG488cH/CgD0oJLa3DvbDyp9v7yEgYbB6H0Oa27PVDen5pCsiZG3byhI/X/wCtXmekeIRaeVZarKWtQoEF1gkx84Ct7dMHt/Lo7gSCUPFJ++HII/iXHf26c0AekafftbqY5GQspG8AdQRxx9c10Gk6vcW8sV3ZvhNm50xlSBjjHevNtI1aK6g8zftmjIBU5zwP8/WuwtLnfEuCigjG3nJOeO3H+fagD2TRtet9Rt3DErIvDoR/nPWtSGUSLnPPpjvXjtjcs7meOVYJUYjejEEEHBH9K7/w/rIuygmISccMB/F6ke1AHVB2CYBwM9utL5jBQFZgcknnrUCp8xbexDds8U1Idspbc20dFzQBZWRtylmPHIOM4okYAZBbGOS3f/61Z91bzSXaSC4ZIAADHgEE57+ucgVYmkVFznBPTOexoAZcTOD/AAlTnAC9fXNZd9N5ak/dY8fTFLPJ85y5z164BJ6E/lWLfXabAjGLgbcnP5UAVrm53SbVZgAu7GOvtikMsjtjzGXPuBWRd3W2ZcS/IwKkBT/nNWo3LwqQVGTjBJGD9aALomlZ4wrcDqOcmrKyM7bjGdm30znNZiSb2QK6n+97CrP3ASjcnuD2/wA/yoAuq75IIDdSMHp7H/PajzGIIC7eoOccemKpxfN/EFIyS3ft/WhpMZfIyp4PTjkmgCe4lKvhiwBwcDsP8asJNuhUsRjt/hisaabbGWLhifukUqSuyhSUYgdAxoAsOxyW3llfqMYPFWbeYCPaQdw6KMkms7cS52shXHTP5UrscEBhlevsKALrhUuCeSDkMoB7j+tFU3k2qAxJwCf8aKAPj3zbe4Pzo2SwzIrggfhUF6V01Zyr7pfKDxMAMDJxnnvnmq87sj8KoeRsjC4GOn40RN/aepWVqSZYYMNLtTaWIPQ/57mgD1n4GeE/JvP7V1CN2v3Vm3M33Qe36ZzX0TY25jUNgH6ngD/OK5H4UolxpEUq4MwyDxyQD1/WvRVimF6ZPPzbeWFW38tcBgSd27r0wMdOKAIfKkCrlWwvO0MKhnE8cqCFY/KLHcS5DDjjAwc9ec4/WrW2VWYKy7QdwHtz7UBGALvGGcMeFwMigByhlaRlDMBwFIx9Tnv/APWpqyExoFjfefmHPB/GnrLvACLhiQWHt61EJdiq2AW2k59RuoAuYUJxndn04oGzGGDdeoNQea+cBMsCcjcBgdqss5K7evv3x6UAV5YVkXpyAcfU1lXGlCXLPHhF5A3c1tOWdgS546+9OTDEbmKgjBGAcUAcFfeFbVoiY4j+Z7n/AOt+lee+KPCIjJMStjBBw3HXr9K9/mtdyBxISCRz2Q9qwtR0kTowwNoznIHPqfxoA+S9Y0pxI2DlfyyK54wvFMyMjDBBHOOe3PevfPGnh3y7gCKIrEAxJxnAx6dTXkXiDTpoZH86MpsIHBGfX8KAO1+GWokaXcoZ0UwoGkiaTa+AeSozzyB0roPEV/FcW8RjZHD7sDOSP88V4azTpKZYWbz4h8uBww962NL8WLcRm2lfZMgOQy4JFAF3UpQxIdSE4BjLE445xx2rj9ZBUMy4zt+6SPmroru78x2RZCzcA/L6+/pWFqYjeNw4PQ5BGenegDl/tU0c2WZtw4bnrWjZ364AJO/IPXnpWTdALcPt6e9PgkAG6QKQCBnbyPSgDqCiXEJSUkqyksMnkf41qeFdXFnfx6XeykxksLaZ5MAcfdP49PriuUivcKgG0leQCCSKgu2FxEWYqeC4IAH+fpQB7GLVkmFxDL5cyEArnaGzzjjrXZ+HbuO+jCFf3yIN0bPz16g9x0/OvKPCPiRNSthZ3uwX0agA7cGQAdc9z6/n611AWeCRJI2MckXzRybcYOeme4NAHqEXMxCs2N2Mg52ADPNa0Tyw3CXABVowGQZxz71ymia2l4jrKCl5EMlcYGf8/wCeldNCpGxim1jwxA6c+nvQB6R4f1RL6zViTuAw6hgdhHX+Va5JbBjbGWyd3ORjtXnuj3jWcql+IiOc8Z57V16SrKgkU71b5lweDQBqTMqxliGwPQ81jT3SLIwbdxnnI+vrVya6CWTHZnGF61xuuX7oQpbDev5/0zQA3WNUHnFYZAp3E53c1zd9qErxAR/LlgB+8Ug5A6E1Wv70CVQ/zPnLbU4/OsifV2bCqwOAo3BFbGMHvQBpSXWxo5JHLRAd2GRz/n/Iq4upLI8KIr4fcc8YGMZzkjFcidThdSr8joyvF0Gas2uqmW4Kwquxgc/LwPQ4PfigDtRMpGY1ywIAYEEDHU1dhmcnEijliuc1zGnFra2W3EabUwRz04rVtJ0cqrn5schewPegDeT584XLHJ5PNVpHIQF0UA8EM3vVcXjxDcQME46cn8fpSSSIGAB43ZQ4HHegBgIdwj5HdQPfp7dvalVVUtuOFBCt7/5xTRJliRt2554HrUquxQvtQ9cjacDoef8APagAmgKrksucgAk9u1N2GJNxJGVyMN3/AM/zq1vZkJUDgDAXGQP5HpULMzsm5o9pGcHoOf8AP60ALLFIcBD0GCM8DjpRTXuMHaCw2jG3A/mKKAPj3EZmi3kZ3rx1OM1V8HyAXc4J+aQKoJ+tT3VzGyyOvGxNoJYEnA7cDvWf4cby53fJG0ryGx60AfWvwjnjj0lYzMN/zLgrtxyf8/lXpQk3TJI6kAep4rwP4d6+0E8IuJsRByyrv+UnH+Ir2m11FZYd4JIP9309OtAG4JQsx3EFCu4Hmmm5hdcZDckEYyBXMpqxEjNI4UJ8pBP4GsmTX4reS4gaXdIHbI3ce386AOj1G/W3uYzEqbHweDg59vyp8FwJX4Zdu3sc85rh9c1gXdlutHzLCwXIkABB6n3xVDTPFqrGEmZ1kjAXJYEMfY9+1AHrEcwAH3d3OTjB/wDr08XX3OABnBGcnFcJL4oET8AmMfeJYH09au2PiOCdSTKcnBCFh/L8MUAdbLLnDrKVBPAPAHrmnWspckSMpOeAa53+2YzEf3qqCcgE9P8APNWLbU0IRozkHgENknFAHSq+3DAjAw3tSfKQwIJP6VQt75HyW3H0A/LNSC4CghFG0dPmxQBkeIdKW9yGUDJ3fXjtXk/jXwiLe2LzBpHdly+3j/PH617arwuuJNw5z6/rVPV9OFxC8Ei7o2bjB49v5UAfIWqWv2Vm42nGQMHmud1jS/tp86Ly47jJJKrtDfX3969x8eeC7i2aS5tkJt2BJBbkDPfp6V5vd6c0TYUbMDPXPH+TQB59b393bOIpmZWRuQwPP1/Sln1BmUkNyykgYz+ddHqGjx3wy+A4HDdOPX1xWfo9hHpOoxyapGksPTO/g89sf1oAoaV4d1HWZibaBghy25lIAA71sy+B7yzjdbiVPnwOEJ28d+1ep+FNQtLxTtkihtufNCEM2zHYdSB3OO1bvjDSVsvNMhKAgBWByDxkY9aAPnW60SaFAwZZQMlsZBP+PWs2VCkhRtpbBHzcEcenau+1RraWYx7meTONqHIHt7f/AF6y9Q08OzZCER8qVYnt1oA5e3lmtJ4ruMhJYnDDOQc+475x/OvZvDWuWur6ZCyuhdV2zxKCTGfXHof1+teY2uno1vKJYmlkPK/P0x296raNqtz4f1BLmykOzIEkZPEig8g8fr1FAHuFrK1lqMV1EVKg7XIPUHuPavS4JllKEE4baRknH868v0O7t9Y0ldQsxutpi6FXkAZCB91h2Pf8jW9putTbE8yJpDH+7kfPIIHp37UAehoUYkscJgkAGtnw3q8ccx02eQ79rSRk55GRkD6Zrk7O7iNgZ98RVQeQ/A9s14h4v+I2pp4odNJne1kt9yB1KjO4DIyfYUAfV2uXQSGGONlLO+PXjBP9K4nVbyNg6uwCMpXG7B7joPrXhB8b+L8R3L6i19DD0DMnGfXAznnvUsvxYeSyEOoWLCfgfI4wxPPOBQB2l9cPLM4BWJRnlGJOKoyxSBOXwrN8u45H1rz7UPHrzORZ2qAE/MSec4/TvWTd6/rupJiS8eOEchVfHGPXFAHfXOqWdjvN7eW8bdT8+Tx1465rOn+IGl2bKtmrXUq5BAJQH8x78Yrz37Ko+a8uIskZYF9zdR2H+eaEutHtZXeCCWaUg8s2B68c0AdndfELVbldllZpGCc7nZiy9sZ/wrPm8beIlkBeUOwP+1z7daxk8QXTJ5NnBHAhIzlRz09eT6/nVG7bUJnQPdKCcgBQR79hQB20XxM8QY/1UWV6j5v8fSnf8LJ8Q5RZUVRgnOW5BHH0rgVF3GXVrrA5zz9MH9asLHd4XzJtxHA+YnH6UAegwfFfWYZAz2UTIO4LAgVu2PxijXi6smCHP3XJwfUZFePtbzlCDOykHOe3+fyoe2beT5o4/iJ5oA99h+Lmkm3zKp6htm4jH04q/a/FDQ76eNTOIwepIx1/D3/WvnaG0BCh9xbvj8OP/wBVWUt0iYFflbI5D9PyoA+qrfU7S+g3206yKwP7xTnB9PrRXzboniq+0C+CJdSva8goOefXpzRQBjXGyOQTNEWCjG1V4OR0x+NZGlq8OoS2+/1U4HUg479K6oWZF5HKyhWQhlDdOD/9bvWBqGnyW3igRucCaTzVZgT8rEn/ABoA6yx1DyDsDqZFzggdD1/rXpPh7xrLbRGNgCchTkc8Y/z9K8yewlijSUpkjOGP8Xqc1Lb3JhwNoPzDGOPzP4UAeo6j4oY3EkkbjylTB4BHfH6kfnXF6v4hkk1Y3DSM+cbvlxk4AA/Lise/1SUQvHxnkZHU81zGr3L4OCGIORj/AD3xQB3B12WORCCGXHOPT0qD+2ds5IcZ3d/euFs9UWRskhDgce4ps98UPJU5OM9M+9AHpX9vbgFDnpxkcA1Yh8SNAxWN+pyuBnkjFeVJqrKcTBlBBy3PJ/T2q1Fqki4LZIPcHNAHq9t4mJUhJGQgFW+XJ/z1ra0/xjLFGkUZHy5wCDjb/kmvF4dVaR1DY2jrjnkn6VrW9/GmHY5bBBIbJ7cf0oA+jdM8X21wqndgoBuYj+Lt+oP5VrW3iRSrB2Xg4J9P8a+brHVX2ttkVM84zg89z71s2mtliFDYKEYYdfzoA+hDrkWxdsm0kknCZ/CrkepSNGu4hxnAB6/T26V89W/iOSGU73yhzgknkmulsvGE8aRoG+QEY3N2A/z+VAHrxMd3HtcmRmHQAYx6V51468JhCZrSIlXZt2V4X3qjb+K5DOuSVQ9PmIIHfHfnFdDY+OdM2yR6jIPlJwrqSZOBz0/zigDxnVNGkimyA+BjAPGQR3NYNwCVMcsYKsMYZe3rn8K9W8TahpV/f7dOUyrIQFBVgFOOij39TXCa5pp27ip4Hy5PIOc4/kKAMnTrlrL7NHZKkc4uQ6SN1JPY9sV3WuXza34sXRmklSGOQCUogbAHXbnPfgV5rIDG7pM4KvkAEfdNbPhKW8vdVS1tBslOI5Hyck5J7fWgDpLjw7aaeDJG6FCmcsBnOcHJ9etZctlEynYQ5Xuefwr1Kz8D+ZaRrcOFlVPnRwSSc89aydR8GeTHJNFMogDsHJTBB75H/wBegDyW5s9haWN9sgwQdv16c9a5yS3njuXktgmGGXQ9znnA9a9X1fw0bWJw5LquPnYHNcTq1l5cocAIQNxIU8jPX/P6UAQeCNUj0jU5GZ3+w3OVlTGdjY4Yfy+hr3DQhbWl2YiSyz4MbNzjjnp+FfO0+sIA0FzBGhQFAypgkZ4J9a9Q+E3iFr+0NpdKvm27Ika7jkgAYJx6jIoA9AvLZ7Q3c1nGr27cXC7vuE9G6/Xj0r58+JGkT2GsSXLRbIZnLA4yAcDAz3r6Vhiht9QSeICSw1HCufvBH5xkds5Ix7e1Y/jvwbDqei3djFCglAaS3fB+bj7v1HFAHzPZRXUsZdS23H8OOKjuI7q1cOzbmUZw4yR/nFbWn3L6PfNbzxjcjCPYykjp79a6qa10TXdjAw2LhQOdzI7fhyv60AebpfXokwjKGK84RRuHvTwl5MhR3fJ4Knn867h/CdrDdMv2m3baSu4Z2n/634VZs9K0y0Uma6QkYGFQ7u9AHAHS5njOxGkbC4wOew/zmtq08NXc8wSOFwp5yijJx2rvLW98P2K4li80gjjO0MB29q05viTZWIxp2labDjkEpub8zQBxo8H3FokbXcLxlsMhYfe4qzcaRDZohu1EYkUOhAB3D2/z2rI8S+NLvVJpJrgZ3YHynaFGMcCucj1q4ki2SSDCHI6nP0/KgDtxYWZkZVZCOuce1WV0qyCrtcR/LkM3J/SuFTWWUEluGBHJPHT9asW+tybjulI4z8zE8f55oA7m18M21ypX7VDHkA/N8oJ+takfw+jCCWfUbNUUYyCD2z0rzVNfk3FQdzY6k8n/ADmpI/EUp2RM5DLnrmgD0G/8JR6dYtMlykwjZVwqHk8nGf8AGuOviFMgG7bjrjHfpj8apwa7PHZSb3YecRtPPIzjP06jio53MkSMJFbA4z/M0AZd6f8ASHO7IzySMUVT1APFONw6g/eByfrRQB0Utw6xFix5bgBhkjp0qn4ivWuL7Srt5CxjiWEsWz9xjz9MFf1q0bQmYMUXdjaTxj8abLZ/bdPniZAJsGSNgnVgTwPr0+tAHtfgd9J8S+F20PUFeG43mWCdWwQ2OPqOTn/OPPfGugat4Vunivod1sSNlxA/ysMZBBx/gazfAuv3NqA7MytEShOOhr3zw9rlprFktvexxXQYqWikjDAn156UAfMk+qoyYBUyAHqcY/XFZM18suSQxP4D9R+FfS2o/BzRNUuDPHM9upYnHlKTjPTqK8l8S/DWbS9RlXLCBemcdMe3T/69AHnyQ/bZytskgOBwx3c9+QBjnJ6URQXc93FaRb5ZpSI40BzuJOAPzNdHeEaO/lx5EeBuJFZGlX8kWrw3UhY+W2VJXp/nNAHcWfwj1690oahFNbSqUJkUMcqBnoCOemeK5jVPCGv6Whea2bygQAVYHH1/Ku903xTcW1uYrC4EZ2kdCCMY5rH1LW9SaPc8odyR8zNnj39+tAHnnmSI7rIWQ45GcY57VNFeyrI7NI2B3DcVYuS07F3y2MgAnsTnvVALh9iFWUHcdwHA9aANq01I8Rs/J/2unfoK3LK6IjLBuQvXOcj1riZVjUgqxHIOMcn3B/M1dsLl48RlX44VSODzQB1LXjEpskYZPzfNjt3q2uou1wgWXDBQCQeK51p1UjIYDoSR0qJb35woKgswAViAD15/l1oA6+O/lKktIwA4Pqeff6VLaX5luY0Rt7NnBJzj/wCtxiuFhv3lcl1CoBweuf8AOK6nw2wW4Vx8r5Kgj6igD6J0Lwla2HhldTg3S3bqsmG4PI7fSvPvF0xleSMNuKkgFsdz0H+PvXo3gjWH1KyazhD4VR5z7MKMjuc4Gccfj9K4Dx7bILyWONflRzggct6EnpzjtQB5LqVtIbpzuxkllXPJrV8Gas2j6ta6g3WKVWc+wxz+HP1qlqx2XIJJ4yemcHgVQXETjIJcYJ46DqaAPsCwuotSsY7uwbImjWbzA2RnjOKbeWS3qyRw5cM5VnzjJHrXjHwb8bRadPDomqyqtmwzbNsPDFuQ1e7Ld/bIQ9sCYyeGK53cZ/xoA5HV9MM2SqNvY52lhgD1/lXlniXR9vmrFE42Eqdwx0617peoWjXyxuOecryOK8z8ZJ/pMaCJkQghjgkKe/P+eaAPBtU0repI2742JCnp781F4currRdZhu9zqAQWBbAK45Bx3967vV9KFrctK4JjkwUkOdrevH14/CuTvpIGLRzKdnHTlvw4oA+gfC2qwalokRdzJZzgE4kG6F8+nb1/Cugtbhrixlg8+N763chtx5AzwcY6YIr5z8I+JrnQLkRptkikGwgjORn8K9m8PtBrMLXmm3E0aqzeWWRd8UmBlT/s88j3zQBxvxO8DjXz/a+mKBctjzFVsfdHOfcDHpXjl1BqGnO8bbyEI4J+YYr6w0vUWkieYxN5yMv2q3dCCDtI3Ln161NqOg6VqiLJe2UUsb/dcoN479ccUAfIravf4ABkCjIOP1qI397Io3BjxgZ/n7V9M3ngXw9K7hLeMA5IBUN+OAKxLz4baa8WbRHR+uFUcj8qAPn2SW7cDZvDZxjcDVhdI1OeBZlB2kd35/GvTte8ONpNtcSvaRsgU/vBGOAD1Pue1ZFhOE2xhQcZAyOB3/xoA89lt5EkaKTfuAwcsPX/AD+tRosYdVfDDZgnPQ57+leqSaJDqsgkgt8XAYAKq/e4z+dc/qPhyMo+8FHBIPy+h5oA52XRJUtPOCmRDkgqwqqF2B2Crk46Z7CtiNrrSiSsnmRFsFHXg9Of8mpLm1tr+Np7BWWcABo9vtnP04oAwSqMgK5UEAnBGR/n+lMmYogjbiLnHzZ9Omfyp06yWy+VKnzAYw645z0P+e1SiATAArkZ5YjH60APtpTO6yXGfLGAfmBJUcYH5Vet1e+uUKJtgXqnQe2TRBaafHETLK0g4wo4B9ferk+rFrQWllBFHEF5Kpgtz3PU9uOlAFPXZBJIixsrGMFARg9KKWOEuGeQEgkjpjNFAFp4wGVVY9FyeSWPt+lWFKSQvs2+ftPOOc+oFULqRxKpVmYDbuUYztxyBirUFs87brcnDL8rHjuDx/nt+NAGTdQTWMyX0mFSZmWRV6g884Pr1rsPDusfZZUkiyCq5DAnDZA5OPpVHUG+z2TRxRLK20xyI54ccf8A1vpWA8w066MaMz2bN+7Jk+70O1sdxQB7FpnjWWzmDBwSQGJZjz/9ftUPjbxemqWI3JH5qkn5Scg4wAT3/wD115tPKwhV0Z87c/e4PHXOaoPcTFRG7sWIIOWAFAHW+D/C9pruoibV5UFvvGIgCS3GexHr79a9K8QfB/TxZ+dopt545E3CBB865xjHJz3/AFrxnStZe0DBZHUrhgwbOP0roNG8d6it4dl5OGTDFt4GQORkUAWLzwBr2jMwttPuJoMYBSNiw46dKx77T72Nf9KsriF1G1VkjKsCevBA9a9jsfjFM0SrLbIQobazyZOMcZ/xFXn+KiSKQbdSrcEKwOM9jkUAfNE+nskUxZG3hSFxlu/NZyafdKA7RMobsyH+WK+iNS8bWF4jKNOizINxJxk+mfzritY1y0nMkfkQqNxbC4G30HvQB5ZJZTSFjg5HGMHj2qACS2djszx1IOK7C7mjdflXYhII+YHBPrisa5CtbshkVnbOMY4FAGe1ykkeAFUsTw2eB9fyqUyDzVUYK/eBPf2/Kren6Gb6LEZUPk4BPOOmasnR7y1DKgDqDwpYBiP970oAytqKzkHa+3jCk/5/+tXX+H2MhgghX95JwoCk9ee1czLGizMsm6GVsFQwAU88jNek/CDT1m1uF5Jdqx5IIIHHrjp7UAfTHgnQbPRvD62kOxp2x50uOXfHv+Ncb430VTBcyKjSyvzwvPDfyFd/o7x/ZkMhdtwDHIx1HpVLxPbA2rblcHaRgHqCaAPl/XdM+eUhwvLLnkD15965G8hNsW3MB06jn616v4ltCpIZAu4ttXJ4z7+tecarGI58upOed3r1oAyJ5HRA0b7ZkG5QGx7kV7D8L/ilLFa29lqYR4FDbizFmX04/CvHQN8rA/cwRnuefzqgJZtP1NpIQyjBbCnO4E/5/KgD7NsNe0+/j/c3KLuOFDNjPGelct4yhiEdv9muorgsmxmc7SOmf5Zrxzw94oTMDDgKcZMnGfpXbReIra4gXz2ebsUeTLdex+nTNAGZr5LWf2eRGdASyZPTjP8AhzXmOoxCDJf5g2DycEjPT616NrzuhEMMr/Z42OwFgTtbkA/1rg9Rjy0hHzKzjjk9B/LFAGOsjiRVwUHqQSeuc/411fg/xdc+G9cjuLh2exYlJ4tx+XOB5mM9R9OnFcvdRL5e/YQwBYjOec9fbipYGWaBhMoYspXOeT+PWgD6Z1KW3hlsNTi27iyxs4f5SrD7x5wR0596l+x3WtaubeKfybNIhKzoSTknGOMV558Mb1tc0KfT7x5JWtmEIZiP9XtBj/LBH/ARXoHgnUha3iyXEhUbfstwm4YjffhWPtwQaANG88HyQQs1jqreaMjE7Hr/AL27iqlneeXPJBqcRt7uPC7H4DDB5HrkV2OpW8iD9yzMpLEgnnHFZV7Zwa1ZGC4GHjYNE4blTg5Gfw6UAc5r2lQ3cE0SYCyg8EZxn0P+e1fP+vWN14d1mS1n2iItlJMHkD/P6V76bmfS7mGx1FFKvlYp0YEOM4Bx2PSs/wAaeHoNa0aWFt8kuGaMgjhu3Tn2oA8p0rWGWMgSYYYIIOD+f51uW1tBqEqIZFTHc5xz3Pp2rg7rSLjTT5qSFrdD/e6H6VZ0rXprWZUk3BcDuMnnnigDrPGvhd9GhjF40TSSbtvlNu+UY9unSvOrm3Kyq0D7JFPJHFdjqPiOXVJUaeSabBIXzHJxxnjPasWeNZcNE2Bjse/1/AUAYN3Kt5FIl0hWcL8suPv/AIVnrujUbioQDkAE1tywK7gMFdVzzux+VU5LTj5NxzwcnGPegCr+BP0Fb+iaU8p34BYjIU8cZ6n271ixxyoxK5zuxjOecVaW8vsBVlYBhgkHqPfFAHQaglvbuLZDHNgnMin5fw4/WisdSNmOvOd3t6UUAak+lNGGjihPmA9gBnn/AOv0onDRR7NzNMU+ZVHSuqKoYgVbbKE2kZ7j0rnprNftvyg52kncx4Oev+fWgCjprLs2zYBb0Xjj6/rQYIpYnRgrK53Mu0YbPf8A+v1qe1sT5TSux6N/Fg45/wA96a+/bjaAzHacnG3mgDnZrW609Q9sGntAm8qeqDqen8/zpYtRsZYlWXMbbssXUt/KuhMTGdWRjvIAAX8+TSS6ZYXKzC+t2acKW3o+3nHOT0/EigDEeNZXEkMkbgYGQwJ/ECs1oXimZwMFgQOMD/69aV/ocdsyGwmuQXIHIBA+rDGPypUtb+3illikiv4oeJURv3iAHGcH5sZ4zQBXtLmSBwCSFQn+H9Pwq5DqTvJtZioOOcZrMN9C0m6VZY5AOgPHSnoyMC8Mq8YIGefXnj2oAvzX8jFQjqcAk8enP9Khilk8wCQbV5P447/4U5UZYwVORsx1x+OajZz5Db2OSSBtPX3/AENADJJQJCUxgc89zx/nj0qixVnKj5nbO5jzj2ouZTGq4DAHrz0OKhtn2NuDYG4bmzzjP+TQB698OtAt7iwae/dYskgIuMsR257c5rtJPDtjLLK0t0VRPmZVQcccDnjNeZ6D4lNta+WjDoRnjgnvXVaFfyXt5b2dxcbYHZA7bsEL/EQfoDQBV1PQLe9c+RbYhckRkoMygHqDU3h6zbQb945IgIWjyu4Drkce/GTXs+naDZM0Mkb/AGp1hUIN+REmcqo46nOSaw/iL4fMenLeQREPC2W2nnZjnn2OKAOu8J6mt5CnlMCRtJwMDJH/AOuulurZbq2Y57c4HXrnNeJ/D3Xha6jBFI8iiV1VdzHOArFv5Cvb9PufPtlkVuqjaD056UAeV/EPQ5mhL26blG4n5R8g459//rV4hrWnuVY7TkkDcRz619e6hZRXMTpuyOwORk/h17fnXjnjbwmbeSaaGIeTwSQc4oA8CNrIDkKCemfxrK1CeIkRnPmIxJ2nIA/Cur1qNbHzGnBEQOeuMjPT29K5SyhWa+YgHEjkAk8gdOf/ANdAGnpOmtPDvM4QsMgsBgDvUjXt1p0iu6I0BHyseNy9yPWtz7I1tYMQBsJCjk8CuQ129e4khVSTEmY1Vj0Oc9PQ0AdXaeJoruB4JCiyjJXcACfbGfpVDVZFP3JgUOApA6cf/X/WuOhEgZBG4JDn+LGQAOfyFWbe/wD3DQzEtnkc8DA/+tQBYQ7rhomKhGHAA6c5p0ccfUYKtuxsXH5D86zy5CsqtICud3ONwHvjn/69JHMAwSTLbWIznnH+f5UAej/CnVW0vxJFE0wKXK7SMcfKCc59gK9v1G1jkaHU1eN0jAM6cEMuRz+lfN/hK4ddf07PGZREg3Z+8Cv8zX0V4Wk+3aMIpcPuj2MD+Wen+c0AdPZ6p9mt90j+fppBKbVBdB6g56fWtB0iuVhudPdZkcZDKw+YY/niuX0KU6dNHpt8g2tvEDjBDDOcHPfBp1nPLoOshYyi6XOVBLH7jnjPPQD+RoA19T0+DWdLmt2AE4Xcrhe/Y/X1HpXIadJLLbPa3qlbmCRkYDAJIrtWSeG786EgQSnIKsAApPXnvXPeLLIQeILbUNzN9rjZJADjDKBg/kOtAHlvim0NlqDylAsTkHmMAdOa5HU9PSZS1um1vRcDNeo+Krd72ExMSsZw+c42vzg/r+VecnzEWMjawbBJX9T+dAHIzbrN9sqt1Ib5ec+9aVlOEU4YKexPHata+hiuMiTblRgHgHJB4/z71ydytxaOqyOCp6HrmgDccRzIAdrNjGQAD1qs9s+3IALZ6DFVrXU9+0bsqBgA4/nWvERKvDA49WHHtQBkyRjdhsEAjntSAgMCMEjqCPer16cRg5UgHlT3qgq4HqQMZPU0ADuATngZyOKKiKy7s7gRk9OoGaKAPU41lt5CGgYlTkbl2sM9iOf8KjnS2vNoI2scEllAI+h/PrU6ahKisl3GrRgjAlzuwOmH9Bxx+FSXBtngEkCp5mP9UVIYcnGD91gPwPtQBzt1pn2TzZkD8McDjHI68/SsYRNJFIJowQz8EEdPbHXvxXSQ6tazyzW0SAzICHjdTu59FI68djTZ9NwuFgKv1G5SuOnHTigDEihWJWKOBhdwUDAfB6nj1FQw7wW2IVWQ7WCjk857/wCcVpNYzXCfO+z2wenb+v50iaZLAAYwGIzgKOvTjn2oAoRsyypgfu2BGB3x7UeUk0pfBRkGSwGDu9/1pZrC5LYO6JBwQwwc9eDU9tbsAy3ZYQgdSSfoRx6UAMvfs+oqwurWK4dicytEN/t8w5/z09MCXw3YOxAmntW3BQJCHB/lXRSWsBkYQMApyM/McEfpU9paWrMruQx7Dr+RoA4q90S90lVInI3jcAUPI9R1zVf7JqQ/doiyL03YwCOuecV6QLSOaNS53jGAeePzot7a1KqCkWTnAC8DjpQB5n/Z9887ARngfwgMfpwc1SuomtpQDC0RwRiRSD+Rr1mO0hlRHS3Vc/e4ziq0+lpJB88CSK4OVPb8KAPPLW5dCREeBnBI6cD17113hO/D6jEpBKLtGPX1OPwqhrPhaSKSWbTyqlwf3Rzt9eD69etYmj3UllrEYkBR0bBU5+hznmgD7c8EyW50iOWJj5rIHc5BJJPU/qMegrVvLeK5tbi3mVWimjaNlxngjH9a8X+Gfi6KOZYrhgFfaFbk/wCePyr2uKVJot9u6uHJG9OR9B2oA+eNRgfw9rV5ZS5VUYIpx1BHBH5mvQvCXjWBYbaGZmAWNEUFcYIAH8xWb8WdIjuLVbxAq3EO1WPPzLk8emeevtivIJNQW33IzDCnkEnjB449aAPrW11S3vId1oyuGBzweOxqrr0cVzayCQttIxkden/1q+ftA8X3dkcW8uWkclst14xyTXeXfxAgEb+a6MEPysrEdBzu+vFAHjnxqFtaarHY2chli8raSq7SCDnknr9elcp4VhEs+CjBQS3CgnOO9aHxJ1KPVfE5ujs2yEsoyWAAPAHPapvCtqXJdlYgnHTj1/rQB0niaOGz0WwMA4eJZGBUHnLf4V5HcMZbiTbvCMOfl/Ee9ep+O3KraALhRbRqRk4b/Jrylt4ndhtLBeBntkdaAI3DRvIRtLElePcU+OIxxiTODnb93p0HFVtx4BHU5Oe9WY5NrOCVZO/WgBjKAzkemW7gfMO5prlcj7xwx+90NIA42EfKTwBk811mi6PBcx4eEPjo3U9On5UAUvCjpa65pDmRY1F3Cxcjphgc/Qc9a+ifCtyump5F0+w5IORg8entXjF5oUEZPl24RkAIxnK/hSzatqFvDEv2yYwxqEVWkJCjqQAelAH0ZqFta6rHB87xvHJ5iMpGQcfyxUVvcvdXD6fq4jkfadpKcuvY9f8APFeI6D47udPU+Yq3EeT1JDn8Rx+YNep6RrVlrNurRyrPvIPzZV0YAcH0P0oA34ZNX0m2SGzeK6hHCpcJnysnsRgkc1QvJb2+lFxqskZeJSgjjQAL9D+VRRy3tmudzTwOd3Ul0Ht6/h6VIL+0uJ22OGkVm3Lggr9RQBzmu6g9peRQQH946ho/kyG6g8fzFczHbRXu6P8AdxpJIyQFVACkt8oB9M8V0fjWxi1HTZIXAOAXUMMtuUZwDnOTjHfrXDeHLuNisdyibSoYKxIHB6UAVpkeC5kgmQpKhKPkYwQcf41kX9ms6NC4JYYKtj6V0HjeA6fqhdUby3wV3x7OCMjOfyrFceZEswI2kKCc/wA/0oA5B4JbN9pUqBwpx16itCzvmEW1jgqpJHUVtS20N3EsbgeZggE+v+f5Vzd9Yy2krKw46kge1AGks5k2lPmYjJGM5Hbj86Y6sqqGTb15xyawYp5HVioIz90knB9PyxV1LomMZIJC4zzyfzoAvn7xOc5Ppiiqn2lUwF+ZeeMYNFAHulxte22krlF6t/Hn/P8AkVhXFl5cbJBJ5LtwuGDKefQ1uPBEG3jbjaCCR0x1OP8ACiVNiK8YUnucDBGKAOUuPtkMO2a3Sfax2lcdD9cfpTINYjMeyRrm3csMc8Djrj/69b00R8xVYPjBywxwDwf1qFLGHytzLuJ5VwO349KAKct0jRR7p1kVeRwM9enHNQyhi4Ec5YFu7ADke9XrjQ4pQBGTjZnBXrUSaI8cY8ueRepIPPTrQBQvLTVZIUMMkQbKlvmVsADjIHPpSpBOsREkzHavJ6YPua0Z9LuIyCs7bMjnYCD79uPxqmDexTfZ0lUzBfMClc5GcdOnXt1oAqR5482aUDJwc9RSwTiWTa83OQANo6/l9PzrQibVXHl+UhAJ5RFHB+mKsWN7qADsLeRc/wAPlbgfqCf0oAy0uljmZmmXaeACuavfakLZkADK2N4cgen8u1OuLi4kRvtUCkMMlxAAB7cf0qkIYYmEsaMm9tpOCA1AF8yRhnMdwx5HzM4Kg49fSoSiK+JMOvbaelQxWtvesrfaZVCkjC7GLe3OCK1re2tyMCUjcOd8GP5HnkfWgCnLaJL5hY+ZHtx5uRkf/Xrg/HGhSWwTUUJZk8vJDcFOgOTzkHA/zmvUoNNnSN5LeRCAOQCdp/ziqywGVhBJDG6P8u1kDIT6de+aAPNfDGrSwxJIJgj4ydrAY+nvxXsXgzx3cafbLHMzyRkE7Q2MZ/8ArY6V4h4l0G68NXjTWaNJYuchyvMfP3Sfy5q1pOsBo/3zbGyflP0GOKAPoTxPrVtq2mSMxIkL42qw5xnB4+gr538ZPLZah+7cgyruUlhjg8jn6109vq7FowWYD+LtzXPeMo0urYy+ZzHluOhyf88UAZllrF9akloHkGcBlOf6VoTeJTKgNyksTEHCsMA/5/pWBpouRA5AlKOSAwyc/wCeKgu45ZHw248gnI6D1P50AWNTu1u76NlJKqvy7enJr0fwDCZRDjDKT0AxkE4ryqzjX7SiFS3OCcdDmvdPhXZLc6hBCx2KdxOwYAoAzPiOoM4UAZCovBx0A/wNeQ3I33LJG2WGTuB7969/+KumSR6hJ5aN84XawXrx/wDWP6V49f6cwmYoBnpkLgH/ADmgDB0+3jku1huSyqxxlWAB/Sup/wCEH1OTT/tNnEk9sxG4qTx3I9jgisK6syshG1gxOfu9Tjg/z4rovCnjvWfDdw/9nzARuF3RyICGHPY/jQByN1a3Nq4juEdTjjDcZzx/StvQ9V+xvyW2DIO09D6V634U8ReHPFsrp4isYbZmXLPBFsPbtyOc+w+lct8WdC8O6RJFFol39quHdvNQKAIlwMdByevegDQ8P3Y1S7itk2nzWVM5ByT/APXo+I9vYw2y2tgg82OPbK+77zgnP4Y4HSsnwPFLFJbtCHVoymOc89sV0PiCxkure4YjfuOTkdD1oA8iikkjPyvjOeDXaeDdblsr1Qk7JbswL4A7cA4PcZrltWsmjnGxn5y2FXBz6Gm6W8lpcZbK4xjcPy6fjQB9NaBqCXsAEzMxjxllPD9OadrGl28j/aof3E3IEi/xdvy6e9ebeD/EKgpHMwUhQquo6nPRj268GvQI9YDSSI25AM8Yzg/4+1AHO6/NfiE3Bsy32cKXeF8nr1I6jNeb6aZVuGkmwhLEgbhnr0r2MuZrgNDIFLHAVV5J9Tk/rXB+OrA297bXkES5Z8ThFAGeMMB796ANbU92r+G44JbdpDASBMDkhW6gjr16GuGs327oXkO5TgHP6V6R4RVgpdQJY+cj07/lXDeLtGbRtfuAD5kZdSGxjORnkZ9KAM5IxFIQwCcfL83Qf/qqWS1jnX97lic8g/kafeRf6PDcL1+nvxTY5GYjlgAcMSuMn0oAw9Q0PLM9pyhAwAQeax5rWWJefqw9K7+LavysoCkdcdOKsXNjb3UZ+Vc9iBx/nigDy+UOp2jqOOvSiu9u/C+5SyozAEhtuDg+gooA9IhMjRh5YWiZl2bSwOcHqSD+nbAzTNyr5pTZvUfdGeef1PNb14qklghzkFAO3H+Nc/eRsrsSShHyjtk+tAFdxuZ2+UKzZ3BSAf8AOKfEyskbJtZywOOg/IUBFMiqmZFTqM9fX+dWUjYQt5gCBGGOentQBEkisiqCFkAAwfamtJ523bt4BZg2cUTxTRiR0ljfb90Mee+RmrFhYwyafFcTsxMpKjawwKAI3UmEAMd0eMhef0qsIWb7ylcZbgHNbMGnzXGsxWCOI1k+ZnDdsds+1aUujaPZQYuLm5eQkh/3ozx/nvQBzDxLIx8sgD/dIx7fmafZLGMKWUSFu759v8a3RaaGrStJc3Dqc7VaYY9ug6cVc0rSdIuwfKtY2J6PvYnj6n/OKAMItFukVigQ5HzYI/z9KjeFGiZdqZB6YwPqPxre0HS4oL28+3xo/kOfJVmzmPPT36DmjxNYMsdvNp6EGWU28oBIC+/5CgDl/wCyrSQgvEhIwT8mcgd/5UTaHaxoGVCu4YJVmH510A0K0SIr9quN/UEsB0HX86hudJ1CG2kMckVxEwBVdwyefT86AOZbSAsoktbh0KnGAxNU5I7iNldsOgI+7uyQD3Het97W9UkeRIrkc4bgdziqtxLJBcokwKvjcu7HPGP6dKAMm3uba7imgufLlyNrI/Qg+ox04rhPEnhDZcy3ehlAuSfsxz8oxztPfPPB5+teh6lZrKvnIWMq8ht2Bj0b1rPsbxXaRZEcjJVxkAg/XuKAPKk1SaHDTbhLHlWUg8+xJqx/a4u7eaNhGFK5Ktmuw8YeHUvYflYfawAUlMu4YzjBxxjr7jjtXlsiNFIUkGGU4IzQBegWPzyWKsq54ZW2j24rckQf2d5lvHCvK48kHkcevJ/+vXLtyzbgeSSAD/nium0WQy2MkJ2qdoyQT0xQBz6oonDNIFJYk454z/8Arr1n4feIP7Mu4LhGUhcgjGOO/wDn2rynUIzG3bOcMAetX9J1AKArZ3dDz2oA+hfFXiCy8Q2qBSolHBb/APX9a4S80lLmIumwnGNvvmsLTb5mPzM3XqeMcVv2V80ZRc5BOSxbrQBknRMuzNkScg59cdqy77QmWQbk42cHJOTXo0NzbNMTNHuwuFLHv9fzq3JZ2lwFbo5x/q2B2gnmgDx5tLvFlDQko3bAK457EVesfDU8si+aHJOSc5y3516VHokCSIdynL9149vpWzBb2NqcENOwBHyt8o46dOv1oAyfAvhqW3Zbloi6QEYHPzHtjA7YH5VqeK9LaG3VHdfNfcSoOAoyP89K3rfxGkFuFWIgJ90j0/zjpWRrupR38IeQ/vnOQA449QQO9AHk2sWebqX5cLkgFenrnFc7d2MkTbvlAHAGOM/SvRby1HnyPjcTnGT3rm7qISKQWbzG4JIwOnWgDBs5zaSRgMcjHHqfSvR/DGpi4t1hMgBcEx7mIIIz8v1wOPy9K8+vLYrGxXO0DPB6+3Pb86k0O4dH2ljuXO07sFWHIwf60Aeu2kpeYMGwx7rnn3o8XQ+f4XlmDr5sYWRec9GA/kc1EJUuDb3UAKx3May7VPQn7w49GDD8Kn1oqNBuwVU7rdmQ59j/AFFAHPeG9RlgRGtnAKsR94jd7GnfFC4F00dxHDNbmSFHMTjBByfmHqO1UfDUJnWNQMod2QTj8at+N3lcQRXC/v4oFxhuMdfy5zQBh4R9HxIfmC4xjk8f55rLs5mWX5jtVXK49RitSJS9iCy7VKjcfTj1rBff9rZULFfvEA84/OgDaScMqnv/ABYBOKtxSMCoLsqA9qyIXwQScgnHUc47H2rTBHlksCG4PXgetAG9Z36o/UEMDuHQsCaKwkzuG04PrnFFAHsF/EktqEywUYy5UH5a5nVZVhhk2RTyBMZwOW+lbE8jAvbGRMouCGPXJOO/t+lZ8/zQsHaJt/TBPyn0/OgDOsZPNKSOrRI3z7WXaR7e1XWkXzIy45U5CkdevaoY4WCuu1BgH5n79OKV9hcDzBuB27gnTjpigCV5VkgJUZG0hh0IB7/lVrQ5FOlzx7c+UzjBHA5BH48n9KybZwhPmbSDxjHv/k1c0BGKX6hSVyRnJwc8dP8APWgDatJUg1XTJWJV2ypfOFHH8652/IN75bTt8zkFlAG4Z61p3Uo8u0jUBgk6gtk4wQR/n61lalZnzj0d+20Y4BHcUATX2FTequxxjEY3N+PtWv4Zu5oJ4oBI6xbt7QmMAPx1J9gK4W7JglAQkc8o2cKfUH1rqfCt+JFRZJD5hcKFcEfr60AdqsPmeI5tpJVrFdxwBg+YPX6fzp187QrYRqSxNzyNvQbT0x+FZtpORr8ojPmbrUqCMkcODgY/GpdSaQ3Fgqn5hOSc9eFoApeJUuI72NYXla3DASKFGcEnk569uPWqcl354KRrKiwggCVR8w79OnT9aoaxfeZ4mie4J8oKGKMSVJ+n0/lWdcSOivJaR+VHdE7S7cHn9f8A6xoAtSX12UkkjkBiTliY8Adq2o7qPxFo1xDNGPORQ6uB1x15PtXHXdtJvFtI0o48xRvOHOMYHp/9atywX7FpToeJ5R5aBcgkn/IoAw7e4n+zqWg3gfKzL6Z71QvowbhLuIHAysmB1Hrz+FdYLJbS1gsyjI5Cg47k9T9P8KxbqwW3vpUkVWSTJAJyOtAFMWguHSNm2h+EJwQp7Z+vFedeMdHEF2JymN+Q5Tpn1+p/pXpOnLmWa0dleRGBBbngjis3xJpTXunOz7c/dYHqhBGMj8qAPGzg4yNqEnDY5rRtpTDIhTf5eR0P+eKh1GFoZmWRFUAsvH96qqEeYMBV5ycc4x1/rQBpXkRk3MAfKYZ6Z5/A1TjXy4nySCD8xA6Y6Vuad5c1skKMpyvfj+VMurMAjAwFJIIU9hjj1oAWyuEEiBQwYkbiRxx/StqG6YAOWGMdQMba5hTtOT1HIIqdbkgIpIz6k9eP8/lQB19nfsJk3Z64J2nP5Vq2l+GIYvkY6bRx9a4mC62DIP3MlgDxz/8AqqxDf/eDYBIyc5HHFAHokGo+ZHtJD7ewXFX7bUI0hCIQQctk847151YXyh8SYUHjA/z1rUjvgx/1jKSc88f/AFqAOpa7QbQhzz3HA96jubtY0bOCVI5xx/nNc+bjzcBWHy88evrmpEvVYKoKkdwTkmgDWlvWEeJNq5BBxWXdqN7sARyB7dKbNMXbKZXuee9VbmUyS7V2qWAwP59vagDN1CKNASzYAPC9T/n/AD61hCVobkhCzfNwQo56/wCfwrfuSY8phN4XoB1xXN6kwZsqAGPIxxjrigDstC8W/wBnxNY3Nu0sTsJYWjwCj4+YHjkdOP8A69XNV8VS6jpogtomheRMSM5yvX+H0/GvPsiS3CgjzFwV2k59f6VqaRcxCUCV9jk8Z4AINAHpXhSAxGLcCSqsMYAz3+n4VX+KtzBcaiTZBvKCRwt8m3JA5OPXtWn4UmhkWZrjb5cEZmf5tpJHTHvkj9K4/wAT6j9u1Dyfl9ZAW79cUAWdP3f2cXKFQVBBIz+BrlJ5WS7kJJyWBPA445rrpX8jS4kU9RnOOox1rjpULXD5O0EseR+NAF5XJlZDgf3SeM1opJtKrKBuVc5Ax9ayYAw+++8noeSB/nmr21wwAbkjkZPbjFAFwuA0agYz7dsUVTSVu8jYGSOcE/zooA9d1OCGaSM/u1kdwoJcDdxyAM+x6dMVU242ptCmPrtP8Wa6N2BdwoZfkGVKK2eMAfr+tYdzb+TIWXcwP3iqjHH+f5UAL5MpkZUdUkOOScVF5LxvIzooGR827t7+lWYt0Luyo33iuHAOSBwcfhUd008rEGBmAGOB2z0P6UAVLW2mMjSNHwwJB/8A1VNo0J82/LeYMttKBsAZA5Iq1ZtM0C4ixKoKhSBt4P8An8qtWNrc2k1wzIJFkbc6gDr0GD3HFAGReoYoRLjhZUwM9WBH6VV1J5DL529kZxtC+YOBnPGeM1sawk9zbTW0EU0URI5KBmJ69fris63trlo1jktpJSoH8IwTz1/CgDCkWa6ZNwLqTkqCD096fbm4tZCw3RvuG05yV9+lddaaReFFSOBYSpLEYzj05zg1eXQNRklR3eNSABjAOTjI70AZdnI663pzK4USIUbJxnPUDj1HetPWZX+3aa0jlWLSAjd04HpSN4b1RbqO5baXhYMp+UDOcZ6+/epda0nUr4xSyRL5kJO3yo/lORz0OTQBwniS5FrrDySqxeQg4yOgBxgfjmk3w3llE0isGjJcEP0z7fQVtarp18s2byxc/dHHTp9apR2sEkarPE0Rcc7gPm5/z+dAFW1uZL68jWR8RxZ5LDkD/wDXWrA5vtUE8bYtYioVc5GQP8/U1QjtFti9tYxmSaVjtA7ZHv7Ct6O0i0yCIuWMCYA+XDSvjtQAalJHbqJpGcSP9xc53EHr9M1gX8F8WjupYgI8tgHrk/y/GrtxdNDsvLh90pH7sbflTB+n05qKHU3n1H7PfOzJIpx7ccUAZxVJ2iu9oBG1Gyw4Hp+fOauyxs0JkETSRSY8wbhnI43AdvT8azYEVJrq2PQNuA+o/wAaU3ssVpI6MGkgGJRjnbu/njvQB5/8QdHEM5u0GIpmPAPR8HHB5wcVw5ZkJ5Kt8vGSM8V9A6np8GqafdRyYZyrZyoyUK469j05rwrX9Nl0jUZLSQccMrDoynoR/n1HagCvaXT2+WQdO4/z/nitNtReVMZJOODu5P0rFP3TtzjPPvTgfnJO0dc4XOP6f/roA0UkCgGUAAn1/wARQJkdDsIwF7nqf8+tUJHDOQWypAwcZI9qd50wyd5HUcgDP+eKALauAQuQHyQQGzQ8zINzPtwQBgcj2NU1kwAXVQc8nAyc0+6bcijGM8kkY5oA0UuyFBZiQBkdvxPFXorsvtcswbO3rnGaw413rHtRQhHzFTjpV2F9qNjAIPG5evHagDbguHjwHZmQjHXJqz9uUbQykAcDPfPt+Nc+ZmkTGcnjI2579v8A69S/am2nzOoAA+X8/T2oA6E3WfvOVYcDLYOKmhnVjuYlnJ4cEcf0rnUZpNzDgAYUEdfetATqm5gwHIbbjOeOe1AFy4kSXeX+XcMdQMVz2pLtlBAK9R17VbdyQO5AxVG4hZkbdjknkKOeP8aAILZf3iKnbjqRWjM6PauAqsduQc46Hn+f6VmLvBLLk7enHAqRZTiQjJ3KVxjpyP0oA2tN8SX9hAUzvjkBHUAkccdOnFWrK8ivbkyZId3G5W6//Xrm0hlnCxqDxkgY6Uot5FIAUgjpjtQB2WqXTQwjJJB4GT+GKx45TJIFAK9eh+v61nSXU8iIlwC6qMDgZGT3q9a3Ua7kd9mOOnc0AX4V8ttxLZ6gnnp0q0uFg4Zj8vPzcKc8VXifc6mM7iuMAHNX1h/dMMYJGMHoDQBXkkyg3tvbOeOCOOmaKbcKRKQFbZnIGMfXFFAHuNwjxuQpVUO0YJPPqcVl3hcudkYfAycPwD0OfoK3ljDIxD/ffCMBuIPPGOneoLrTkmSMxJPMrx7mkVwoXnuAPb1FAGNHEpRVVcBSxITnsMc45qYNHAql4yvm4DAf59KSeydZpoQ4ITcAQ34A1MIpzJGgUYK5IDY9e/WgB1pclyhgEJQ5Yl8EMP8AOamn1SeCaQXMcaEghemDx1+vT8xWCsz2rSwSy4IXMOHPHsfWs221Sa5fyb0O7ZIDO3Rh0OPSgDsbfWRwGVWJAORgbfxH0605dVG92EJwwyeT1PfP+Nc7p8hcb3wsisFK55FS3M7rDMjbVUqdnzdhQBuw67NdM6WUMDhCynzASD9D35q/peuzTyyRXECJLHhdrcjHbk1yVhPNDYmSFiNmdyggAH1/Q/rW3NefvLS+YsCQu5gAAw9cfXNAHRtf3YYBihQnk46DPB9xVRtcnFyYIY1knUFiEXsRmkmmSSIzLuwehJ9Tx+GKxzOLZbi7Zt7mRsksMY6YzQB0P9ux7kg1GA27PtZSw3qRz7e341X1PQbS9jMiKih0ypBJUk/y4zXKtqM97ZPE3nBhiSJXPzcdx+FdPoOozNbW75Z4WQBlfoo/LGaAOMeBvD1/JMLeKdwSgRgRt7cVYvpf3fnX5XziRgDgRrgYHP8ASu08U6KmqaYxiOJYgShVuvtn34rh9RZ9S0pbpd/mRnD+oxxg/pQBzdxc/bLjnACkgEkgVFqCmwjtJZEJlJCnjnH+R+tQp5y2pSQ78ZZQef8APNP1SeWexZ5iGLMQ21ujBc8d/WgDTvmhka2vY+BIiq+Cep4/z/Ss7UgkTiYYCSArIByCPU1Z01Vn0+4MqsIsr1OBk5/z+FNtTHc2bRtsdsEYz+GSKAGWF2bGRQf3tqVbayguUJB4Psea5z4kx2c2irKzWvnxFGhdXG9gesePTBJ56EHjmt9Y5NKaUKCbTqVznaDUd5pdpr1sy3o8xNv7qQvkqwHHIGcf0oA8TLg5yoyRj0/Gm/w+2a6y88Cavblgj200o6okvXJxwxwD7nIrGvdIureKWWaHAViWZWB2/X296AM5iS+QoycY29jxRIwY46jGB7c/SnIocfdbGecep6D/AOvQQUIyQc+hx7c0AMch2ZsAZOetT7Y22/MuOOeeO+D+FRlC0ijCtnshx+GaaA3O3DDgcDj2oAnQrCCyNkFcgHtz3xVgzKyEqeg4yDiqQjLISwb5FP8AP/8AXSRt5bMCflIIOO9AF5LoAsM7U4O7n8OKmkl7nAIBOe9UVV/KLKFyOjZ7e30p0owpfAZMYJU4yfWgDSS7VmYkdCehPX3pwu/MRihAOAVGMnHr/OswyykkbWwxIADDt/k0tuJCXL5UkjnHXj/9VAGyJl8sMSvTOAentVczq4IMaqvf39BVEMTCFV/lUY+9j1GfamiY5UMHA3H6Z/z/ACoAuIgf5cJH0A7dfzqWGINCwyN5AbBJ5GcVFbykR4mdtwGBtqy7J5AVXG3GPmGf896AJtMt/nVxnBBG7p+VbLWJZVcxk47gdRjHbtWbY480bSdvbB61v2t9JEhHVuxNAGeumMXJ5CjoP89aq3mk/KQCAQML7e2a7K2ubWTPmx7XAysiHv70+Gzt52YJOF2nGScZ/SgDzs2k1vLG0bbfx6+vFElxfQHIlcEDnBPH4fgK9AuPD87AsqB8AF2RgcdvyrI1LSWj2iSKRWAxg+/egDkRrt5DJIDHHIBwFYHPTnpRW3FpgYsfL3PypP8ATFFAH0jKBCp8iNZIwwAVh0IycH2461mzTLKZZJw2wLlto4z0/D0qe4cvbSqXUkEDIbr9OfTPNc1qF4S0yWtzGDCMyAKR1Hv/AJ5oA3YprYWX2iS2AVf3a+WgYMSCRhs57elVI3M0zS+WuAoOPTPTnHSqFheiWGKIPIbqQtkgFvl68c8D6VszQwOFFv5RKoN4HO8gckZwTj1FAHPX1jugZ3AEi4KnBOTkdB+FYtzA8cxlcqUkQjbt6EdxXX3cW/TisZEQKEJLjJGa5K+gmltAizBmikKsw7/h/wDqoAu2F2r8oV2NhWYjO0gfpwatqyzou0nAPzAjr14rm9HmVPOikjPkykY+vqPrmtrTpBGqowUqV3K4J+cA4xigC3p7rHFPCV5TIdSo+UY4P/1+Kl0m/N27wORtYYBGQFA7DH/16imhEF9DNKQqt8j7v0waRTEl2JEmjj8l+FZflbPX9OKAOp0yQSWMauGG1drAj09u/es2YRrbXcOAxaUsgI67gCAOPWmGUW14x8xDFcAOrAdD3Bz3qtfP9nuUuNytGTsbn24H5igDNtjIdRSa6P3uox0AGBx+H+eK6Hw5crHbGJUDDcULdcDd+XeuPki2XE0yyqAjAlQccE8Y/nW5pxEN1sLDy7j94uTjHNAHeaXehIHBfEY5UgZyf8KwNYtmtdVZsAW16ArMwz84yR9PSnw3HIG8fKxwxY89atXtuup6dJGrFWYh8q33HA657UAeYanp1wLq4iSEmPeQh6c59ParNjZQ28ISRPPlZTgBOD2xXT6Xp1zfac09xKuyRjGqqnzDkg5Pbpn8c1cs7S0sYs7XWQE4b+Jhn8xQBiR2kxRRdIqIGAS3Vcbu2f6VlX8dvb6p5kETJFt2MAvyq2eR9OBXURW8lzcxysyQoGAVFzuz3znt/jWPcXFvcyPavHGEdWCHPzZ5xk0AVrlgHDp9znqOMYFVJnhEfmN/rE+6R1/LvwapSWxn05oElaDy3YFwCTtB+oI7d6oQSzo7re42qF2yKp+b1oA1rG4a4hYG1dSozJlflyT2Pf19qZJZwSwSmaFJFlUq6v2HPT0NQ286bVDMgQkLk9WPXp/nrV+KRZgy7lIOemelAHC6z4PjnBe0iaB9nJAJB47g/TqK4S+sLqzlWO5hkjf7uWHH4e1e8RxrH2LcdjyeKoXFjDcIXeOFyoJI27h+f4D9KAPDyBsdWwrDttyfzpA+FCso29ye2f5V61d+ELW7idJUhUlTtkRdrI3Y8dfpXPT/AA5njXzBqEBiJx/q3yPr9KAOGD/KBvKqOQMfy9aMY3qxG7PXr65962r3QZrW7FpHLDcbk371LAJ25BH0rOu7C5s5czAdyHXkcD9PxoAYJN0oHBj4GP6j0oYruI2FQEycjrg+g96hUDDOxXGeU5wfypRF+7Z+CTjCjPGaAHPIhIBfcCfmO0A9KSDdvKxA7TzkjnAqMjaQuFYkdjn/ACafF1A8sHdweaALQiC7SNxwNvXkg/4VDMuyEKgBDN+RxT2LhASSoAzuGeo9c/ypfvoy7RvGQDnuc9KAJlZep2kgZOe3H6VNNIpVAAeOOmeneqysGCq4yTxnHB4602RwYXAOMAEHOe//ANagDV0pwJdr42e4yM4P+FbUjuF+RQeAc54H41y8LvG+4Acj1zg/jVu3upOIzjBIGc9R/jQBvx3nlbSsh+fjGPfk/TgflV+C8Ksm4jIzklfyrnEYMn8OevBz/n/61WozibLOGGSSR7DrQB0lvq7wyBo3ZSBjpx+lW18SXQfBmDLjGWXPGelcxGSZCQ6sp6gN0PtURucYBPzFue+0f1oA66C+srrie2wxbkx/KSfX3/8A10VzSzqrA8bgwHcjPpRQB6rqGsGTO792u/I+cFT9fzrNluVkUs53bhjaDyeee/PNVb2Q/aUiYhlJ+8FyTnGfx7/nVV1BJ2FsAdSBmgDQtroRT5XdjJC7OvTHftzXXWeqWUiq92G3RqsSLG3J4x0xhQec85NcCxK7SiliSQMdenBreivorRDFYuTPJGgecINwOOVU9uo56n+YB1Or3XmW8CoRtK7hGh5iAPfqQa5G5MSMzEl4WJGGbDf5/wAKBLL5Cl2O1VBOOPxqvBOTsVCP7zBjux/9egBFtHkffBJ+6HZZMnvxV/ypIobMShN6Oo+VskKTzkfhVaPDSssatvGCMgD1P8/5VIDhA247xwuRx1zQBf1S8Sdp7cK5ZOUkJGAcdPf0qtGg8oy+T5zMv+rY4+bPXP6+9T21wdwZ8ArkYxx6c/nTXgkjR2ji8yI8KoH3CewoAsafGbmxnhnkDyEBoyGBCnuOKsRxNqGnTwuC0ke/cGbHI9Kr6dNbWL7yjK2MuqoeMYJq5Yyss9xcom2OYl1Xq3uR9eaAKL6fLdXcD27GMMVZyBjBC+nr/KrmrWV4mmW0zZMlsc4Vugz09M+tT21q+/das6Fyp2lc88+v1/SpprSYrI1wQYzyE2gBue5/woAr3SCWGzLSyoJnO4hsYznv9cVespZNK1FIpmka1dgodzwDg8H346/hVS+tS1tOfLC+XyuD3A4rN1DUJJI7YXKj7NPgMQPut1yP/wBVAFjxOLjRGd7C6dLW5fLAHIRic/1p07x2MQaZ5ZZZFJDZyQfQ81Lprm+tpNOvggdogsW5QTkHj+VZcqSQM2n3C7ViLeUSvRep59s0AVNWv7hriMQhgwKkDPQn29aozXCNcm5iBW5RssqjjIIJP0wf0qB7htkcEaFpEwD82cYPerEVgzShrnbHGTubAy3J5x6dP1oAY04F2S2BFcAn2B7g1T1TC28jF3SMqCrbsfQD/CtKexuHiDRRKscOWUyL97jGP896jaESxB3jJBUHy+AFb1/PmgDy201i4F9ZreMxTeMjhSMHr712WnavbXEklvburTRvkuGwNp9/r3rL8dadDNphu3DCeEDaVxkgnpWL4Smux558lRbA5ZsAnPpn8KAPQ1uHk3RhvnBB4bkjFWYJWAj+ZUX7oUcE+/HvXGQ64BqpslOSSAXVeMc46/T0rorSdiodTg468c0Aais0ZCuydckk4OPpStOoSTY27GOAcjPX/wCvWe00hbGc5zuJHaowVbIUjB6kUAaBaFyQ6JK7KF3N1IJ6A/XtVS60a1uTIGjAjIbcpbAPHr+X5UiFTndnpxj1qeRWjhw2cHt2+v8A9b2oAxrnwVp93G4T90VwPlbAB/H2rldV8CXkEjfY5UaPb0c+/YgV6BFI8agjGwHkZ6mrUd8yOf7hH8Qzx7fr+tAHiN1pd3ZAm4hY9QGU5AOOKgVjvBKjI+9tP55Pb/8AXXvS2dtfRq0kQ8uRiuQg5OBkZ/Ede1cV4i8BsyPdafEUJI+TbhW/w/lmgDzx5cqw5IIbBPQ/SmQgB1HVmzhgeAe+B9Kv3+n3to5WezlAOQTt3e3as94j5j7Q6YPIA6f5NADpCQyvGw2Zzg8c/wBKnhKFGYBst0/P/wDXUUSMIxtyjfjgnnt+XNEasPLYqFOcYA657+1AEpTZJwM8nJUj1p+VG/bwucmkB5YnPBx/Kkl+42QSPQDJoAmjuGVVXeADyAMVLHdlSTKflAJJFVHU4++Rgdh3pRndySAexFAGkl3lkERALAEHPANSiUmQEHaRgknrknisoEbhyOvenhyrHo3qfWgDVhcCdVDLnIB6ZHIoqjBIHu7fkFjIuSQB3H9aKAPombwFfThG+0wLIMNuVGPbt09v1p0Xw6m3kvqCqGABBhJAPt81elyB2wQx4YHr29KrneCC5zHtyxyDnP8AnFAHnb+AJo2UJeK791aIgH6YJ9+aH8BX4Vwl3Z4DDlSwI7DjBr0YpucMJMADgluMc/5/H8abKJCAdxULyRjpx2PfvQB5ovg3UUfKTW7RsMgBzjrnuPaoofB+qMzebJbhOfl3nn9K9JiBbLRle3GcZ56fpTJraQRl9wUjjGe/agDzk+HryNnEs0ORgnAbgflUUXh+9w0vnwshHuMjHUcV2c9ri7G2SRpW65OeT0/nRbfITHI5EJxjp8pOOM0AcadCuoVEpniO3O9RnHOf8a0LPTLtzthuoApAxjPSte9ijMbMJBnOTsYDgd/8+tMdJSweMlsjA6ccfp1oAy5dMvFO+PZLERkspznJ68/55pY5ZI3xNAsajuBwW9OatNO6PGWLAE8knIbngVLHdTs/lqDkgkMD0/yB+uKAK0Gos0fBiynPBxnPbHSrENxkrvwy7QGAHHtRdWFvHEZUQf7W0/xH8MdazYIrxGkkRBImcEhsY57dOlAGw+fMmiDb1fPQ9Pwrlhpcl7FLbIENxESVDORnuOnrWpEEhl89w4lZSMZJ4xz3+nWkvGki1BNQsskoAsiqcblx2/P1oAoWPmXenxBEAmtlyHBJIO7278Cpb101q0YLsj1KDLfeJJ45+vQU1rqxnmEljNc2dyVJki3nBJwQcVRjlaG9kuod0dyCTk8bhj0HTtQA3RYBeS3E0UaJMpAd5DhV9P6VpS2NnbgSXl0sjkkBQCF55xj+LrSQwm+tLm80xhExAE9uW6kDsOuD/OqVjEslg97du80yLgqW+VeemO1AF2ENqEnBaC1+YlmH3wOw6YHSmahpds1i82kOrTQAb7cH5z9R3+tZt5rLTIUtUAwShYdfw/IVhxard6fdrJFK8T4wQTyc9jmgCcxWt7GBNHHIjD5kck4b6d6qppMNtC5tIUjEj7mj28A/T3/rWnsju7Vrq2VEm27mXORnOMEf5zxT4bpJ3kCk/ux8wPX/ADigDy3WdDudOv5by3QGJGDgnO4DrnFQ/wDCRvsRUj2sB8w3HHXnPHHevRdUgW5iZDucHacZwSMeteea1oEs1+zaeGOMhwzj5WHp7UAXNI8RmTUHSZlSAr+68xz97jPI7da6c3QWLZkLtI5PrXmVza3EE485JEYMVVh1J69vYjpXUxarcw2Ki6tJHmAADFiATjqRj2oA69LlcK24GNhwcZ2/j36GnNdKzAhg27I4/wA/hXFW41D7R592hfK7kBl2459AD71oXcWq3MJksrmKLnCrG5Djjvkc9/zoA1bzU7e02NJNvnJ4gT5j0/SqEGrXz3KO1q1tb7S4Uo0jS89/Tj0xVnQbeOCISC1dLsnAdnyx4557de1b9raqxG9CrEbvvcgHrzQBDomrTSMXewVVD7f30pwRxzgA4/M10Uuo7Aot7Rpw/OzzNxI9iQM9elUo7WJndSANvPzGpVXygrJuLYCkg455/IUASLBpWsTfulh3KCZUK4ZXzjbtPI5/Cq03hKxyxMEbStn5VXGPy9qy9bimSUXlhJ5d5Eo+62N4z0I7irmieNLRWkGoia2uEzuRxuAPcA9+/wCdAGNrHha1LhJEX94Dycg8Ang+nauL17QZtPYCMMyMN211OQO31rvNU8U2s118sM06nbtLuF+Xrj8T9aw768F/eF76UztjhUOAoHQY9PagDgJHILIVXepzgAnH6U6RikZGAFXAyRkHj/8AVXZ6xpdtKjSQqqTE5OOp64rlb21lVkUIoDEEDOQRQBSSQt8xOcLyR196eCjMgQsOCQc+vbnr61J9n8t1LriQD1zn396JF+XK4DDkFu1ADlzzyDz2qE70LYKls5xgk4yff61KhDZIKk9Mio58MmBgtnAPofY+vFAFjTmjn1KzQgtmZflwcg5H+NFJo+9Na01Tkk3EYwTkn5h27UUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upward pressure on head is applied as downward traction is exerted on feet.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pritchard, JA, MacDonald, PC. Williams Obstetrics, 16th Edition, Appleton-Century-Crofts, New York 1980. Copyright &copy;1980 McGraw Hill. p.1078.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4584=[""].join("\n");
var outline_f4_30_4584=null;
var title_f4_30_4585="Management of perineal complications following an abdominal perineal resection";
var content_f4_30_4585=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of perineal complications following an abdominal perineal resection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Robin Boushey, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Lara J Williams, MD, MSc, FRCSC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Martin Weiser, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4585/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/30/4585/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 11, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H492489\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An abdominal perineal resection (APR) is a surgical procedure that removes the rectum and anus (perineal component) and creates an end colostomy (abdominal component). An APR is primarily used to resect a very low rectal cancer or anal cancer. It also is a salvage treatment for recurrent rectal or anal cancer and is a surgical treatment for severe inflammatory bowel disease.",
"   </p>",
"   <p>",
"    The most frequent complications of a perineal resection include hemorrhage, perineal wound complications, persistent perineal sinus, and perineal hernia. Factors associated with an increased risk of perineal complications include intraoperative hemorrhage, intraoperative gross contamination, operative perineal wound management, preoperative radiation therapy, and indications for surgery (malignant versus benign) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Management of the perineal wound ranges from packing to partial closure, primary closure, and closure with continuous irrigation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/3\">",
"     3",
"    </a>",
"    ]. Primary closure of the perineum following an APR is widely accepted when intraoperative hemostasis is intact and no gross contamination has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The perineal complications following an APR are reviewed here. Anastomotic and intra-abdominal, pelvic, and genitourinary complications are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/5/4186?source=see_link\">",
"     \"Management of anastomotic complications of colorectal surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1946?source=see_link\">",
"     \"Management of intra-abdominal, pelvic, and genitourinary complications of colorectal surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H150458379\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE PERINEUM AND PELVIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The perineum lies below the pelvic floor and anterior to the sacrum and coccyx. The perineum is bounded anteriorly by the pubic symphysis and the arcuate ligament, posteriorly by the coccyx, anterolaterally by the ischiopubic rami and the ischial tuberosities, and posterolaterally by the sacrotuberous ligaments (",
"    <a class=\"graphic graphic_figure graphicRef54523 \" href=\"UTD.htm?20/54/21348\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef63229 \" href=\"UTD.htm?10/37/10837\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef74060 \" href=\"UTD.htm?28/57/29588\">",
"     figure 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef79236 \" href=\"UTD.htm?14/47/15093\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef52520 \" href=\"UTD.htm?27/45/28375\">",
"     figure 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492656\">",
"    <span class=\"h1\">",
"     HEMORRHAGE AND HEMATOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meticulous hemostasis during the perineal portion of the dissection is essential for reducing the risk of postoperative hemorrhage. The incidence of early and delayed postoperative perineal hemorrhage ranges from 0 to 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/4\">",
"     4",
"    </a>",
"    ]. Perineal bleeding can develop from several sources, including the presacral venous plexus, the prostate in men or vagina in women, the pelvic floor musculature, or distal branches of the internal iliac vessels. Life-threatening postoperative hemorrhage is related to lack of intraoperative control of hemostasis. Hematomas occur as fluid accumulates in an undrained or inadequately drained space.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47741652\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent and uncontrolled intraoperative bleeding is the typical cause of early, life-threatening postoperative perineal hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/3\">",
"     3",
"    </a>",
"    ]. Packing of the perineal wound is a maneuver used to control severe intraoperative pelvic and presacral hemorrhage. Early postoperative hemorrhage occurs with the first dressing change if the packing only temporarily tamponaded the bleeding vessels. Delayed bleeding is caused by erosion of the packing into previously sealed blood vessels and often becomes evident when the packing is removed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1946?source=see_link&amp;anchor=H98515550#H98515550\">",
"     \"Management of intra-abdominal, pelvic, and genitourinary complications of colorectal surgery\", section on 'Presacral bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493527\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of perineal bleeding depends upon the source and severity of blood loss. For severe bleeding, such as bleeding from presacral or pelvic vessels, repacking serves as a temporizing measure until the patient is stabilized and transferred to the operating room where the bleeding source can be identified and adequately controlled. Management of presacral bleeding and other pelvic sources of bleeding are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1946?source=see_link&amp;anchor=H98515550#H98515550\">",
"     \"Management of intra-abdominal, pelvic, and genitourinary complications of colorectal surgery\", section on 'Presacral bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For bleeding sites directly involving the perineal tissues, bleeding can be controlled with direct suture ligature of bleeding points, spray electrocautery, or application of topical hemostatic agents. Most minor venous bleeding can be controlled with temporary perineal packing, which usually stops the bleeding within 48 to 72 hours. Operative intervention is rarely required to localize and control the site of minor bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493535\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no high quality data from randomized trials to determine the optimal treatment for perineal bleeding or to assess the outcomes of postoperative hemorrhage or hematoma formation. There is anecdotal evidence to suggest that perineal hemorrhage and hematoma predisposes patients to the development of subsequent perineal wound complications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492663\">",
"    <span class=\"h1\">",
"     PERINEAL WOUND COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of perineal wound complications following an APR ranges from 14 to 80 percent and includes wound infection, abscess, dehiscence, and delayed healing [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1\">",
"     1",
"    </a>",
"    ]. The following findings were noted in a retrospective review of 153 patients undergoing an APR [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A major perineal wound complication (&gt;2 cm dehiscence, perineal abscess, or any wound requiring reoperation or readmission) occurred in 14 percent",
"     </li>",
"     <li>",
"      A minor perineal wound complication (&lt;2 cm dehiscence, stitch abscess, or sinus tracts) occurred in 24 percent. Patients with a major wound complication were excluded from the analysis for minor wounds.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence of perineal wound infection with subsequent delayed healing ranged from 11 to 50 percent in different series [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/11-17\">",
"     11-17",
"    </a>",
"    ]. A variety of factors can contribute to the development of infection. Following resection of the pelvic contents (eg, rectum, mesentery) and perineum (eg, pelvic floor musculature, anus), a large cavity is created that is partially surrounded by the pelvic bone. Serous fluid and blood accumulate in this space, which can serve as a reservoir for bacterial colonization, and can contribute to wound infection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    formation of a chronic perineal sinus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493543\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for perineal wound complications can be classified according to the following subgroups: patient characteristics, indications for surgery, preoperative radiation treatment, and intra-operative findings and technical approach. The following are associated with an increased risk of perineal wound complications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1,4,11\">",
"     1,4,11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Patient characteristics",
"      </strong>",
"      &mdash; Patient-related risk factors include diabetes, obesity, tobacco smoking, and excessive alcohol consumption [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/2,3,18\">",
"       2,3,18",
"      </a>",
"      ]. As an example, in a retrospective review of 120 rectal cancer patients undergoing an APR, significantly higher rates of perineal complications occurred in obese patients (odds ratio 1.14, 95% CI 1.04-1.25) and patients with diabetes (OR 8.75, CI 1.69-45.3) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Indications for surgery",
"      </strong>",
"      &mdash; Indications for an APR include anal and rectal cancers and inflammatory bowel disease. A perineal resection performed for anal cancer or inflammatory bowel disease is associated with a higher risk of wound complications. The following findings were noted in the above retrospective review [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with a diagnosis of anal cancer had a significantly higher rate of major complications compared with patients with rectal cancer or inflammatory bowel disease (8 of 16 versus 12 of 120 and 1 of 12 patients, respectively).",
"     </li>",
"     <li>",
"      Patients with anal cancer and patients with inflammatory bowel disease had higher rates of minor wound complications compared with patients with rectal cancer (4 of 8 versus 5 of 11 versus 23 of 108 patients).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Preoperative radiation treatment",
"      </strong>",
"      &mdash; Preoperative radiation treatments to the rectum and pararectal tissues are associated with a significant increase in perineal wound complications [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/19-24\">",
"       19-24",
"      </a>",
"      ]. In two randomized trials of 626 and 434 patients who were randomly assigned to preoperative radiation therapy (25 Gy in five fractions over one week) followed by an APR or an APR alone, patients receiving preoperative radiation had a significantly higher rate of perineal wound complications (20 versus 10 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/20\">",
"       20",
"      </a>",
"      ] (29 versus 18 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Intra-operative findings and technical approach",
"      </strong>",
"      &mdash; Intra-operative fecal contamination or hypothermia, rectal injury during dissection, and prolonged operating times have been associated with an increased risk of perineal wound complications [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/11\">",
"       11",
"      </a>",
"      ]. Closure of the pelvic peritoneum is associated with a fixed fibrotic cavity [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/25\">",
"       25",
"      </a>",
"      ] and a prolonged time (&gt;6 months) for perineal wound healing after primary closure [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1\">",
"       1",
"      </a>",
"      ]. On the other hand, failure to close the perineum is associated with an increased risk of formation of a chronic perineal sinus [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1,3\">",
"       1,3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392080646\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meticulous surgical technique, including the avoidance of fecal contamination and control of hemostasis, is critical to reducing the risk of perineal wound infection. A variety of other techniques can also be beneficial:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Intersphincteric dissection for benign disease",
"      </strong>",
"      &mdash; When performing an APR for benign disease, the dissection should be performed in the intersphincteric space rather than the wide resection performed for malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Primary closure",
"      </strong>",
"      &mdash; Primary closure",
"      <strong>",
"      </strong>",
"      of the perineum in multiple layers is the optimal approach for the uncontaminated perineal wound [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/5,9,10,17,27\">",
"       5,9,10,17,27",
"      </a>",
"      ]. The rigidity of the surrounding pelvic structures and the limited tissue for primary reapproximation of the perineal wound can create tension on the closure and lead to dehiscence and other perineal wound complications [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1\">",
"       1",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In the setting of inadequate hemostasis or gross contamination, primary closure with drainage is associated with expedited healing but increased morbidity. The potential benefit of a primary closure was illustrated in a randomized trial of 45 patients undergoing an APR for rectal cancer who had incomplete intraoperative hemostasis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      septic contamination who were treated with primary closure or perineal packing [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/10\">",
"       10",
"      </a>",
"      ]. Primary closure was associated with a significantly higher rate of wound closure at one month (30 versus 0 percent) and a significantly higher risk of postoperative perineal complications such as hematoma, perineal abscess, and reoperation (19 versus 1 event).",
"     </li>",
"     <li>",
"      <strong>",
"       Closed suction drainage",
"      </strong>",
"      &mdash; Closed suction drainage is associated with improved perineal wound healing [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1,28,29\">",
"       1,28,29",
"      </a>",
"      ]. A randomized trial of 165 patients undergoing abdominal perineal resection for rectal cancer found that patients treated with closed suction drainage had a significantly higher rate of perineal wound healing at one month compared with patients treated with passive drainage (75 versus 61 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/29\">",
"       29",
"      </a>",
"      ]. There are no high quality data from large randomized trials on optimal placement of the drains (transabdominal or transperineal) or the duration of usage. Drains typically remain in place for two to five days [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/13,30\">",
"       13,30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Pelvic floor reconstruction by tissue transposition",
"      </strong>",
"      &mdash; Several retrospective studies have evaluated the utility of reconstruction of the pelvic floor with tissue transfer of muscle flaps, pedicled myocutaneous flaps, and pedicled omental flaps [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/31-36\">",
"       31-36",
"      </a>",
"      ]. The reconstructive procedures are complex and provide minimal benefit [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. Therefore, the authors do not advocate pelvic floor reconstruction for uncomplicated perineal resections.",
"      <br/>",
"      <br/>",
"      However, if the resection is more extensive (eg, pelvic exenteration) or if intra-operative radiation is employed, use of rectus abdominus or gracilis flaps can be considered [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/1,35\">",
"       1,35",
"      </a>",
"      ]. In a retrospective review that included intra-operative radiation therapy, patients undergoing perineal reconstruction with a gracilis flap had significantly fewer major perineal wound complications (2 of 16 versus 11 of 24 patients) but no difference in minor wound complications (4 versus 5 patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Antibiotic prophylaxis",
"      </strong>",
"      &mdash; Antibiotic prophylaxis should be administered to all patients no later than 60 minutes prior to skin incision [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/37\">",
"       37",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H7#H7\">",
"       \"Overview of control measures to prevent surgical site infection\", section on 'Antimicrobial prophylaxis'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Supplementary local application of reabsorbable gentamicin-impregnated collagen fleece sponges inserted into the sacral cavity (carriers releasing antibiotics) is associated with a reduction of perineal wound infections and higher healing rates following an APR [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/38-40\">",
"       38-40",
"      </a>",
"      ]. The following studies illustrate the benefit of administration of local antibiotics:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A randomized trial of 97 patients with rectal cancer undergoing an APR with primary closure of the perineum and drainage found a significantly lower rate of perineal wound infections (6.1 versus 21 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A review of 40 consecutive patients treated with preoperative radiation therapy followed by an APR, primary perineal wound closure, and drainage for rectal cancer found a significantly higher rate of wound healing with the application of supplementary local antibiotics (84 versus 43 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493551\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of a perineal wound complication depends on the clinical findings (eg, fever, pain, drainage) and radiographic findings if performed (eg, pelvic abscess). In the acute phase, patients typically present with drainage from the perineal wound. A physical examination must be performed to directly assess the wound for purulent drainage, abscess formation, dehiscence, and small bowel or other organ evisceration. A CT scan of the pelvis and a white blood count (WBC) is indicated when the patient has pain and fever. The following steps are performed when managing a perineal wound complication:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with draining wounds in the absence of overt pelvic sepsis (eg, fever, pain), the management includes local wound opening and drainage, debridement of ischemic tissues, removal of foreign bodies, and packing with wet-to-dry dressings or the application of a vacuum-assisted closure (VAC) device. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27642?source=see_link\">",
"       \"Basic principles of wound management\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=see_link\">",
"       \"Negative pressure wound therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with a pelvic abscess, management includes hospital admission, image-guided percutaneous drainage, and administration of broad-spectrum intravenous antibiotics.",
"     </li>",
"     <li>",
"      For patients with evisceration of bowel or other abdominal contents, the management is emergent operative intervention.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493559\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of perineal wound complications are effectively managed when the above principles are followed. However, some perineal wounds fail to heal despite these measures and risk, management, and outcomes are discussed in the following section (See",
"    <a class=\"local\" href=\"#H492670\">",
"     'Persistent perineal sinus'",
"    </a>",
"    below.).",
"   </p>",
"   <p>",
"    Retrospective evidence suggests that patients with perineal wound infections following an APR for rectal cancer have a higher incidence of local recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/41\">",
"     41",
"    </a>",
"    ]. A retrospective review of 228 patients with rectal cancer who had undergone an APR with curative intent reported perineal wound infection in 30 patients (13 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/41\">",
"     41",
"    </a>",
"    ]. The incidence of local recurrence was significantly higher in patients with perineal infections compared with those without a perineal infection (33 versus 9 percent). An intra-abdominal infection occurred in 24 patients and was not associated with an increased risk of local recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492670\">",
"    <span class=\"h1\">",
"     PERSISTENT PERINEAL SINUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A persistent perineal sinus is a perineal wound that remains unhealed for longer than six months after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/42\">",
"     42",
"    </a>",
"    ]. The sinus is typically a long fibrous tract covered by infected granulation tissue with a narrow external opening [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/43\">",
"     43",
"    </a>",
"    ]. It is a common occurrence, especially in patients with inflammatory bowel disease, with an incidence ranging from 14 to 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients can present with pain, discharge, and bleeding from the sinus. Careful examination of the perineal area is essential to confirming the diagnosis, with bacterial swabs to identify a possible secondary infection and biopsy of the tract to diagnose malignant transformation or a local recurrence. The sinus tract should be evaluated with imaging to define the anatomy and rule out causes of non-healing such as an enteroperineal fistula, undrained sepsis, retained rectal mucosa, or retained foreign body. An MRI of the pelvis is routinely performed as our initial study, with sinography, small bowel series, and CT enterography used as adjuncts, depending on the index of suspicion of an enteroperineal fistula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493580\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the risk factors for development of a persistent perineal sinus following an abdominal perineal resection (APR) mirror risk factors for other perineal wound complications (See",
"    <a class=\"local\" href=\"#H492663\">",
"     'Perineal wound complications'",
"    </a>",
"    above.). A number of risk factors for the development of a persistent perineal sinus have been identified. The supportive data are generally limited to small case series.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Crohn&rsquo;s disease versus ulcerative colitis",
"      </strong>",
"      &mdash; Patients with Crohn&rsquo;s disease have poorer healing rates than patients with ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/16\">",
"       16",
"      </a>",
"      ]. In a retrospective review of 39 patients with Crohn&rsquo;s disease and 388 patients with ulcerative colitis who had undergone a proctocolectomy, nonhealing of the perineal wound occurred significantly more often in patients with Crohn&rsquo;s disease compared with patients with ulcerative colitis (12.8 versus 0.8 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Perianal Crohn&rsquo;s disease",
"      </strong>",
"      &mdash;In a small, retrospective series, the incidence of a persistent perineal sinus was significantly higher in patients with preoperative perianal disease compared with patients who have no perianal Crohn&rsquo;s disease (19 of 27 versus 0 of 9 patients in one series) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/46\">",
"       46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25273?source=see_link\">",
"       \"Perianal complications of Crohn's disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Pelvic or perineal sepsis",
"      </strong>",
"      &mdash; In a series of 35 consecutive patients with inflammatory bowel disease who underwent pouch excision at a single institution, pelvic or perineal sepsis was an independent predictor for the development of a persistent perineal sinus following an APR (odds ratio 8.0, 95% CI 1.4-46) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Preoperative radiation therapy",
"      </strong>",
"      &mdash; Preoperative radiation therapy is a risk factor for the development of a chronic perineal sinus. A retrospective review of 94 patients undergoing an APR for rectal cancer found significantly delayed perineal wound healing in patients treated with preoperative radiation therapy compared with no radiation therapy at one month (64 versus 23 percent), three months (48 versus 9 percent), and at one year (25 versus 4 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/48\">",
"       48",
"      </a>",
"      ]. Experimental studies suggest that this effect is mediated at least in part by the development of endarteritis obliterans [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5177?source=see_link\">",
"       \"Wound healing and risk factors for non-healing\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493587\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with a persistent perineal sinus, initial conservative management with the application of topical analgesics, antiseptics, and local wound care can decrease perineal pain and alleviate odor, but rarely results in complete healing [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/42\">",
"     42",
"    </a>",
"    ]. As a result, early intervention is recommended.",
"   </p>",
"   <p>",
"    There are no randomized trials to determine the optimal management of a perineal sinus, but the following options are available:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Curettage and primary closure",
"     </li>",
"     <li>",
"      Sinus excision with partial coccygectomy and either primary closure or reconstruction with a flap or skin graft",
"     </li>",
"     <li>",
"      Cleft closure, which is a modification of the Bascom cleft lift for pilonidal disease [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reconstruction with split thickness skin grafting, omentoplasty, gracilis muscle transposition, rectus abdominus myocutaneous flap, or gluteus maximus VY-advancement flap [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/51-53\">",
"       51-53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Vacuum-assisted closure has potential to assist with healing complicated perineal wounds [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27642?source=see_link\">",
"       \"Basic principles of wound management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At our institution, we routinely perform a wide local excision of the sinus and sinus tract, with or without partial coccygectomy, and use vacuum-assisted closure devices to facilitate healing by secondary intention. We reserve reconstruction with flaps for extremely large defects in otherwise suitable surgical candidates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493594\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of complete healing with the above techniques for patients with a persistent perineal sinus varies widely in the literature, ranging from 15 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492677\">",
"    <span class=\"h1\">",
"     PERINEAL HERNIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A perineal hernia, defined as a protrusion of intra-abdominal contents through a defect in the pelvic floor, may contain small bowel, large bowel, bladder, uterus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    omentum [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/3\">",
"     3",
"    </a>",
"    ]. The most common symptoms include pain, discomfort when standing or sitting, urinary symptoms (eg, dysuria, stress incontinence), intestinal obstruction,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    breakdown of the perineal skin [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/57-60\">",
"     57-60",
"    </a>",
"    ]. A perineal bulge, wound dehiscence, or evisceration can be identified on physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21277999\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important risk factor is the type of closure of the perineal wound. Symptomatic perineal hernia is estimated to occur in less than 1 percent of patients following an APR with the use of primary closure of the perineal wound [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/57,61\">",
"     57,61",
"    </a>",
"    ]. In contrast, the historic incidence of asymptomatic perineal hernia was as high as 7 percent, when packing of the perineal wound was the standard of care [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other risk factors for perineal herniation are unclear given the small number of reported cases using current techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/57-59,61\">",
"     57-59,61",
"    </a>",
"    ]. In addition to packing of the perineal wound, other risk factors for perineal herniation include coccygectomy, previous hysterectomy, pelvic irradiation, neoadjuvant chemoradiation, female gender, failure to close the peritoneal defect, poor nutrition, history of tobacco use greater than 15 years, and perineal wound infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493621\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of the perineal hernia depends upon the clinical presentation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the acute setting with evisceration of the abdominal contents, immediate operative reduction and packing is performed [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the elective setting for symptomatic patients, several options for repair are available, including primary repair via the perineal approach, abdominal approach, or a combined approach, insertion of prosthetic or biologic mesh material, omentoplasty, closure with myocutaneous flaps (eg, gracilis flap, rectus abdominus flap),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      retroflexion of the uterus [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/57-60,62,63\">",
"       57-60,62,63",
"      </a>",
"      ]. The procedures are challenging and there is no consensus on the optimal repair.",
"     </li>",
"     <li>",
"      In patients with an asymptomatic perineal hernia, surgical repair is",
"      <strong>",
"       not",
"      </strong>",
"      indicated. There is no high quality data to suggest that repair of asymptomatic perineal hernias results in a reduction in complications such as incarceration or strangulation. We recommend counseling patients regarding the common symptoms associated with perineal hernias and prompt them to seek medical attention should these symptoms arise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The surgical principles for repair of a perineal hernia are the same as for other hernias and include mobilization of the hernia sac, reduction of the contents, excision of the sac, and repair of the defect. The abdominal approach is",
"    <strong>",
"     preferred",
"    </strong>",
"    because of superior visualization of the hernia sac and contents and therefore a lower risk of injury to major blood vessels and the bowel [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/64\">",
"     64",
"    </a>",
"    ]. The abdominal approach also facilitates placement of mesh or a myocutaneous flap, but there are no high quality data supporting efficacy following the use of the modalities during perineal hernia repair. At our institution, we prefer an abdominal approach with mesh placement, using a running, continuous suture to secure the mesh to avoid creating smaller potential defects (as can happen with the use of interrupted sutures) through which incarceration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    strangulation can occur.",
"   </p>",
"   <p>",
"    Attempting to primarily repair the hernia from the perineum alone is the",
"    <strong>",
"     least likely",
"    </strong>",
"    approach to effectively repair the hernia. Exposure is limited and the pelvic floor must be reconstructed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493628\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is little information available on the outcomes following repair of a postoperative perineal hernia. The recurrence rates range from 0 to 38 percent, with perineal wound infection being cited as the major risk factor for recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4585/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Prevention of a perineal hernia with meticulous operative technique and primary closure of the perineum is the optimal approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493511\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perineal wound complications are common following an APR. The most frequent complications include hemorrhage, perineal wound complications, pelvic sepsis, persistent perineal sinus, and perineal hernia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meticulous hemostasis must be achieved when performing an APR, particularly with respect to the presacral vessels, to reduce the risk of early postoperative hemorrhage. For severe bleeding, such as bleeding from presacral or pelvic vessels, repacking serves as a temporizing measure. For bleeding sites directly involving the perineal tissues, bleeding can be controlled with direct suture ligature of bleeding points, spray electrocautery, or application of topical hemostatic agents. (See",
"      <a class=\"local\" href=\"#H492656\">",
"       'Hemorrhage and hematomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The technical principles that reduce perineal wound complications include: avoidance of fecal contamination, meticulous hemostasis, primary closure of the perineal wound in several layers, and closed-suction drainage of the pelvis. (See",
"      <a class=\"local\" href=\"#H392080646\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with draining wounds in the absence of overt pelvic sepsis (eg, fever, pain), management includes local wound opening and drainage, debridement of ischemic tissues, removal of foreign bodies, and packing with wet-to-dry dressings or the application of a vacuum-assisted closure (VAC) device. (See",
"      <a class=\"local\" href=\"#H492663\">",
"       'Perineal wound complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with a pelvic abscess, management includes hospital admission, image-guided percutaneous drainage, and administration of broad-spectrum intravenous antibiotics is warranted. (See",
"      <a class=\"local\" href=\"#H492663\">",
"       'Perineal wound complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Persistent perineal sinuses will rarely heal with conservative management alone. Optimal management includes an initial trial of vacuum-assisted closure (VAC) device, with operative repair reserved for those who fail to heal. (See",
"      <a class=\"local\" href=\"#H492670\">",
"       'Persistent perineal sinus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A perineal hernia is a rare complication following an APR. In the acute setting with evisceration of the abdominal contents, management includes immediate operative reduction and packing. (See",
"      <a class=\"local\" href=\"#H492677\">",
"       'Perineal hernia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the elective setting for patients with a symptomatic perineal hernia (eg, pain or discomfort), the perineal hernia can be repaired using the combined abdominal and perineal approach and placement of a prosthetic or biologic mesh or myocutaneous flap to reconstruct the pelvic floor. (See",
"      <a class=\"local\" href=\"#H492677\">",
"       'Perineal hernia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/1\">",
"      Wiatrek RL, Thomas JS, Papaconstantinou HT. Perineal wound complications after abdominoperineal resection. Clin Colon Rectal Surg 2008; 21:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/2\">",
"      Christian CK, Kwaan MR, Betensky RA, et al. Risk factors for perineal wound complications following abdominoperineal resection. Dis Colon Rectum 2005; 48:43.",
"     </a>",
"    </li>",
"    <li>",
"     MacKeigan JM, Cataldo PA.. Chapter 21: Abdominoperineal Resection. In: Complications of Colon and Rectal Surgery, Hicks TC, Beck DE, Opelka FG, Timmcke AE..  (Eds), Williams &amp; Wilkins, Media 1996. p.312.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/4\">",
"      Robles Campos R, Garcia Ayllon J, Parrila Paricio P, et al. Management of the perineal wound following abdominoperineal resection: prospective study of three methods. Br J Surg 1992; 79:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/5\">",
"      Irvin TT, Goligher JC. A controlled clinical trial of three different methods of perineal wound management following excision of the rectum. Br J Surg 1975; 62:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/6\">",
"      Terranova O, Sandei F, Rebuffat C, et al. Management of the perineal wound after rectal excision for neoplastic disease: a controlled clinical trial. Dis Colon Rectum 1979; 22:228.",
"     </a>",
"    </li>",
"    <li>",
"     Chapter 63: True pelvis, pelvic floor and perineum. In: Gray's Anatomy, 40th, Standring S.  (Ed), Churchill, Livingstone, Elsevier, 2008. p.1083.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/8\">",
"      Baqu&eacute; P, Karimdjee B, Iannelli A, et al. Anatomy of the presacral venous plexus: implications for rectal surgery. Surg Radiol Anat 2004; 26:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/9\">",
"      Altemeier WA, Culbertson WR, Alexander JW, et al. Primary closure and healing of the perineal wound in abdominoperineal resection of the rectum for carcinoma. Am J Surg 1974; 127:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/10\">",
"      Delalande JP, Hay JM, Fingerhut A, et al. Perineal wound management after abdominoperineal rectal excision for carcinoma with unsatisfactory hemostasis or gross septic contamination: primary closure vs. packing. A multicenter, controlled trial. French Association for Surgical Research. Dis Colon Rectum 1994; 37:890.",
"     </a>",
"    </li>",
"    <li>",
"     Dietz, DW, Bailey, HR. Postoperative complications. In: The ASCRS Textbook of Colon and Rectal Surgery, Wolff, BG, Fleshman, JW, Beck, DE, Pemberton, JH, Wexner, SD (Eds), Springer, New York 2006. p.152.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/12\">",
"      Pollard CW, Nivatvongs S, Rojanasakul A, Ilstrup DM. Carcinoma of the rectum. Profiles of intraoperative and early postoperative complications. Dis Colon Rectum 1994; 37:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/13\">",
"      Rothenberger DA, Wong WD. Abdominoperineal resection for adenocarcinoma of the low rectum. World J Surg 1992; 16:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/14\">",
"      Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002; 89:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/15\">",
"      Papaconstantinou HT, Bullard KM, Rothenberger DA, Madoff RD. Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity. Colorectal Dis 2006; 8:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/16\">",
"      Corman ML, Veidenheimer MC, Coller JA, Ross VH. Perineal wound healing after proctectomy for inflammatory bowel disease. Dis Colon Rectum 1978; 21:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/17\">",
"      Murrell ZA, Dixon MR, Vargas H, et al. Contemporary indications for and early outcomes of abdominoperineal resection. Am Surg 2005; 71:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/18\">",
"      Artioukh DY, Smith RA, Gokul K. Risk factors for impaired healing of the perineal wound after abdominoperineal resection of rectum for carcinoma. Colorectal Dis 2007; 9:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/19\">",
"      Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group. Ann Surg Oncol 1996; 3:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/20\">",
"      Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg 1993; 80:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/21\">",
"      Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002; 20:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/22\">",
"      Horn A, Halvorsen JF, Dahl O. Preoperative radiotherapy in operable rectal cancer. Dis Colon Rectum 1990; 33:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/23\">",
"      Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet 1996; 348:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/24\">",
"      Bujko K, Nowacki MP, Kepka L, et al. Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis 2005; 7:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/25\">",
"      Silen W, Glotzer DJ. The prevention and treatment of the persistent perineal sinus. Surgery 1974; 75:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/26\">",
"      Leicester RJ, Ritchie JK, Wadsworth J, et al. Sexual function and perineal wound healing after intersphincteric excision of the rectum for inflammatory bowel disease. Dis Colon Rectum 1984; 27:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/27\">",
"      McLeod R, Cohen Z, Langer B, Taylor B. Primary perineal wound closure following excision of the rectum. Can J Surg 1983; 26:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/28\">",
"      Hartz RS, Poticha SM, Shields TW. Healing of the perineal wound. Arch Surg 1980; 115:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/29\">",
"      Fingerhut A, Hay JM, Delalande JP, Paquet JC. Passive vs. closed suction drainage after perineal wound closure following abdominoperineal rectal excision for carcinoma. A multicenter, controlled trial. The French Association for Surgical Research. Dis Colon Rectum 1995; 38:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/30\">",
"      Tompkins RG, Warshaw AL. Improved management of the perineal wound after proctectomy. Ann Surg 1985; 202:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/31\">",
"      Khoo AK, Skibber JM, Nabawi AS, et al. Indications for immediate tissue transfer for soft tissue reconstruction in visceral pelvic surgery. Surgery 2001; 130:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/32\">",
"      Kapoor V, Cole J, Isik FF, et al. Does the use of a flap during abdominoperineal resection decrease pelvic wound morbidity? Am Surg 2005; 71:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/33\">",
"      Nilsson PJ. Omentoplasty in abdominoperineal resection: a review of the literature using a systematic approach. Dis Colon Rectum 2006; 49:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/34\">",
"      Shibata D, Hyland W, Busse P, et al. Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum. Ann Surg Oncol 1999; 6:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/35\">",
"      Radice E, Nelson H, Mercill S, et al. Primary myocutaneous flap closure following resection of locally advanced pelvic malignancies. Br J Surg 1999; 86:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/36\">",
"      De Broux E, Parc Y, Rondelli F, et al. Sutured perineal omentoplasty after abdominoperineal resection for adenocarcinoma of the lower rectum. Dis Colon Rectum 2005; 48:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/37\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/38\">",
"      Meyer L, Bereuter M, Marusch F, et al. Perineal wound closure after abdomino-perineal excision of the rectum. Tech Coloproctol 2004; 8 Suppl 1:s230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/39\">",
"      de Bruin AF, Gosselink MP, Wijffels NA, et al. Local gentamicin reduces perineal wound infection after radiotherapy and abdominoperineal resection. Tech Coloproctol 2008; 12:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/40\">",
"      Gruessner U, Clemens M, Pahlplatz PV, et al. Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer. Am J Surg 2001; 182:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/41\">",
"      Kressner U, Graf W, Mahteme H, et al. Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 2002; 45:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/42\">",
"      Lohsiriwat V. Persistent perineal sinus: incidence, pathogenesis, risk factors, and management. Surg Today 2009; 39:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/43\">",
"      Karoui M, Cohen R, Nicholls J. Results of surgical removal of the pouch after failed restorative proctocolectomy. Dis Colon Rectum 2004; 47:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/44\">",
"      Rosen L, Veidenheimer MC, Coller JA, Corman ML. Mortality, morbidity, and patterns of recurrence after abdominoperineal resection for cancer of the rectum. Dis Colon Rectum 1982; 25:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/45\">",
"      Bauer JJ, Gelernt IM, Salk BA, Kreel I. Proctectomy for inflammatory bowel disease. Am J Surg 1986; 151:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/46\">",
"      Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis 1986; 1:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/47\">",
"      Lohsiriwat V, Clark SK. Persistent perineal sinus after ileoanal pouch excision in inflammatory bowel diseases: incidence, risk factors, and clinical course. Dis Colon Rectum 2008; 51:1795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/48\">",
"      Chadwick MA, Vieten D, Pettitt E, et al. Short course preoperative radiotherapy is the single most important risk factor for perineal wound complications after abdominoperineal excision of the rectum. Colorectal Dis 2006; 8:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/49\">",
"      Wiseman JS, Senagore AJ, Chaudry IH. Relationship of pelvic radiation to intestinal blood flow. J Surg Res 1996; 60:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/50\">",
"      Bascom T, Bascom JU. Persistent perineal sinus after proctectomy for Crohn's disease; simplified repair using skin flap. Am J Surg 2002; 184:85; author reply 85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/51\">",
"      Yamamoto T, Mylonakis E, Keighley MR. Omentoplasty for persistent perineal sinus after proctectomy for Crohn's disease. Am J Surg 2001; 181:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/52\">",
"      Ryan JA Jr. Gracilis muscle flap for the persistent perineal sinus of inflammatory bowel disease. Am J Surg 1984; 148:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/53\">",
"      Hurst RD, Gottlieb LJ, Crucitti P, et al. Primary closure of complicated perineal wounds with myocutaneous and fasciocutaneous flaps after proctectomy for Crohn's disease. Surgery 2001; 130:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/54\">",
"      Yousaf M, Witherow A, Gardiner KR, Gilliland R. Use of vacuum-assisted closure for healing of a persistent perineal sinus following panproctocolectomy: report of a case. Dis Colon Rectum 2004; 47:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/55\">",
"      Schaffzin DM, Douglas JM, Stahl TJ, Smith LE. Vacuum-assisted closure of complex perineal wounds. Dis Colon Rectum 2004; 47:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/56\">",
"      Loessin SJ, Meland NB, Devine RM, et al. Management of sacral and perineal defects following abdominoperineal resection and radiation with transpelvic muscle flaps. Dis Colon Rectum 1995; 38:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/57\">",
"      Aboian E, Winter DC, Metcalf DR, Wolff BG. Perineal hernia after proctectomy: prevalence, risks, and management. Dis Colon Rectum 2006; 49:1564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/58\">",
"      Beck DE, Fazio VW, Jagelman DG, et al. Postoperative perineal hernia. Dis Colon Rectum 1987; 30:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/59\">",
"      Sarr MG, Stewart JR, Cameron JC. Combined abdominoperineal approach to repair of postoperative perineal hernia. Dis Colon Rectum 1982; 25:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/60\">",
"      Skipworth RJ, Smith GH, Anderson DN. Secondary perineal hernia following open abdominoperineal excision of the rectum: report of a case and review of the literature. Hernia 2007; 11:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/61\">",
"      So JB, Palmer MT, Shellito PC. Postoperative perineal hernia. Dis Colon Rectum 1997; 40:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/62\">",
"      HULLSIEK HE. Perineal hernia following abdominoperineal resection. Am J Surg 1956; 92:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/63\">",
"      Ryan S, Kavanagh DO, Neary PC. Laparoscopic repair of postoperative perineal hernia. Case Rep Med 2010; 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4585/abstract/64\">",
"      Ogilvie JW, Ricciardi R. Complications of perineal surgery. Clin Colon Rectal Surg 2009; 22:51.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15712 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-125.39.66.147-DB4EA05A22-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4585=[""].join("\n");
var outline_f4_30_4585=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H493511\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H492489\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H150458379\">",
"      ANATOMY OF THE PERINEUM AND PELVIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H492656\">",
"      HEMORRHAGE AND HEMATOMAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47741652\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493527\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493535\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H492663\">",
"      PERINEAL WOUND COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493543\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H392080646\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493551\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493559\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H492670\">",
"      PERSISTENT PERINEAL SINUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493580\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493587\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493594\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H492677\">",
"      PERINEAL HERNIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21277999\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493621\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493628\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H493511\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15712\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15712|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/54/21348\" title=\"figure 1\">",
"      Anal rectal anatomy lateral view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/37/10837\" title=\"figure 2\">",
"      Anatomy of the ischiorectal fossa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/63/32756\" title=\"figure 3\">",
"      Female pelvic muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/57/29588\" title=\"figure 4\">",
"      Female perineum muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/47/15093\" title=\"figure 5\">",
"      Male perineum muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/45/28375\" title=\"figure 6\">",
"      Anatomy of the presacral venous plexus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27642?source=related_link\">",
"      Basic principles of wound management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/5/4186?source=related_link\">",
"      Management of anastomotic complications of colorectal surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1946?source=related_link\">",
"      Management of intra-abdominal, pelvic, and genitourinary complications of colorectal surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=related_link\">",
"      Negative pressure wound therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25273?source=related_link\">",
"      Perianal complications of Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5177?source=related_link\">",
"      Wound healing and risk factors for non-healing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_30_4586="Pulmonary lymphangioleiomyomatosis";
var content_f4_30_4586=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary lymphangioleiomyomatosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4586/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4586/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4586/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4586/contributors\">",
"     Kevin R Flaherty, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?4/30/4586/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?4/30/4586/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?4/30/4586/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease that afflicts young women of childbearing age [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. It is characterized pathologically by the proliferation of atypical pulmonary interstitial smooth muscle cells and by cyst formation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1,5-10\">",
"     1,5-10",
"    </a>",
"    ]. Pulmonary LAM is categorized as a generally benign mesenchymal neoplasm with perivascular epithelioid cell differentiation (PEComa) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary LAM has more in common clinically, radiographically, and physiologically with pulmonary emphysema than with classic interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF) or sarcoidosis. In fact, it is often misdiagnosed as asthma or chronic obstructive pulmonary disease (COPD) because of significant airflow limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/6,8,12\">",
"     6,8,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features, pathophysiology, and treatment of pulmonary LAM will be reviewed here. The tuberous sclerosis complex and pulmonary involvement in tuberous sclerosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link\">",
"     \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5142?source=see_link\">",
"     \"Pulmonary involvement in tuberous sclerosis complex\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7596684\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of pulmonary LAM are unknown. Based on data from the LAM registry, there are approximately 1300 known patients with LAM in North America. Based on the prevalence of tuberous sclerosis complex (TSC), it is estimated that at least 8000 to 10,000 women have cystic lesions consistent with LAM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Caucasians are afflicted much more commonly than other racial groups, especially Asians and individuals of African descent. LAM has rarely been reported in men, almost always in association with definite or probable TSC [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. One case of pulmonary LAM has been described in a man with no clinical or genotypic evidence of TSC [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary pathological abnormality is the proliferation of atypical smooth muscle and epithelioid cells around bronchovascular structures and into the interstitium (",
"    <a class=\"graphic graphic_picture graphicRef66775 graphicRef77252 \" href=\"UTD.htm?31/1/31764\">",
"     picture 1A-B",
"    </a>",
"    ). The proliferating cells are composed of two types, those that resemble vascular smooth muscle cells, but they are often somewhat shortened and pleomorphic, and perivascular epithelioid cells (PECs) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/21\">",
"     21",
"    </a>",
"    ]. PECs, which have a clear to granular, lightly eosinophilic cytoplasm, are located in an immediate perivascular location. Immunohistochemistry stains for melanocytic markers (eg, HMB-45, Melan-A, tyrosinase, microphthalmia transcription factor,",
"    <span class=\"nowrap\">",
"     NKI/C3)",
"    </span>",
"    and muscle markers (eg, smooth muscle actin, pan-muscle actin, muscle myosin, calponin) are positive [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/11,22\">",
"     11,22",
"    </a>",
"    ]. Another unique pathologic feature is the occurrence of diffuse, cystic dilatation of the terminal airspaces [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1,7,12\">",
"     1,7,12",
"    </a>",
"    ]. Hemosiderosis is common and is a consequence of clinically insignificant hemorrhage due to the rupture of dilated and tortuous venules [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The normal architecture of the lung is distorted by multiple small cysts, ranging from 0.1 cm to several centimeters in diameter (",
"    <a class=\"graphic graphic_picture graphicRef64389 graphicRef53690 graphicRef68405 \" href=\"UTD.htm?0/9/150\">",
"     picture 2A-C",
"    </a>",
"    ). The interstitium is thickened, with evidence of smooth muscle-like proliferation around and within the pulmonary lymphatics, venules, and airways [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. The lymphatic and venous vessels are often tortuous and dilated. Hilar, mediastinal, and retroperitoneal lymph nodes are often involved and enlarged. The thoracic duct is frequently thickened and dilated. Extrapulmonary involvement with renal, retroperitoneal, intraabdominal, and pelvic angioleiomyomata is common [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of LAM is unknown, but data are accumulating which suggest a role for the loss of tumor suppression functions of certain cellular proteins, or abnormalities in enzymes involved in the synthesis of catecholamines [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/4,22\">",
"     4,22",
"    </a>",
"    ]. Many of these pathophysiologic features appear shared with lung involvement in tuberous sclerosis complex (TSC), a condition similar to LAM in terms of its lung pathology, immunohistochemistry, and presence of renal angiomyolipomas, which are also categorized as neoplasms with perivascular epithelioid cell differentiation (PEComas) (",
"    <a class=\"graphic graphic_picture graphicRef79407 \" href=\"UTD.htm?28/34/29219\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1,11,22,26-29\">",
"     1,11,22,26-29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5142?source=see_link\">",
"     \"Pulmonary involvement in tuberous sclerosis complex\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetic associations",
"    </span>",
"    &nbsp;&mdash;&nbsp;While it is not entirely clear how defects in these proteins or in catecholamine synthesis could produce the LAM phenotype, evidence for such an association includes the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lesions at a TSC locus on chromosome 16p13 (TSC2) cause defective production of tuberin, a tumor suppressor [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. Somatic TSC2 mutations are detected in approximately one-half of renal angiomyolipomas in patients with either LAM or TSC [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/29\">",
"       29",
"      </a>",
"      ], and have also been found in abnormal pulmonary smooth muscle cells in all of four LAM patients in one study [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. These observations suggest one of two possibilities: somatic mosaicism for TSC2 mutations within the lungs and kidney results in foci of disease superimposed upon a background of normal cells within these tissues (although multiple discrete sites of disease might be expected); or that LAM represents dissemination of angiomyolipoma tissue to the lung in a fashion analogous to the syndrome of benign metastasizing leiomyoma [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/29,34-37\">",
"       29,34-37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      LAM cells stain with HMB-45, a monoclonal antibody derived from melanoma hybridomas and previously thought to be a specific marker for melanoma and immature melanocytes (",
"      <a class=\"graphic graphic_picture graphicRef55243 \" href=\"UTD.htm?43/40/44687\">",
"       picture 4",
"      </a>",
"      ). The antigen to which HMB-45 binds has total cDNA homology with the gene Pmel 17, the product of which is involved in the synthesis of melanin and catecholamines from the amino acid tyrosine.",
"     </li>",
"     <li>",
"      The human Pmel 17 gene has been mapped to chromosome 12. One of the candidate gene loci for tuberous sclerosis complex has been mapped to a similar site on this chromosome. The gene for the enzyme phenylalanine hydroxylase is found at or near this tuberous sclerosis locus; this enzyme catalyzes the conversion of phenylalanine to tyrosine, the substrate for catecholamine synthesis.",
"     </li>",
"     <li>",
"      The tuberous sclerosis locus (TSC1) on chromosome 9q34 contains the gene hamartin, and is near or contains the gene dopamine-beta-hydroxylase, an enzyme that catalyzes the conversion of L-dopamine to norepinephrine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, it should be emphasized that LAM and tuberous sclerosis complex are distinct syndromes, as the latter entity also affects the skin and central nervous system and demonstrates clear Mendelian inheritance. It is possible patients with LAM are mosaic, with TSC2 mutations in the lung (and sometimes the kidney) but not elsewhere, or that environmental factors play a critical role in the development of clinically apparent LAM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link\">",
"     \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Role of estrogen",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is likely that estrogen plays a central role in disease progression, since the disease does not present prior to menarche and only rarely after menopause. The disease is also known to accelerate during pregnancy and to abate after oophorectomy. Furthermore, estrogen and progesterone receptors have been demonstrated in a subpopulation of the abnormal smooth muscle cells that are characteristic of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. These receptors may be down-regulated following the institution of hormonal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/40\">",
"     40",
"    </a>",
"    ]. In addition, in an animal model, estrogen promotes the survival and lung metastasis of tuberin-null cells [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mechanism of cyst formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of the cyst formation and emphysema-like disease is unknown. Contributing factors are believed to include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smooth muscle proliferation within the airways, creating a \"ball-valve\" obstruction that leads to distention of the terminal airspaces.",
"     </li>",
"     <li>",
"      Elastic fiber degradation related to an imbalance of elastase and alpha-1-antitrypsin. This may be a major mechanism leading to the emphysema-like changes [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Compression of the conducting airways by the proliferating smooth muscle cells in the interstitium, but this is controversial [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is likely that some combination of these mechanisms best explains the pathogenesis of the pulmonary changes [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/5,6,43\">",
"     5,6,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7596689\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presenting characteristics of patients with LAM were evaluated in a national registry that enrolled 243 patients in a three year period (from 1998 to 2001). Review of the registry revealed the following [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/44\">",
"     44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patient age ranged from 18 to 76 years (mean age 44 years)",
"     </li>",
"     <li>",
"      Average age at onset of symptoms was 39 years and at diagnosis was 41 years",
"     </li>",
"     <li>",
"      Approximately 60 percent of patients were premenopausal",
"     </li>",
"     <li>",
"      Approximately 60 percent of patients had never smoked",
"     </li>",
"     <li>",
"      Spontaneous pneumothorax was the primary event leading to diagnosis in 36 percent of patients",
"     </li>",
"     <li>",
"      An abnormal chest radiograph or pleural effusion was the presenting manifestation in 19 and 3 percent, respectively",
"     </li>",
"     <li>",
"      An obstructive abnormality was detected by spirometry in 57 percent of patients, whereas 34 percent had normal spirometry",
"     </li>",
"     <li>",
"      Tuberous sclerosis complex was present in 15 percent of patients",
"     </li>",
"     <li>",
"      Women with tuberous sclerosis-related LAM were younger and had less impaired lung function than those with sporadic LAM",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings support previous, smaller studies [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1,5,6\">",
"     1,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26516324\">",
"    <span class=\"h1\">",
"     SYMPTOMS AND SIGNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common presentations in patients with sporadic LAM are those of progressive dyspnea (approximately 70 percent) and spontaneous pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/5,6,8,44,45\">",
"     5,6,8,44,45",
"    </a>",
"    ]. In many patients, symptom onset and diagnosis occur while the patient is receiving estrogen replacement therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/7,46-48\">",
"     7,46-48",
"    </a>",
"    ]. Other common complaints include wheezing, cough, hemoptysis, and phlegm [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The physical examination can be unrevealing or may demonstrate end-expiratory crackles (22 percent), hyperinflation, decreased or absent breath sounds, ascites, and intraabdominal or adnexal masses. Clubbing is uncommon (5 percent or less) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with sporadic LAM have some of the extrapulmonary manifestations of tuberous sclerosis complex (TSC), such as renal angiomyolipomas, axial and retroperitoneal adenopathy, and abdominal lymphangiomyomas, but not the central nervous system, skin, or ocular manifestations required for a diagnosis of TSC [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/44\">",
"     44",
"    </a>",
"    ]. Angiomyolipomas are benign masses that contain blood vessels, muscle tissue, and fat; they are reported in approximately 30 to 60 percent of patients with LAM, depending on the case series [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link&amp;anchor=H140866536#H140866536\">",
"     \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\", section on 'Diagnostic criteria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=see_link\">",
"     \"Renal manifestations of tuberous sclerosis and renal angiomyolipoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H98315087\">",
"    <span class=\"h1\">",
"     PULMONARY FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function testing usually reveals an \"obstructive\" or \"mixed\" pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/2,6-8,51,52\">",
"     2,6-8,51,52",
"    </a>",
"    ]. The lungs are often hyperinflated, with an increased total lung capacity (TLC) and increased thoracic gas volume. Gas trapping, as evident by an increase in residual volume (RV) and",
"    <span class=\"nowrap\">",
"     RV/TLC",
"    </span>",
"    ratio, is commonly present. Airflow limitation and reductions in diffusing capacity occur in the majority of patients. Studies of pulmonary mechanics show that mean elastic recoil is reduced and that upstream resistance is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/8,51\">",
"     8,51",
"    </a>",
"    ]. Both a loss of elastic recoil and an increase in airway resistance contribute to the observed airflow limitation.",
"   </p>",
"   <p>",
"    In a series of 235 patients with lymphangioleiomyomatosis, bronchodilator responsiveness to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    varied from visit to visit [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/53\">",
"     53",
"    </a>",
"    ]. Overall, 12 percent responded to albuterol on more than 50 percent of the visits and 30 percent responded on at least one visit. Among those with a positive bronchodilator response, the rate of subsequent decline in FEV1 and diffusing capacity was greater. A slightly greater number of patients showed reversibility with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/37/33360?source=see_link\">",
"     ipratropium",
"    </a>",
"    than albuterol.",
"   </p>",
"   <p>",
"    Gas exchange is often abnormal, with a markedly reduced DLCO and an increase in the alveolar-arterial oxygen difference [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/49\">",
"     49",
"    </a>",
"    ]. Diminished exercise performance is found in most patients, generally characterized by [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduced oxygen consumption",
"     </li>",
"     <li>",
"      Low anaerobic threshold",
"     </li>",
"     <li>",
"      An abnormal and excessive ventilatory response, with a high respiratory rate, excessive minute ventilation, and reduced breathing reserve",
"     </li>",
"     <li>",
"      Abnormal baseline or exercise dead space to tidal volume",
"      <span class=\"nowrap\">",
"       (VD/VT)",
"      </span>",
"      ratio",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The primary determinants of the exercise limitation are related to airflow limitation and to mechanical factors (eg, decreased breathing reserve, increased work of breathing). In addition, pulmonary vascular",
"    <span class=\"nowrap\">",
"     dysfunction/destruction",
"    </span>",
"    also leads to severe impairment in exercise performance in many patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H98315093\">",
"    <span class=\"h1\">",
"     IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiographic findings in patients with LAM are variable (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75498 graphicRef56652 \" href=\"UTD.htm?9/62/10216\">",
"     image 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/1,7,9,44,54\">",
"     1,7,9,44,54",
"    </a>",
"    ]. Possible appearances include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal (early in the course of the disease)",
"     </li>",
"     <li>",
"      Interstitial opacities (reticular or nodular) that result from the compression of smooth muscle-rich interstitial tissue by more dilated, cystic airspaces",
"     </li>",
"     <li>",
"      Hyperinflation (33 to 62 percent of patients) with severe emphysematous-like changes in advanced disease",
"     </li>",
"     <li>",
"      Pleural effusion due to a chylothorax",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    High resolution computed tomography (HRCT) scanning of the lungs is very useful and is much more sensitive than routine chest radiography in demonstrating the cystic nature of the disease (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69954 graphicRef55093 graphicRef78552 \" href=\"UTD.htm?30/8/30856\">",
"     image 2A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/49,55-57\">",
"     49,55-57",
"    </a>",
"    ]. The findings of diffuse, homogeneous, small, thin-walled cysts (ie, 2 to 40 mm in diameter and walls from 0.1 to 2 mm in thickness) scattered throughout both lung fields can be highly suggestive of the diagnosis in an appropriate clinical context [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/9,56,58,59\">",
"     9,56,58,59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a close correlation between the extent of the cystic parenchymal changes (as measured by quantitative HRCT) and disease severity (as determined by spirometry, diffusing capacity, lung volumes, or exercise performance) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/9\">",
"     9",
"    </a>",
"    ]. Thus, HRCT scanning may have both a diagnostic and a prognostic role.",
"   </p>",
"   <p>",
"    <br/>",
"    Among patients who have undergone pleurodesis for recurrent pneumothorax, complex pleural masses may develop [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. The masses may be solid or complex and may contain areas of calcification. Longitudinal follow-up rather than biopsy is appropriate, as long as the patient has a history of pleurodesis (chemical, mechanical, or talc), thoracentesis, or thoracostomy.",
"   </p>",
"   <p>",
"    Guidelines suggest baseline abdominal-pelvic computed tomography (CT) at the time of diagnosis of LAM to identify renal angiomyolipomas, enlarged pelvic lymph nodes, and lymphangioleiomyomas [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/63\">",
"     63",
"    </a>",
"    ]. The characteristic CT finding of an angiomyolipoma is areas of fat attenuation, although this is occasionally not present [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/49\">",
"     49",
"    </a>",
"    ]. Hemorrhage into an angiomyolipoma gives the appearance of a complex renal mass that may be confused with a renal cell carcinoma. Knowledge of a preexisting angiomyolipoma and the presence of fat attenuation help in the differentiation of these entities [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lymphangioleiomyomas can develop in lymphatics resulting in lymphadenopathy, which can mimic the appearance of lymphoma. Lymphangioleiomyomas exhibit substantial diurnal variation in size, related to changes in chyle flow with eating and exercise. This feature can be used to differentiate lymphangioleiomyomas from lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, the diagnosis should be strongly suspected in any young woman who presents with emphysema, recurrent pneumothorax, or a chylous pleural effusion. HRCT can often confirm the diagnosis, so tissue confirmation may not always be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/49,63\">",
"     49,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, lung tissue is frequently obtained, and pulmonary LAM can be readily diagnosed by its characteristic histologic findings on open lung or thoracoscopic biopsy. Often, transbronchial lung biopsy can yield an adequate sample for pathologic evaluation, especially when immunohistochemical stains specific for smooth muscle components (actin, desmin, or HMB-45) have been employed to improve diagnostic sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/64-68\">",
"     64-68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differential diagnosis consists of other causes of cystic interstitial lung disease with normal lung volume, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Emphysema, with or without alpha-1-antitrypsin deficiency",
"     </li>",
"     <li>",
"      Asthma",
"     </li>",
"     <li>",
"      Pulmonary Langerhans cell histiocytosis (eosinophilic granuloma) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=see_link&amp;anchor=H7#H7\">",
"       \"Pulmonary Langerhans cell histiocytosis\", section on 'Diagnostic evaluation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Stage IV cystic sarcoidosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical manifestations and diagnosis of sarcoidosis\", section on 'Stage IV'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lymphocytic interstitial pneumonitis (LIP)",
"     </li>",
"     <li>",
"      Tuberous sclerosis complex (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Birt-Hogg-Dube syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=see_link&amp;anchor=H4#H4\">",
"       \"Hereditary kidney cancer syndromes\", section on 'Birt-Hogg-Dube syndrome'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hypersensitivity pneumonitis (Chronic extrinsic allergic alveolitis)",
"     </li>",
"     <li>",
"      Panacinar emphysema due to intravenous drug use (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38439?source=see_link&amp;anchor=H6#H6\">",
"       \"Overview of pulmonary disease in injection drug users\", section on 'Bullous lung disease and emphysema'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7596701\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of intra- and extrathoracic complications have been associated with pulmonary LAM:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spontaneous pneumothorax occurs in 50 percent of cases. It is often recurrent, can be bilateral, and may necessitate pleurodesis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/47,69\">",
"       47,69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chylothorax, due to obstruction of the thoracic duct or rupture of the lymphatics in the pleura or mediastinum by proliferating smooth muscle cells, is characteristic of this disorder but is present in only a minority of patients at diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/70\">",
"       70",
"      </a>",
"      ]. Chyle can be recognized by its milky white appearance, high triglyceride level (usually greater than 110",
"      <span class=\"nowrap\">",
"       mg/dL),",
"      </span>",
"      and the presence of chylomicrons. Chylothorax can be difficult to treat and is typically associated with nutritional wasting and some degree of immunocompromise [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/71\">",
"       71",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=see_link\">",
"       \"Etiology, clinical presentation, and diagnosis of chylothorax\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chyloperitoneum (chylous ascites) occurs in approximately 10 percent of cases.",
"     </li>",
"     <li>",
"      Chyluria, due to abnormal connections between dilated retroperitoneal lymphatics and the renal collecting system, is seen in 2 percent of reported cases.",
"     </li>",
"     <li>",
"      Chylopericardium has been rarely reported.",
"     </li>",
"     <li>",
"      Lymphangioleiomyomas are common in patients with lymphangioleiomyomatosis. They result from the proliferation of smooth muscle cells in the lymph vessels, which causes mural thickening, obstruction, dilation, and the formation of collections of chylous material. The most common symptoms associated with lymphangioleiomyomas are bloating, abdominal pain, and edema of the lower extremities [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/72\">",
"       72",
"      </a>",
"      ]. The majority of the patients report worsening of symptoms as the day progresses. Diurnal variation in size may explain worsening symptoms during the day.",
"     </li>",
"     <li>",
"      Renal angiomyolipomas (hamartomas), a characteristic pathologic finding in the genetic disorder tuberous sclerosis complex, are also common, occurring in as many as 50 percent of patients (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50146 graphicRef60127 \" href=\"UTD.htm?17/56/18307\">",
"       image 3A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/73\">",
"       73",
"      </a>",
"      ]. They may grow to enormous size prior to clinical detection, but only uncommonly affect renal function. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=see_link\">",
"       \"Renal manifestations of tuberous sclerosis and renal angiomyolipoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hemoptysis of mild to moderate severity is a well described manifestation and may be life-threatening.",
"     </li>",
"     <li>",
"      Although resting pulmonary hypertension is uncommon, pulmonary artery pressures (PAP) may rise at low exercise levels (eg, performing activities of daily living) [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/74\">",
"       74",
"      </a>",
"      ]. A decline in oxygen saturation correlated with the rise in PAP in this report, but hypoxemia did not entirely explain the exercise-induced pulmonary hypertension.",
"     </li>",
"     <li>",
"      Women with LAM appear to have an increased incidence of meningioma, regardless of associated tuberous sclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/75\">",
"       75",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7596707\">",
"       'Management'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25540?source=see_link\">",
"       \"Meningioma: Clinical presentation and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;LAM is classified as a neoplasm of soft tissue, but it is considered a benign tumor, and features of malignant behavior (mitotic activity, angiolymphatic invasion, necrosis, and metastases) have not been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, prognosis for women with pulmonary LAM is variable. Progression is common, with a median survival of 8 to 10 years from diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Sudden onset of rapid deterioration rarely complicates the course of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/6\">",
"     6",
"    </a>",
"    ]. Pregnancy and the use of supplemental estrogen accelerate the disease process [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Monitoring the response to treatment is difficult and has not been well studied. We use lung function studies (spirometry, lung volumes to assess the degree of airflow obstruction and hyperinflation) and measure gas exchange (diffusing capacity and arterial blood gases) to assess the patient's clinical course. Gas exchange measurements during serial exercise testing might be the most sensitive test but are difficult to perform and are expensive. Serial HRCT scans may be shown to be useful since the abnormalities can be quantified; however, this awaits further study.",
"   </p>",
"   <p>",
"    One study found that an elevated TLC and reduced",
"    <span class=\"nowrap\">",
"     FEV1/FVC",
"    </span>",
"    at presentation was a negative prognostic indicator [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/7\">",
"     7",
"    </a>",
"    ]. In addition, a predominantly cystic pattern of histopathology predicts a worse prognosis compared to a predominantly muscular pattern. It is unknown whether these patterns represent two distinct histopathologic categories of disease or different stages in disease evolution [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uncommonly, long term survival 20 years after diagnosis has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/78\">",
"     78",
"    </a>",
"    ]. In several large case series [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/6,7,10\">",
"     6,7,10",
"    </a>",
"    ], there was an apparent improvement in survival compared to earlier series [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/5\">",
"     5",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_figure graphicRef78678 \" href=\"UTD.htm?13/43/14014\">",
"     figure 1",
"    </a>",
"    ). The reasons for this improved survival are unknown, but could be related to an inherent bias in the methods, hormonal interventions, better supportive treatments, or a change in the natural history of the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7596707\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;No therapy is of proven benefit in lymphangioleiomyomatosis, although some studies support hormonal manipulation [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/63,79\">",
"     63,79",
"    </a>",
"    ]. In patients with airflow obstruction, inhaled bronchodilator therapy may provide symptomatic relief. The efficacy of molecular targets designed to offset the effects of mutations in the genes TSC1 and TSC2 is being evaluated in multicenter studies.",
"   </p>",
"   <p>",
"    Alpha-interferon has also been tried for treatment of pulmonary LAM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/80\">",
"     80",
"    </a>",
"    ]. In our experience, it has not been of benefit, primarily because of side effects that limit its use. There is no role for either glucocorticoids or cytotoxic agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hormonal manipulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hormonal manipulation has been frequently used to treat pulmonary LAM, based on the recognition that female hormones play an etiologic role in the pathogenesis of the disease. Oophorectomy, progestin therapy (high dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    given as IM depot or PO),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    (20",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    and luteinizing hormone-releasing hormone (LHRH) analogs have been employed [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/81-85\">",
"     81-85",
"    </a>",
"    ]. Oophorectomy is not recommended in patients with LAM due to morbidity and a lack of proven benefit.",
"   </p>",
"   <p>",
"    Treatment with progestational and antiestrogen agents may provide improvement or stabilization of the disease in a subset of patients, although supportive data are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/63,82,83,85\">",
"     63,82,83,85",
"    </a>",
"    ]. In a retrospective review of 36 patients with LAM who received hormonal manipulation, survival rates at 10 years were 90 percent compared with 20 percent in historical controls [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It should be noted that response to hormonal manipulation is not universal; in one retrospective series of 275 patients, progesterone did not slow the decline in forced expiratory volume in one second (FEV1) or diffusing capacity (DLCO) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/86\">",
"     86",
"    </a>",
"    ]. In another study of 57 patients who received hormonal therapy, only 4 manifested an improvement in FEV1 of greater than 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our experience, oophorectomy or treatment with progestins has been of limited or no benefit. Patients with documented declines in lung function may be given a trial of progestin therapies (oral or intramuscular) or gonadotropin releasing hormone (GnRH) agonists (eg, Lupron) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, women with LAM appear to have a high incidence of meningiomas, regardless of associated tuberous sclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5142?source=see_link\">",
"     \"Pulmonary involvement in tuberous sclerosis complex\"",
"    </a>",
"    .) Furthermore, progesterone may have a mitogenic effect in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/87\">",
"     87",
"    </a>",
"    ]. In one report, eight of 250 women with sporadic LAM who underwent routine cranial imaging had meningiomas; five had received prior progestin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/75\">",
"     75",
"    </a>",
"    ]. The authors recommended that progestins not be administered if women with LAM have an MRI that is consistent with meningioma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sirolimus",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, patients with LAM typically have somatic gene mutations in the hamartin or tuberin genes, known as the hamartin-tuberin complex. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Genetic associations'",
"    </a>",
"    above.) The gene product of the hamartin-tuberin complex regulates the activity of rapamycin complex 1, which plays a role in cell growth and proliferation (",
"    <a class=\"graphic graphic_figure graphicRef58634 \" href=\"UTD.htm?38/36/39494\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/88\">",
"     88",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     Sirolimus",
"    </a>",
"    inactivates the rapamycin complex 1 and, thus, may have an ameliorative effect in LAM. &nbsp;",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     Sirolimus",
"    </a>",
"    , an inhibitor of the mammalian target of rapamycin (mTOR) appears to be an active agent for LAM and other PEComas [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/88-91\">",
"     88-91",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/11/41146?source=see_link&amp;anchor=H5#H5\">",
"     \"Systemic treatment of metastatic soft tissue sarcoma\", section on 'Histologic subtype and response to chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    on lung function was compared with placebo in a randomized trial of 89 patients with moderate lung impairment due to LAM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/89\">",
"     89",
"    </a>",
"    ]. The initial dose of sirolimus was 2 mg per day, and the dose was adjusted to maintain a trough level between 5 and 15 mg per mL. After 12 months, the forced vital capacity in one second had not declined in the sirolimus group, but had declined in the placebo group; improvements in forced vital capacity, functional residual capacity, quality of life, and functional performance were also noted in the sirolimus group compared with placebo. However diffusing capacity for carbon monoxide (DLCO) and six minute walk did not improve. Adverse effects (eg, mucositis, diarrhea, nausea, hypercholesterolemia, acneiform rash, peripheral edema) were more common in the sirolimus group, but serious adverse effects were not increased. Subjects were followed off sirolimus for an additional 12 months, during which time pulmonary function declined at the same rate as in the placebo group.",
"   </p>",
"   <p>",
"    In a case series, 19 patients with LAM received off-label",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    1 to 5 mg per day to achieve a serum level of 5 to 15",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    for up to 5.4 years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/90\">",
"     90",
"    </a>",
"    ]. Among the 11 patients with effusions, 10 experienced resolution of their effusion(s) and one had a decrease in the size. Among those with decreasing forced vital capacity, forced expiratory volume in one second, or diffusion capacity in the two years prior to initial of sirolimus, stabilization or improvement in these parameters occurred in the approximately 2.6 years on sirolimus. Adverse effects were similar to those noted above.",
"   </p>",
"   <p>",
"    However, as LAM typically progresses slowly and as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    therapy has substantial long-term side effects, additional trials are needed to assess the optimal dose and timing of therapy and also which patients are most likely to benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Lung transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several series have reported results of lung transplantation for LAM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/92-96\">",
"     92-96",
"    </a>",
"    ]. In the largest series (45 bilateral, 34 single), 30 day mortality was 5 percent, and the actuarial survival was 86 percent at one year, 76 percent at three years, and 65 percent at five years [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/94\">",
"     94",
"    </a>",
"    ]. Lung function and quality of life after transplant are improved compared with patients with advanced LAM [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/95\">",
"     95",
"    </a>",
"    ]. The main causes of death after transplant are primary graft dysfunction (early), and infection and bronchiolitis obliterans (late). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36057?source=see_link\">",
"     \"Primary lung graft dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=see_link\">",
"     \"Lung transplantation: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the overall benefit, there was a relatively high frequency of disease-related complications [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/92\">",
"     92",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extensive pleural adhesions were present in 18 patients, leading to moderate to severe intraoperative hemorrhage in four.",
"     </li>",
"     <li>",
"      Pneumothorax in the native lung occurred in 6 of the 27 patients who received a single lung transplant.",
"     </li>",
"     <li>",
"      Postoperative chylothorax occurred in 3 patients.",
"     </li>",
"     <li>",
"      Recurrent LAM in the allograft occurred in one patient; this complication has also been noted in other reports [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/97,98\">",
"       97,98",
"      </a>",
"      ]. Recurrent LAM in the transplanted lung demonstrates cellular aggregates derived from recipient cells, suggesting hematogenous migration of LAM cells as a mechanism of recurrent disease [",
"      <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/98\">",
"       98",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, patient survival after lung transplantation for pulmonary LAM is similar to that for other diseases such as pulmonary fibrosis and emphysema. However, the course is complicated by problems related to the underlying disease [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/92,97,99\">",
"     92,97,99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether or not to become pregnant is a difficult question to answer for patients with LAM. We have cautioned patients to avoid pregnancy because of the impression that the disease progresses during pregnancy and because patients with LAM often suffer progressive declines and early death, thereby leaving the child without its mother [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/100,101\">",
"     100,101",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Air travel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with LAM, the risk of spontaneous pneumothorax during air travel is low, based on data from two series. In one series, 299 patients traveled 816 times by air with a risk of a new pneumothorax of 3 percent, compared to less than 2 percent for those who traveled by land [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/102\">",
"     102",
"    </a>",
"    ]. In a separate report, 448 patients with LAM noted problems with air travel, including 10 (2 percent) who suffered a pneumothorax in flight [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It remains unclear what advice should be offered to women who plan to travel by commercial airlines. We believe the risk is probably small but that air travel should be avoided by women who have (a), new or worsening respiratory symptoms (breathlessness or chest pain); (b) a history of a pneumothorax or hemoptysis; or (c) evidence of extensive subpleural bullous or cystic changes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/10/28840?source=see_link&amp;anchor=H15#H15\">",
"     \"Traveling with oxygen aboard commercial air carriers\", section on 'Pulmonary lymphangioleiomyomatosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H522979756\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information about clinical trials for patients with LAM can be accessed at",
"    <a class=\"external\" href=\"file://clinicaltrials.gov/ct2/results?term=lymphangioleiomyomatosis\">",
"     file://clinicaltrials.gov/ct2/results?term=Lymphangioleiomyomatosis",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The LAM Foundation Clinical Research Network (LFCRN) has identified the following regional LAM Clinics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cleveland Clinic, Cleveland, OH",
"      <br/>",
"      Joseph Parambil, MD",
"      <br/>",
"      (216) 444-6503",
"     </li>",
"     <li>",
"      Mayo Clinic, Rochester, MN",
"      <br/>",
"      Jay Ryu, MD",
"      <br/>",
"      (507) 284-2447",
"     </li>",
"     <li>",
"      Medical University of South Carolina, Charleston, SC",
"      <br/>",
"      Charlie Strange, MD",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      Steve Sahn, MD",
"      <br/>",
"      (843) 792-3174",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      (843) 792-3161",
"     </li>",
"     <li>",
"      National Jewish Health, Denver, CO",
"      <br/>",
"      Gregory Downey, MD",
"      <br/>",
"      (303) 398-1436 x1881",
"     </li>",
"     <li>",
"      New York",
"      <span class=\"nowrap\">",
"       Presbyterian/Columbia,",
"      </span>",
"      New York, NY",
"      <br/>",
"      Jeanine D'Armiento, MD, PhD",
"      <br/>",
"      (212) 305-3745",
"     </li>",
"     <li>",
"      Stanford University Medical Center, Stanford, CA",
"      <br/>",
"      Stephen Ruoss, MD",
"      <br/>",
"      (650) 723-6381",
"     </li>",
"     <li>",
"      Tufts Medical Center, Boston, MA",
"      <br/>",
"      Geraldine Finlay, MD, Co-Director",
"      <br/>",
"      (617) 636-7751",
"     </li>",
"     <li>",
"      University of California, Los Angeles, CA",
"      <br/>",
"      Joseph Lynch, MD",
"      <br/>",
"      (310) 825-8599",
"     </li>",
"     <li>",
"      University of California, San Francisco, CA",
"      <br/>",
"      Harold Collard, MD",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      Talmadge King Jr., MD",
"      <br/>",
"      (415) 206-8314",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      (415) 476-0909",
"     </li>",
"     <li>",
"      University of Cincinnati Medical Center, Cincinnati, OH",
"      <br/>",
"      Francis McCormack, MD, Co-Director",
"      <br/>",
"      (513) 558-4831",
"     </li>",
"     <li>",
"      University of Michigan, Ann Arbor, MI",
"      <br/>",
"      MeiLan Han MD, Director",
"      <br/>",
"      (734) 998-5759",
"     </li>",
"     <li>",
"      University of Pennsylvania, Philadelphia, PA",
"      <br/>",
"      Robert Kotloff, MD",
"      <br/>",
"      (215) 349-5488",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional registries have been developed in other countries [",
"    <a class=\"abstract\" href=\"UTD.htm?4/30/4586/abstract/4\">",
"     4",
"    </a>",
"    ]. Further information is available from the LAM Foundation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The LAM Foundation",
"      <br/>",
"      4015 Executive Park Drive, Suite 320",
"      <br/>",
"      Cincinnati, OH 45241",
"      <br/>",
"      Phone: (513) 777-6889",
"      <br/>",
"      Fax: (513) 777-4109",
"      <br/>",
"      Email: apowers@thelamfoundation.org",
"      <br/>",
"      Website:",
"      <a class=\"external\" href=\"file://www.thelamfoundation.org/\">",
"       file://www.thelamfoundation.org",
"      </a>",
"     </li>",
"     <li>",
"      LAM Treatment Alliance",
"      <br/>",
"      64 Church Street, 2nd floor",
"      <br/>",
"      Cambridge, MA 02138",
"      <br/>",
"      Phone: (617) 460-7339",
"      <br/>",
"      Fax: (617) 864-0614",
"      <br/>",
"      Email: info@lamtreatmentalliance.org",
"     </li>",
"     <li>",
"      Tuberous Sclerosis Alliance",
"      <br/>",
"      801 Roeder Road, Suite 750",
"      <br/>",
"      Silver Spring, MD 20910",
"      <br/>",
"      Phone: (800) 225-6872 or (301) 562-9890",
"      <br/>",
"      Fax: (301) 562-9870",
"      <br/>",
"      Email: info@tsalliance.org",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7594517\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are two forms of LAM. Pulmonary lymphangioleiomyomatosis (LAM) is a rare lung disease characterized pathologically by cyst formation and multifocal, nodular proliferation of immature smooth muscle and perivascular epithelioid cells (LAM cells). The majority of affected patients are young women of childbearing age. A very similar disease process is seen in approximately 30 percent of women with tuberous sclerosis complex (TSC). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5142?source=see_link&amp;anchor=H2#H2\">",
"       \"Pulmonary involvement in tuberous sclerosis complex\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The pathogenesis of LAM is unknown, but may involve somatic mutations in one of the tuberous sclerosis genes, meaning that patients with LAM may have TSC-associated mutations in the lung (and sometimes the kidney) but not elsewhere. Another possibility is that estrogen supplementation participates in the development of clinically apparent LAM in genetically predisposed individuals. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link&amp;anchor=H2#H2\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\", section on 'Genetics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nearly all patients are symptomatic at presentation, and approximately 70 percent report dyspnea. (See",
"      <a class=\"local\" href=\"#H26516324\">",
"       'Symptoms and signs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Potential complications of LAM include pneumothorax, hemoptysis, chylothorax, chyloperitoneum, chylopericardium, and development of lymphangioleiomyomas of the lymph vessels. (See",
"      <a class=\"local\" href=\"#H7596701\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      High resolution computed tomography of the lung in LAM typically shows diffuse, homogeneous, small (less than one cm diameter) thin-walled cysts. Pleural nodules and complex masses may be seen in patients who have undergone prior thoracentesis, thoracoscopy, or pleurodesis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of pulmonary LAM may be strongly suggested by the clinical presentation and HRCT findings. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No therapy is of proven benefit in pulmonary LAM, although studies of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"       sirolimus",
"      </a>",
"      are promising. LAM management is aimed at easing symptoms and preventing complications. (See",
"      <a class=\"local\" href=\"#H7596707\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of progressive respiratory failure, patients with LAM may eventually require lung transplantation. Selection criteria and outcomes are similar to those for other chronic lung diseases. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Lung transplantation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/1\">",
"      Kalassian KG, Doyle R, Kao P, et al. Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997; 155:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/2\">",
"      Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest 1998; 114:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/3\">",
"      NHLBI Workshop Summary. Report of workshop on lymphangioleiomyomatosis. National Heart, Lung, and Blood Institute. Am J Respir Crit Care Med 1999; 159:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/4\">",
"      Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/5\">",
"      Corrin B, Liebow AA, Friedman PJ. Pulmonary lymphangiomyomatosis. A review. Am J Pathol 1975; 79:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/6\">",
"      Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990; 323:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/7\">",
"      Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/8\">",
"      Crausman RS, Jennings CA, Mortenson RL, et al. Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity. Am J Respir Crit Care Med 1996; 153:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/9\">",
"      Crausman RS, Lynch DA, Mortenson RL, et al. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis. Chest 1996; 109:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/10\">",
"      Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies \"Orphelines\" Pulmonaires (GERM\"O\"P). Medicine (Baltimore) 1999; 78:321.",
"     </a>",
"    </li>",
"    <li>",
"     Folpe AL. Neoplasms with perivascular epithelioid cell differentiation (PEComas). In: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni K, Mertens F.  (Eds), IARC Press, Lyon 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/12\">",
"      Berger JL, Shaff MI. Pulmonary lymphangioleiomyomatosis. J Comput Assist Tomogr 1981; 5:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/13\">",
"      Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000; 75:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/14\">",
"      Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001; 164:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/15\">",
"      McCormack F, Brody A, Meyer C, et al. Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis. Chest 2002; 121:61S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/16\">",
"      Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med 2002; 96:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/17\">",
"      Aubry MC, Myers JL, Ryu JH, et al. Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med 2000; 162:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/18\">",
"      Miyake M, Tateishi U, Maeda T, et al. Pulmonary lymphangioleiomyomatosis in a male patient with tuberous sclerosis complex. Radiat Med 2005; 23:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/19\">",
"      Kim NR, Chung MP, Park CK, et al. Pulmonary lymphangioleiomyomatosis and multiple hepatic angiomyolipomas in a man. Pathol Int 2003; 53:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/20\">",
"      Schiavina M, Di Scioscio V, Contini P, et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 2007; 176:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/21\">",
"      McCormack FX, Travis WD, Colby TV, et al. Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. Am J Respir Crit Care Med 2012; 186:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/22\">",
"      Martignoni G, Pea M, Reghellin D, et al. Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors. Arch Pathol Lab Med 2010; 134:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/23\">",
"      Torres VE, Bj&ouml;rnsson J, King BF, et al. Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clin Proc 1995; 70:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/24\">",
"      Woodring JH, Howard RS 2nd, Johnson MV. Massive low-attenuation mediastinal, retroperitoneal, and pelvic lymphadenopathy on CT from lymphangioleiomyomatosis. Case report. Clin Imaging 1994; 18:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/25\">",
"      McIntosh GS, Dutoit SH, Chronos NV, Kaisary AV. Multiple unilateral renal angiomyolipomas with regional lymphangioleiomyomatosis. J Urol 1989; 142:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/26\">",
"      Wagner SN, Wagner C, H&ouml;fler H, et al. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA. Lab Invest 1995; 73:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/27\">",
"      Castro M, Shepherd CW, Gomez MR, et al. Pulmonary tuberous sclerosis. Chest 1995; 107:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/28\">",
"      Bonetti F, Chiodera P. Lymphangioleiomyomatosis and tuberous sclerosis: where is the border? Eur Respir J 1996; 9:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/29\">",
"      Smolarek TA, Wessner LL, McCormack FX, et al. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 1998; 62:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/30\">",
"      Green AJ, Smith M, Yates JR. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994; 6:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/31\">",
"      Goncharova EA, Goncharov DA, Lim PN, et al. Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 2006; 34:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/32\">",
"      Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 2000; 97:6085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/33\">",
"      Astrinidis A, Khare L, Carsillo T, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet 2000; 37:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/34\">",
"      Tietze L, G&uuml;nther K, H&ouml;rbe A, et al. Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease. Hum Pathol 2000; 31:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/35\">",
"      Ito M, Sugamura Y, Ikari H, Sekine I. Angiomyolipoma of the lung. Arch Pathol Lab Med 1998; 122:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/36\">",
"      Abramson S, Gilkeson RC, Goldstein JD, et al. Benign metastasizing leiomyoma: clinical, imaging, and pathologic correlation. AJR Am J Roentgenol 2001; 176:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/37\">",
"      Cai X, Pacheco-Rodriguez G, Fan QY, et al. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. Am J Respir Crit Care Med 2010; 182:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/38\">",
"      Berger U, Khaghani A, Pomerance A, et al. Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study. Am J Clin Pathol 1990; 93:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/39\">",
"      Ohori NP, Yousem SA, Sonmez-Alpan E, Colby TV. Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung. Am J Clin Pathol 1991; 96:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/40\">",
"      Matsui K, Takeda K, Yu ZX, et al. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med 2000; 161:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/41\">",
"      Yu JJ, Robb VA, Morrison TA, et al. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci U S A 2009; 106:2635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/42\">",
"      Fukuda Y, Kawamoto M, Yamamoto A, et al. Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis. Hum Pathol 1990; 21:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/43\">",
"      Sobonya RE, Quan SF, Fleishman JS. Pulmonary lymphangioleiomyomatosis: quantitative analysis of lesions producing airflow limitation. Hum Pathol 1985; 16:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/44\">",
"      Ryu JH, Moss J, Beck GJ, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006; 173:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/45\">",
"      Silverstein EF, Ellis K, Wolff M, Jaretzki A 3rd. Pulmonary lymphangiomyomatosis. Am J Roentgenol Radium Ther Nucl Med 1974; 120:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/46\">",
"      Sinclair W, Wright JL, Churg A. Lymphangioleiomyomatosis presenting in a postmenopausal woman. Thorax 1985; 40:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/47\">",
"      Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/48\">",
"      Baldi S, Papotti M, Valente ML, et al. Pulmonary lymphangioleiomyomatosis in postmenopausal women: report of two cases and review of the literature. Eur Respir J 1994; 7:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/49\">",
"      Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/50\">",
"      Bosniak MA, Megibow AJ, Hulnick DH, et al. CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol 1988; 151:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/51\">",
"      Burger CD, Hyatt RE, Staats BA. Pulmonary mechanics in lymphangioleiomyomatosis. Am Rev Respir Dis 1991; 143:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/52\">",
"      Baldi BG, Albuquerque AL, Pimenta SP, et al. Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2012; 186:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/53\">",
"      Taveira-DaSilva AM, Steagall WK, Rabel A, et al. Reversible airflow obstruction in lymphangioleiomyomatosis. Chest 2009; 136:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/54\">",
"      Berger JL. X-ray of the month. Pulmonary lymphangioleiomyomatosis. J Tenn Med Assoc 1980; 73:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/55\">",
"      Lenoir S, Grenier P, Brauner MW, et al. Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings. Radiology 1990; 175:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/56\">",
"      M&uuml;ller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/57\">",
"      Hagaman JT, Schauer DP, McCormack FX, Kinder BW. Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effective. Am J Respir Crit Care Med 2010; 181:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/58\">",
"      Rappaport DC, Weisbrod GL, Herman SJ, Chamberlain DW. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases. AJR Am J Roentgenol 1989; 152:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/59\">",
"      Templeton PA, McLoud TC, M&uuml;ller NL, et al. Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr 1989; 13:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/60\">",
"      Avila NA, Dwyer AJ, Moss J. Imaging features of lymphangioleiomyomatosis: diagnostic pitfalls. AJR Am J Roentgenol 2011; 196:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/61\">",
"      Avila NA, Dwyer AJ, Rabel A, et al. CT of pleural abnormalities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. AJR Am J Roentgenol 2006; 186:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/62\">",
"      Narayanaswamy S, Kamath S, Williams M. CT appearances of talc pleurodesis. Clin Radiol 2007; 62:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/63\">",
"      Johnson SR, Cordier JF, Lazor R, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 2010; 35:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/64\">",
"      Matthews TJ, Hornall D, Sheppard MN. Comparison of the use of antibodies to alpha smooth muscle actin and desmin in pulmonary lymphangioleiomyomatosis. J Clin Pathol 1993; 46:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/65\">",
"      Chan JK, Tsang WY, Pau MY, et al. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology 1993; 22:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/66\">",
"      Bonetti F, Chiodera PL, Pea M, et al. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 1993; 17:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/67\">",
"      Hoon V, Thung SN, Kaneko M, Unger PD. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med 1994; 118:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/68\">",
"      Guinee DG Jr, Feuerstein I, Koss MN, Travis WD. Pulmonary lymphangioleiomyomatosis. Diagnosis based on results of transbronchial biopsy and immunohistochemical studies and correlation with high-resolution computed tomography findings. Arch Pathol Lab Med 1994; 118:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/69\">",
"      Berkman N, Bloom A, Cohen P, et al. Bilateral spontaneous pneumothorax as the presenting feature in lymphangioleiomyomatosis. Respir Med 1995; 89:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/70\">",
"      Ryu JH, Doerr CH, Fisher SD, et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/71\">",
"      Valentine VG, Raffin TA. The management of chylothorax. Chest 1992; 102:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/72\">",
"      Avila NA, Bechtle J, Dwyer AJ, et al. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology 2001; 221:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/73\">",
"      Bernstein SM, Newell JD Jr, Adamczyk D, et al. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med 1995; 152:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/74\">",
"      Taveira-DaSilva AM, Hathaway OM, Sachdev V, et al. Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study. Chest 2007; 132:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/75\">",
"      Moss J, DeCastro R, Patronas NJ, Taveira-DaSilva A. Meningiomas in lymphangioleiomyomatosis. JAMA 2001; 286:1879.",
"     </a>",
"    </li>",
"    <li>",
"     Folpe AL. Neoplasms with perivascular epithelioid cell differentiation (PEComas). In: Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK, Mertens F..  (Eds), IARC Press, Lyon 2002. p.221.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/77\">",
"      Shen A, Iseman MD, Waldron JA, King TE. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 1987; 91:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/78\">",
"      Sawicka EH, Morris AJ. A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy. Br J Dis Chest 1985; 79:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/79\">",
"      McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest 2008; 133:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/80\">",
"      Klein M, Krieger O, Ruckser R, et al. Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report. Arch Gynecol Obstet 1992; 252:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/81\">",
"      Rossi GA, Balbi B, Oddera S, et al. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis. Am Rev Respir Dis 1991; 143:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/82\">",
"      Eliasson AH, Phillips YY, Tenholder MF. Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 1989; 96:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/83\">",
"      Urban T, Kuttenn F, Gompel A, et al. Pulmonary lymphangiomyomatosis. Follow-up and long-term outcome with antiestrogen therapy; a report of eight cases. Chest 1992; 102:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/84\">",
"      Banner AS, Carrington CB, Emory WB, et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 1981; 305:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/85\">",
"      Schiavina M, Contini P, Fabiani A, et al. Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients. Sarcoidosis Vasc Diffuse Lung Dis 2007; 24:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/86\">",
"      Taveira-DaSilva AM, Stylianou MP, Hedin CJ, et al. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 2004; 126:1867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/87\">",
"      Blankenstein MA, Verheijen FM, Jacobs JM, et al. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000; 65:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/88\">",
"      Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/89\">",
"      McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011; 364:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/90\">",
"      Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med 2011; 154:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/91\">",
"      Moua T, Olson EJ, St Jean HC, Ryu JH. Resolution of Chylous Pulmonary Congestion and Respiratory Failure in LAM with Sirolimus Therapy. Am J Respir Crit Care Med 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/92\">",
"      Boehler A, Speich R, Russi EW, Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996; 335:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/93\">",
"      Kpodonu J, Massad MG, Chaer RA, et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant 2005; 24:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/94\">",
"      Pechet TT, Meyers BF, Guthrie TJ, et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004; 23:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/95\">",
"      Maurer JR, Ryu J, Beck G, et al. Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry. J Heart Lung Transplant 2007; 26:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/96\">",
"      Benden C, Rea F, Behr J, et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 2009; 28:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/97\">",
"      Nine JS, Yousem SA, Paradis IL, et al. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 1994; 13:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/98\">",
"      Karbowniczek M, Astrinidis A, Balsara BR, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 2003; 167:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/99\">",
"      Collins J, M&uuml;ller NL, Kazerooni EA, et al. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. Radiology 1999; 210:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/100\">",
"      Warren SE, Lee D, Martin V, Messink W. Pulmonary lymphangiomyomatosis causing bilateral pneumothorax during pregnancy. Ann Thorac Surg 1993; 55:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/101\">",
"      Brunelli A, Catalini G, Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int J Gynaecol Obstet 1996; 52:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/102\">",
"      Taveira-DaSilva AM, Burstein D, Hathaway OM, et al. Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis. Chest 2009; 136:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?4/30/4586/abstract/103\">",
"      Pollock-BarZiv S, Cohen MM, Downey GP, et al. Air travel in women with lymphangioleiomyomatosis. Thorax 2007; 62:176.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4335 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-B6AD6E7C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4586=[""].join("\n");
var outline_f4_30_4586=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7594517\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7596684\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetic associations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Role of estrogen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mechanism of cyst formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7596689\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26516324\">",
"      SYMPTOMS AND SIGNS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H98315087\">",
"      PULMONARY FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H98315093\">",
"      IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7596701\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7596707\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hormonal manipulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sirolimus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Air travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H522979756\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7594517\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4335\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4335|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/36/16960\" title=\"diagnostic image 1A\">",
"      Pulmonary LAM PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/48/28421\" title=\"diagnostic image 1B\">",
"      Lymphangioleiomyomatosis PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/40/1666\" title=\"diagnostic image 2A\">",
"      Lymphangioleiomyomatosis CT I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/7/20593\" title=\"diagnostic image 2B\">",
"      Lymphangioleiomyomatosis CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/47/24319\" title=\"diagnostic image 2C\">",
"      Lymphangioleiomyomatosis CT II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/57/35743\" title=\"diagnostic image 3A\">",
"      Renal angiomyolipoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/27/17855\" title=\"diagnostic image 3B\">",
"      Angiomyolipoma renal bleed CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4335|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/43/14014\" title=\"figure 1\">",
"      Survival in pulmonary LAM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/36/39494\" title=\"figure 2\">",
"      Hamartin tuberin complex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4335|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/37/13919\" title=\"picture 1A\">",
"      Pulmonary LAM microscopy Low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/54/4961\" title=\"picture 1B\">",
"      Pulmonary LAM microscopy High",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/22/21870\" title=\"picture 2A\">",
"      Pulmonary LAM lung biopsy Low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/5/2129\" title=\"picture 2B\">",
"      Pulmonary LAM lung biopsy High",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/33/37396\" title=\"picture 2C\">",
"      Cysts in LAM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/34/29219\" title=\"picture 3\">",
"      LAM in tuberous sclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/40/44687\" title=\"picture 4\">",
"      Pulmonary LAM HMB 45",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=related_link\">",
"      Etiology, clinical presentation, and diagnosis of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=related_link\">",
"      Hereditary kidney cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3480?source=related_link\">",
"      Lung transplantation: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25540?source=related_link\">",
"      Meningioma: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38439?source=related_link\">",
"      Overview of pulmonary disease in injection drug users",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/13/36057?source=related_link\">",
"      Primary lung graft dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=related_link\">",
"      Pulmonary Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5142?source=related_link\">",
"      Pulmonary involvement in tuberous sclerosis complex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43303?source=related_link\">",
"      Renal manifestations of tuberous sclerosis and renal angiomyolipoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/11/41146?source=related_link\">",
"      Systemic treatment of metastatic soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/10/28840?source=related_link\">",
"      Traveling with oxygen aboard commercial air carriers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f4_30_4587="Cancer pain interventions";
var content_f4_30_4587=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common interventional therapies for cancer pain management",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Celiac plexus/splanchnic nerve blocks for abdominal pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypogastric plexus/ganglion impar block for pelvic pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intercostal blocks for fractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kyphoplasty and vertebroplasty for vertebral compression fractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lumbar sympathetic block for rectal tenesmus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myofascial injections for muscle spasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuraxial infusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Suprascapular block for shoulder pain",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4587=[""].join("\n");
var outline_f4_30_4587=null;
var title_f4_30_4588="ESC risk strat catechol poly VT";
var content_f4_30_4588=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    European Society of Cardiology recommendations for risk stratification for sudden cardiac death: catecholaminergic polymorphic ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Documented ventricular fibrillation",
"       </td>",
"       <td>",
"        Class I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history of sudden cardiac death",
"       </td>",
"       <td>",
"        Class IIa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early onset of symptoms (pediatric age)",
"       </td>",
"       <td>",
"        Class IIa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Syncope",
"       </td>",
"       <td>",
"        Class IIb",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\" rowspan=\"1\">",
"        Classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class I:",
"        </strong>",
"        Conditions for which there is evidence and/or",
"general agreement that a given procedure or treatment is",
"useful and effective.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class II:",
"        </strong>",
"        Conditions for which there is conflicting",
"evidence and/or a divergence of opinion about the",
"usefulness/efficacy of a procedure or treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class IIa:",
"        </strong>",
"        Weight of evidence/opinion is in favor of",
"usefulness/efficacy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class",
"IIb:",
"        </strong>",
"        Usefulness/efficacy less well established",
"by evidence/opinion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Class",
"III:",
"        </strong>",
"        Conditions for which there is evidence and/or",
"general agreement that the procedure/treatment is not useful and in",
"some cases may be harmful.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Priori, SG, Aliot, E, Blomstrom-Lundqvist, C, et al, Eur Heart J 2001; 22:1374.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4588=[""].join("\n");
var outline_f4_30_4588=null;
var title_f4_30_4589="B cell surface markers II";
var content_f4_30_4589=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F57546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F57546&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Surface markers during B cell development-II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"5\" rowspan=\"1\">",
"        Antigen-independent phase",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Antigen-dependent phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Pre-pro B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Pro-B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Pre B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Immature B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Mature B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Activated B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Blast B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Memory B cell",
"       </td>",
"       <td class=\"subtitle2\">",
"        Plasma B cell",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD121, IL-1R",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD122, IL-2R beta",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD123, IL-3R alpha",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD124, IL-4R alpha",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD125, IL-5R alpha",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD126, IL-6R alpha",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD127, IL-7R alpha",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IL: interleukin; R: receptor; alpha: alpha chain.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Bona, CA, Bonilla, FA, Textbook of Immunology, 2nd edition, Harwood Academic Publishers, Amsterdam, 1996. page 102",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4589=[""].join("\n");
var outline_f4_30_4589=null;
var title_f4_30_4590="Mgmt electrolyte abn TLS";
var content_f4_30_4590=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F70281&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F70281&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Management of electrolyte abnormalities in tumor lysis syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Abnormality",
"      </td>",
"      <td class=\"subtitle1\">",
"       Management recommendation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Hyperphosphatemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"7\">",
"       Moderate, &ge;2.1 mmol/L (6.5 mg/dL)",
"      </td>",
"      <td>",
"       Restrict phosphate intake (avoid IV and oral phosphate; limit dietary sources)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Phosphate binders:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Calcium acetate",
"       </strong>",
"       * Adult: 2 to 3 tabs (1334 to 2668 mg) with each meal; or",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Calcium carbonate",
"       </strong>",
"       * Adult: 1 to 2 grams with each meal; Pediatric: 30 to 40 mg/kg with each meal; or",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Sevelamer",
"       </strong>",
"       &bull; Adult: 800 to 1600 mg with each meal; Pediatric: 40 to 54 mg/kg with each meal; or",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Lanthanum carbonate",
"       </strong>",
"       Adult: 500 to 1000 mg with each meal&Delta;; or",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Aluminum hydroxide",
"       </strong>",
"       Adult: 300 to 600 mg with each meal; Pediatric: 12.5 to 37.5 mg/kg four times daily with meals; (avoid use in patients with renal insufficiency)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Severe",
"      </td>",
"      <td>",
"       Dialysis, CAVH, CVVH, CAVHD, or CVVHD",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\" colspan=\"2\">",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Hypocalcemia, total serum calcium &le;1.75 mmol/L (7 mg/dL) or ionized calcium &le;0.8 mmol/L (3.2 mg/dL)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Asymptomatic",
"      </td>",
"      <td>",
"       No therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Symptomatic",
"      </td>",
"      <td class=\"sublist1_start\">",
"       Calcium gluconate administered slowly with ECG monitoring; patients with acute hypocalcemia and hyperphosphatemia should not be treated with calcium until the hyperphosphatemia is corrected (unless they have tetany or a cardiac arrhythmia from hypocalcemia)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Calcium gluconate",
"       </strong>",
"       &loz; Adult: 1 gram (10 mL of 10 percent solution); Pediatric: 50 to 100 mg/kg. Slow IV infusion (maximum 50 to 100 mg per minute) in large vein. May be repeated after 5 to 10 minutes if symptoms or ECG changes persist.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\" colspan=\"2\">",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Hyperkalemia&sect;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"3\">",
"       Moderate and asymptomatic, &ge;6.0 mmol/L",
"      </td>",
"      <td>",
"       Avoid IV and oral potassium",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       ECG and cardiac rhythm monitoring",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Sodium polystyrene sulfonate",
"       </strong>",
"       &yen; Adult: 15 to 30 grams orally; Pediatric: 1 gram/kg orally. Onset 1 to 2 hours. Repeat every 4 to 6 hours up to four times daily as needed based on repeat serum K+ level.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"12\">",
"       Severe (&gt;7.0 mmol/L) and/or symptomatic",
"      </td>",
"      <td>",
"       <strong>",
"        Same as above, plus:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       To stabilize cardiac membranes:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       For patients with ECG changes (widening of the QRS complex or loss of p-waves but not peaked t-waves alone),",
"       <em>",
"        give calcium gluconate by slow IV infusion",
"       </em>",
"       to prevent life-threatening arrhythmias:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       <strong>",
"        Calcium gluconate",
"       </strong>",
"       Adult: 1 gram (10 mL of 10 percent solution); Pediatric: 50 to 100 mg/kg. Slow IV infusion (maximum 50 to 100 mg per minute) in large vein. May be repeated after 5 to 10 minutes if ECG changes persist.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       To temporarily shift potassium into cells:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Give IV insulin and dextrose:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       <strong>",
"        IV insulin and dextrose",
"       </strong>",
"       Adult: regular insulin (10 units) IV plus 100 mL of a 50 percent dextrose solution (D50) IV; Pediatric: regular insulin (0.1 unit/kg) IV, plus 25 percent dextrose solution (D25) 0.5 gram/kg (2 mL/kg of D25) IV over thirty minutes. May be repeated after thirty to sixty minutes. Monitor fingerstick glucose closely.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Sodium bicarbonate can be given to induce influx of potassium into cells if patient is acidemic. Sodium bicarbonate and calcium solutions should not be administered through the same line due to incompatibility.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       <strong>",
"        Sodium bicarbonate",
"       </strong>",
"       Adult: 45 to 50 mEq; Pediatric: 1 to 2 mEq/kg. Slow IV infusion over five to ten minutes.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Beta 2 agonist inhalation: Albuterol per nebulisation or metered dose inhaler",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       <strong>",
"        Albuterol",
"       </strong>",
"       Adult: 10 to 20 mg in 4 mL saline nebuilzed over 20 minutes or 10 to 20 puffs per metered dose inhaler over 10 to 20 minutes; Pediatric: 0.1 to 0.3 mg/kg per nebulisation.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dialysis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\" colspan=\"2\">",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Uremia (renal dysfunction)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"5\">",
"       &nbsp;",
"      </td>",
"      <td>",
"       Fluid and electrolyte management",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Uric acid and phosphate management",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Adjust renally excreted drug doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dialysis (hemo- or peritoneal)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hemofiltration (CAVH, CVVH, CAVHD, or CVVHD)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Pediatric dose should not exceed usual adult dose.",
"    <div class=\"footnotes\">",
"     IV: intravenous; CAVH: continuous arterial-venous hemodialysis; CVVH: continuous veno-venous hemofiltration; CAVHD: continuous arterial-venous hemodialysis; CVVHD: continuous veno-venous hemodialysis.",
"     <br>",
"      * Calcium-containing binders are generally preferred in presence of hypocalcemia; avoid if hypercalcemic.",
"      <br>",
"       &bull; Preferred binder in presence of hypercalcemia.",
"       <br>",
"        &Delta; A pediatric dose of lathanum carbonate 7 mg/kg with each meal has been suggested based on limited experience. US FDA product information states pediatric use is not recommended.",
"        <br>",
"         &loz; 10% calcium gluconate (90 mg elemental calcium/10 mL) or 10% calcium chloride (270 mg elemental calcium/10 mL) can be used. Calcium gluconate is usually preferred because it is less likely to cause tissue necrosis if extravasated. For additional information see \"Treatment of hypocalcemia\".",
"         <br>",
"          &sect; For additional information, see \"Clinical manifestations and treatment of hyperkalemia\".",
"          <br>",
"           &yen; Patients receiving sodium polystyrene sulfonate should be monitored for the development of hypocalcemia and hypomagnesemia.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Coiffier B, Altman A, Pui CH, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26:2767.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4590=[""].join("\n");
var outline_f4_30_4590=null;
var title_f4_30_4591="Voiding diary";
var content_f4_30_4591=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Voiding diary",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 760px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <ul>",
"     <li>",
"      This diary will help us determine why you have trouble holding your urine, or why you go to the bathroom very often",
"     </li>",
"     <li>",
"      <strong>",
"       Keep this record for at least 2 days.",
"      </strong>",
"     </li>",
"     <li>",
"      Please write down 4 things every time you pass or leak urine:",
"     </li>",
"     <ol>",
"      <li>",
"       The time (for example, \"10:30 AM\")",
"      </li>",
"      <li>",
"       The amount of urine that you pass",
"      </li>",
"      <li>",
"       Whether you leaked any urine (were \"wet\") or not (were \"dry\")",
"      </li>",
"      <li>",
"       Whether anything special may have caused you to go (for instance, \"just had coffee,\" \"coughed,\" \"was running to the bathroom,\" \"just took my water pill\")",
"      </li>",
"     </ol>",
"     <li>",
"      Start the record in the morning the first time you go to the bathroom after you get up.",
"      <strong>",
"       Please&nbsp;write on the form the time you got up and the time you went to bed.",
"      </strong>",
"     </li>",
"     <li>",
"      To measure the amount of urine you pass, we will give you a special receptacle (called a \"hat\"). Place the hat in the toilet to catch the urine every time you go. Look at how high the urine fills the hat, and write down the amount from the numbers on the inside of the hat. Remember to empty the hat after each time you go.",
"     </li>",
"     <li>",
"      If you leak urine and cannot measure the amount that came out, write down your best guess.",
"     </li>",
"    </ul>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f4_30_4591=[""].join("\n");
var outline_f4_30_4591=null;
